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Abstract 
Chemical synthesis of oligonucleotides by solid supported methods has been dominated bythe 
use of triarylmethyl ether protecting groups at the 5'-hydroxyl site of the deoxyribose moiety. 
These groups, eg. 4,4'-dimethoxytrityl, are cleaved with acids. Here I describe studies in the 
application of the base labile 9-fluorenylmethoxycarbonyl group to the protection of the 5'-
hydroxyl in deoxyoligonucleotide synthesis and in oligoribonucleotide synthesis. 
Comercially available long chain alkylamine controlled pore glass resin was found to be 
unstable to the strong non-nucleophilic bases used to cleave the 9-fluorenylmethoxcarbonyl 
protecting group. After a model study to elucidate the mechanism of the cleavage reaction, a long 
chain alkylamine controlled pore glass resin, with a sarcosyl spacer group between the alkyl chain 
and the succinyl link to the first nucleoside, was synthesised. This sarcosyl resin was found to be 
stable to bases such as DBU and DBN. 
Solid supported synthesis of chemically labelled oligonucleotides was also investigated. A 
monomer for oligonucleotide synthesis, which carried a 2,4-dinitrophenyl group for use as a 
fluorescent and immunogenic label, was designed and synthesised. This monomer was used to 
label deoxyoligonucleotides for use in hybridisation studies and polymerase chain reaction. 
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The primary chemical structure of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in 
single stranded form (Fig.1)consists of a chain of furanose rings linked by 3'-5' phosphodiesters, 
with each sugar carrying one of four possible heterocyclic bases in a beta configuration at the 1'-
sugar site. For DNAthe sugar ring is D-deoxyribose and the bases are adenine, guanine, cytosine 
and thymine. In the case of ribonucleic acid the sugar ring is D-ribose and the 4 bases adenine 
guanine, cytosine and uracil (Fig.2). 
The sequence of bases along the the chain is vital to successful protein synthesis. DNA in the 
cell nucleus acts as a template in the synthesis of messenger-RNA(m-RNA) of complementary 
sequence and this sequence in its mature form codes for amino-acids at the ribosome where 
proteins are synthesised. The sequence of the RNA is read as a triplet code, each amino-acid 
having a different 3-base code to describe it. Transfer-RNA (t-RNA) transfers the code between 
RNA and proteins. Each t-RNA carries an amino-acid and a recognition site with the appropriate 
triplet code for that amino-acid. By hybridising to the m-RNA at the ribosome the correct amino-
acid is delivered to the correct place in the growing protein. 
Chemical synthesis allows oligonucleotides of specific sequence to be prepared for a wide 
variety of applications. For molecular biology hybridisation probes, primers and entire genes can 
be prepared. Recent discoveries in structure and properties of RNA' have led to much interest 
in the synthesis of oligoribonucleotides. In chemical synthesis2, nucleotide monomers are suc-
cessively added to an oligonucleotide chain until the sequence is complete. The formation of the 
internucleotide link must be directed exclusively between the 3' and 5-hydroxyl functions and this 
is achieved by protection of all other nucleophilic moieties. Thus in a synthesis, working in the 
normal way from 3' to Send of the oligonucleotide, the initial monomer would be a 3-protected 
nucleoside which could the be coupled with a 5-protected nucleotide (Scheme 1). For addition 
of the next nucleotide, the 5-protecting group must be cleaved off. When the sequence is 
complete permanent protecting groups on exocyclic amine functions can be cleaved along with 
the 3'-protecting group and any phosphorus protecting groups, to leave the free oligonucleotide. 
The concept of solid supported synthesis of polymers was introduced by Merri Iield3and initially 
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(Figure 2. Bases and sugars in Oligonucleotides) 
applied to peptide synthesis. In solid supported oligonucleotide synthesis the protecting group on 
the terminal 3'-nucleoside is replaced by a linker to a solid insoluble particle. Each reaction 
performed on the oligonucleotide is then pushed to completion with excess reagents which can 
then be washed away and the synthesis completed without the need for intermediate purification 
steps. Solid phase synthesis is therefore much quicker than solution synthesis for small scale 
work. A 20mer can easily be synthesised by solid phase methods in a single day whereas a 
synthesis in solution would require months to complete. Because the procedure amounts to a 
series of soaking and washing steps at room temperature, solid phase synthesis has been 
successfully automated. 
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1.2 The Solid Support 
Solid phase synthesis, first introduced by Men ifield for peptides3, was initially applied to 
oligonucleotide synthesis in 1965 using low crosslinking "popcorn" polymer and phosphotriester 
chemistry to produce the dimer d(CpG).4 
Early attempts at solid phase oligonucleotide synthesis involved organic polymers as solid 
supports. However these compounds swell to varying degrees indifferent solvents, interact with 
solvents and in most cases are strongly hydrophobic. In addition they tend to adsorb the growing 
oligonucleotide chain onto their surface making it less accessible to synthetic procedures2. 
More inert matrices were developed in the shape of polydimethyla,.amide-kieselgel, a kieselgel 
framework with polydimethylacrylamide trapped in its pores. This support, used in phosphot-
nester synthesis, is capable of high loading ( up to 200micromol/g) and has good wetting 
properties ensuring the growing oligonucleotide contacts all synthesis reagents. However it is still 
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Figure 3.) 
Completely rigid inert inorganic supports have also been developed and are now commonly used. 
The nonswellable nature of these matrices allow solvents and reagents to be pumped through 
during automated synthesis. Alkyl functionalised silica gel such as fractosil5, the first of these 
substances, has a tendency to be easily fragmented releasing fine particles to the detriment of 
most automated synthesisers. 
5 
The support of choice is now long chain alkylamine controlled pore glass6(Fig. 4). This material 
is prepared commercially from borosilcate glass, the borates being etched out by acid to leave 
pores of regular size. Resins may have pore size of 500 or 1000 angstroms in diameter, with 500 
angstrom being used in most commercial supports. Recently it has been noted 7 that supports with 
larger pore size give more homogeneous results for long oligonucleotides although at high pore 
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Figure 4.) 
Silica supports are functionalised by reaction of surface silanols with 3-aminopropyl-trialkoxysi-
lane and unreacted hydroxyls are capped with trimethylsilyl chloride (Scheme 2). The amine 
groups can then be reacted with suitable groups to extend the chain and form the desired linker. 
Recent work suggests that the nature of this linkage can significantly affect the purity of 
oligonucleotide, especially if the sequence is long (ie.>50). It has been shown that the quality of 
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Scheme 2. Furictionalisation of silica supports) 
N. 
In the same study it was noted a polyethylene glycol spacer (Fig. 5) performed well and an 
efficiency of greater than 99% was achieved in oligonucleotide synthesis with this linker. This is 
explained by dipole/dipole interactions which are thought to cause this linkage to remain in an 
extended form. Conversely a polyglycine spacer (Fig. 6, m=1 ) would be expected to adopt some 
form of folded structure due to hydrogen bonding between adjacent amide moieties, and this type 
of linkage did give a very poor quality product, which was a mixture of oligonucleotides, and a low 
coupling efficiency of 92%. When amide bonds were moved apart, by increasing alkyl chain length 
between them, the product purity was improved (increase in n in Fig 6). 
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Controlled pore glass can be obtained commercially already functionalised with long chain 
alkylamines, where the alkyl chain is 14 carbon units in length. This support has the advantages 
of being both rigid and robust, allowing high flow rates and solvent pressures to be used. The resin 
has good wetting properties, functional groups are normally accessible in all solvents and the 
matrix is chemically inert to all but very strong alkalis. Problems with surface adsorbed 
oligonucleotides do not occur and small adsorbed molecules can usually be washed off easily. 
Because of the uniform pore size, diffusion is the same through all particles and functionalisation 
is easy. 
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Attachment of the first nucleoside to the amine group of the long chain alkylamine spacer on the 
resin is normally by means of a further succinyl linker. The 5'-protected nucleoside is succinylated 
at the 3'-hydroxyl position with succinic anhydride in dry pyridine. Coupling of the 3-succinate with 
the resin can be either by direct N,N-dicyclohexylcarbodi-imide(DCC) activated condensation or 
by an active ester such as 4-nitrophenol, which can be prepared by a DCC coupling reaction. This 
latter approach lessens the risk of precipitates of N,N-dicyclohexylurea(DCU) becoming mixed 
with the resin and the ester is stable during the long coupling time that is required. Alternative 
coupling reagents" have been investigated, that give more soluble ureas, and alternative links to 
the spacer7 have been tried. Carbonate and carbamate groups appear to perform as well as 
succinate groups and are cleavable by ammonolysis. 
After the first nucleoside is attached at suitable loading, unreacted amine sites on the support 
must be "capped" to prevent their reaction with nucleotide monomers during synthesis. This is 
normally done by acylation with acetic anhydride and catalysis with DMAP in the presence of 
base. Pons has stated" that both coupling and capping are more efficient after acid activation of 
the resin, the theory being that some sites on the cpg remain inactive under the basic conditions 
of the functionalisation step only to become activated by the first acid wash of the oligonucleotide 
synthesis. This is thought to be the cause of capped resins giving greater than 100% effiency for 
the first coupling reaction in syntheses. 
[:1 
1.3 Chemical Methods of Oligonucleotide Synthesis 
Four principle methods of oligonucleotide synthesis have been investigated, phosphodiester, 
phosphotriester, phosphite-triester and H-phosphonate. Only the latter 3 have been extensively 
used in solid supported synthesis. 
1.3.1 The phosphodiester approach. 
In 1956 Khorana and co-workers910 showed that thymidine-5'-O-phosphate could be activated 
by toluene-4-su 1phonyl chloride and coupled to the 3'-hydroxyl group of a 5'-protected thymidine 
(Scheme 3). Another condensing agent DCC was also found to be successful. The first of these 
reagents tends to suiphonylate the free 5'-hydroxyl in a competing reaction with condensation so 
a more sterically hindered sulphonyl chloride, 2,4,6-triisopropyl-benzenesulphonyl chloride has 
been subsequently used. This reagent cannot directly approach the 5'-hydroxyl. 
As the oligonucleotide chain length is increased the coupling reaction becomes steadily less 
selective due to phosphorylation of the nucleophilic phophodiester backbone. The oligonucleo-
tide backbone, being charged, is rather insoluble in organic solvents which are used in purification 
in solution syntheses. Thus the purification must be carried out in polar solvents, risking loss of 
protecting groups due to hydrolysis. The phosphate monomers themselves are only soluble in 
polar solvents and cannot be purified by conventional chromatographic techniques11. While much 
pioneering synthesis was achieved by this method, it is no longer in common use. 
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1.3.2 Phosphotriester synthesis 
The phosphotriester approach initially proposed by Letsinger12 has been developed into a 
routine method of solid phase oligonucleotide synthesis. The 5' protected 3'-phosphodiester 
monomers are condensed with the 5'-hydroxyl group of the support bound oligonucleotide with 
the aid of an activating agent, 1-mesitylenesulphonyl-3-nitro-1,2,4-triazole, and a catalyst, N-




















Scheme 4. Phosphotriester Synthesis 
After capping u nreacted 5'-hydroxyl sites with acetyl groups, the 5'-protecting group of the newly 
added monomer can be removed and the next monomer added(Table 1). The oligomer thus 
grows with an uncharged phosphotriester backbone. Several phosphate protecting groups have 
been investigated in this context, the aim being to allow the protecting group to be removed at the 
end of synthesis without any concommitant phosphate backbone cleavage. The initial syntheses 
employed 2-cyanoethyl protection, removable with concentrated ammonia solution, while Eck-
stein and Rizk introduced 2,2,2-trichloroethyl13 later abandoned because of the difficulties in 
removal. The 2,2,2-trichloroethyl moiety was removed with zinc dust in 80% glacial acetic acid. 
10 
Procedure Reagent Time/s 
Wash Pyridine 120 
Wash 1 ,2-dichloroethane 120 
Deblock 5'-hydroxyl Tnchloroacetic acid in pyridine 
(3g/1 OOml) 
120 
Wash 1 ,2-dichhloroethane 120 
Wash Pyridine 120 
Coupling reaction 120mg monomer, 15mg MSNT, 0.2m1 
10% N-methylimidazole in pyridine 
900 
Table 1 Phosphotriester Synthesis Cycle 
The acidic conditions may lead to depurination side reactions and a zinc/copper couple in 90% 
acetic acid was shown by Cook to induce loss of u.v. absorbance in the case of 4-N-benzoyl-2-
deoxycytidine14. 
Reese and coworkers chose aryl groups for internucleotide protection15, reasoning that the 
acidity of these groups should ensure that hydrolysis of the phosphotriester led exclusively to the 
loss of a phenol group without backbone cleavage. It was found 15  however that removal of these 
internucleotide protecting groups with strongly basic and nucleophilic reagents such as hydroxide 
ion caused backbone degradation. Milder nucleophilic reagents such as syn-4-nitrobenzaldoxime 
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Figure 7.) 
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The initial aryl groups employed were phenyl groups, where internucleotide protection had to be 
stable to the mild alkaline hydrolysis of the aryloxyacetyl protection at the 5'-hydroxyl site. Where 
non-hydrolytic means are used to remove 5'-protection more acidic phosphate protection such 
as 2-chlorophenyl16 can be employed and it is this group along with 2,5-dichlorophenyl17 which 
is now commonly used in solid phase triester synthesis. Oximate ions are routinely used for their 
expulsion 2. Once the backbone has been converted to a phosphodiester it is completely stable 
to the more stringent conditions required to remove the exocyclic amine protecting groups. The 
4-nitrophenylethyl group"' (Fig. 8), which is removed by non-nucleophilic bases such as 1,8-
diazabicyclo[5.4.0]undec-7-ene (DBU) (Fig. 8) in a beta-elimination mechanism, has also been 
used for phosphate protection. 
02N O",~ 
DBU 	 DBN 	 4-nitrophenylethyl 
Figure 8. 
Coupling time for phosphotriester synthesis is slow by comparison to phosphoramidite and H-
phosphonate chemistries but the monomers are easy to prepare and relatively stable. This 
stability causes them to require activation before coupling and side reactions are caused by the 
MSNT activator, which can react with the 0(6)-atom of guanosine19 during synthesis and lead to 
creation of diaminopurine bases after ammonolysis. However treatment with oximate reagent 
before hydrolysis of the amine protecting groups is believed to reverse this side reaction 2. 
1.3.3 Phosphite-Triester Synthesis 
This method was first introduced by Letsinger20, the reactive monomer being nucleoside -3-
phosphomonochioridite or monotetrazolide, with the other phosphorus protecting group being 
2,2,2-trichioroethyl. These very reactive compounds couple in seconds to alcoholic hydroxyl 
12 
groups but are extremely unstable, being easily hydrolysed. Thus they are difficult to handle, 
purify and store, and reactions must be carried out at -78°C in an inert atmosphere; conditions 
which are unsuitable for automation and synthesis of long sequences. 
Alternatives were therefore introduced and Caruthers suggested the use of 3'-O-(N,N-
dimethylphosphoramidites)21. These compounds are more stable to hydrolysis than the phosphite 
triesters but are still prone to oxidation and decomposition on silica gel, making chromatographic 
purification impossible. With bulkier alkyl groups,22 phosphoramidites are more stable, their 
stability increasing with increased steric hindrance at the phosphoramidite nitrogen 23. N,N-
Diisopropyl and morpholino phosphoramidites are now commonly used (Fig. 9). 
R'O 
	
RO 1J  
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( Figure 9.) 
The third group attached to the phosphorus atom, a phosphate protecting group, ensures that, 
after oxidation the oligonucleotide grows with a phosphotriester backbone. Early syntheses 
employed methoxy phosphoramidites (Fig. 10) with the methyl group being removed as the first 
step in deprotection bythiophenate ion. This strategy, still in common use, can lead to methylation 
of pyrimidines in basic conditions.24 In addition, the thiophenol solutions which are necessary to 
cleave the methyl groups can be unpleasant to work with. 
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(Scheme 5. Preparation of Cyanoethyiphosphoramidites) 
Operation Reaçient/solvent Time/s 
1. Wash dichloromethane 30 
2.deblock 5 3% trichloroacetic acid in dichloromethane 50 
3. wash dichloromethane 30 
4.wash anhydrous acetonitrile 60 
5.coupling step 0.1M phosphoramidite in acetonitrile 
0.5M tetrazole in acetonitrile 
30 
6.capping step acetic anhydride/Iutidine/THF 1/1/8 
17.6% N-methylimidazole in THE 
40 
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(Scheme 6. Phosphoramidite Synthesis) 
A protecting group with none of these drawbacks is 2-cyanoethy125 (Fig. 10, Scheme 5). This 
group is rapidly removed by a beta elimination mechanism upon addition of ammonia solution, 
the product being the relatively unreactive acrylonitrile. 
Synthesis cycle for phosphoramidite chemistry(Scheme 6, Table 2). 
It is essential that the capping step is carried out before oxidation because the acylation and 
hydrolytic washes remove ring adducts such as tervalent phosphites and phosphoramidites 
which, if oxidised, become stable and lead to extensively branched products-. 
15 
In situ phosphitylation has also been investigated for phosphoramidite oligonucleotide synthe-
Sis27. In this approach the 5'-protected nucleoside is functionalised using a di-(dialkylamine) 
methoxyphosphine and a di-isopropylamine tetrazolide salt activator in a pre-reaction before 
addition of a mixture of the nucleotide and tetrazole to the support bound oligomer. 
1.3.4 H-Phosphonate Chemistry in Oliçionucleotide Synthesis 
This method was originally explored by Todd and coworkers28 in the early days of oligonucleo-
tide synthesis. In the late 1970's Sekine and Hata used nucleoside 3'-H-phosphonates in 
reactions with 3'-O-protected nucleosides in oxidative phosphorylating conditions using 2,4,6-tn-
isopropylbenzenesu Iphonyl chloride as a condensing agent 29  . 
More recently the H-phosphonate method has been adapted for automated solid phase 
oligonucleotide synthesis30'31. The coupling reaction leads to the formation of an internucleotide 
H-phosphonate linkage which is then oxidised to give a phosphodiester backbone. Because the 
H-phosphonate is stable to acidic conditions but unstable towards basic conditions, a single 
oxidation step is used once the entire oligonucleotide has been assembled (Table 3). The 
oligonucleotide is cleaved from the resin in the normal way by treatment with concentrated 
ammonia solution at room temperature for 90 minutes and the acyl protecting groups are removed 
by heating in concentrated ammonia at 55°C for 5hours. 
H-Phosphonate monomers are simple to synthesise by a variety of methods, one of which 
involves the reaction of phosphorus trichloride with triazole to give a triazolide which is further 
reacted in situ with the protected nucleoside and subsequently hydrolysed to the H-phosphonate32  
(Scheme 7). In another approach a punifiable phosphite reagent is obtained from the reaction of 
phosphorus trichloride with salicylic acid and this salicylate is then combined with the nucleoside 
and hydrolysed in situ to the H-phosphonate33 (Scheme 8). 
16 
Operation Reagent/solvent time/s 
wash anhydrous acetonitrile 45 
deblock 5' 2.5%dichloroacetic acid in dichloromethane 60 
wash pyridine/acetonitrile 1/1 45 
coupling step 10mM deoxynucleotide H-phophosphonate 
50mM pivaloyl chloride in pyridine/acetonitrie 
90 
repeat 1-4 until sequence complete 
deblock 5' 2.5%dichloroacetic acid in dichloromethane 45 
oxidise a)0.1M 12 in pyridine/N-methylimidazole/water- 
/tetrahydrofu ran 	5/1/5/90 




(Table 3. Phosphon ate Synthesis Cycle) 
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The coupling agents in H-phosphonate oligonucleotide synthesis are acid chlorides which react 
with the H-phosphonates to give acylated reactive intermediates. Pivaloyl (trimethylacetyl) 
chloride was initially used but this reagent degrades upon storing and has been shown to acylate 
the internucleotide phosphonate linkage. An alternative reagent, adamantoyl carbonyl chloride 
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A capping step35 has also been introduced into the H-phosphonate oligonucleotide synthesis 
cycle using isopropyl phosphite (Fig. 11) with the adamantoyl chloride activating reagent. 
H-phosphonate intermediates provide a convenient route to a number of modified oligonucleo-
tides. Phosphorothioates, phosphoramidates3738 and phosphotriesters39 can all be produced by 
chemical treatment of the H-phosphonate backbone. 
1.4 Protecting groups for Oligonucleotide Synthesis 
Two classes of protecting groups are required during conventional solid supported oligonucleo-
tide synthesis.The first is temporary protection for the 5'-hydroxyl group of the added monomer 
during the condensation reaction. This protection is then removed during the synthesis to provide 
the next phosphorylation site. The second variety of protection is semi-permanent blocking of any 
nucleophilic moiety capable of interfering with the chain extension procedure. Thus exocyclic 
amino functions, the 2'-hydroxyl of ribonucleosides and in a few cases the imide nitrogen of the 
heterocyclic base require protection which remains in place throughout the synthesis. 
1.4.1 Amino Protection 
The N(6) amino group of adenosine, the N(4) amino group of cytosine, and the N(2) amino group 
of guanosine all require protection during synthesis. This is commonly acyl protection which is 
removed after completion of synthesis by mild alkaline hydrolysis with concentrated aqueous 
ammonia solution at 55°C overnight. Benzoyl groups are commonly used for adenosine and 
cytosine, while isobutyryl-protection is used for guanosine, as benzoyl groups are too slow in 
hydrolysing and often lead to solubility problems40(Fig. 12). p-Methoxybenzoyl(anisoyl) protec-
tion is also common (Fig. 12). As the acid chloride is slightly more reactive and the protecting 
group slightly more labile than benzoy Iit can be used on both exocyclic amino functions and imido 
ring nitrogens. 
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Figure 12. 
Acyl protection is commonly introduced by one of two methods. 
(1) Traditionally per-acylation of the nucleoside followed by hydrolysis of the ester linkages with 
dilute sodium hydroxide solution (saponification) was employed 41  (Scheme 9). 
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Scheme 9. Saponification route to protect amino functions) 
(2) More recently a transient hydroxyl protection method, employing trimethylsilyl groups, has 
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Scheme 10. Transient methodology for the introduction of protecting groups) 
21 
Selective N -acylating reagents have also been designed to avoid the saponification route, 
including 2-(chloromethyl)-4-nitrophenyl benzoate", O-ethyl-S-benzoyl dithiocarbonate, p-
nitrophenyl benzoate / hydroxybenzotriazole45 and pentaflorophenyl benzoate". However the 
active ester method is only effective for the protection of N(4) in cytosine. With the other bases 
N-acylation is slow and concommitant 0-acylation occurs42 . 
The phenylacetyl group40 has been used to protect the N(2) of guanosine. The group is easily 
introduced by the transient protection methodology, has good solubility and is significantly more 
labile to aqueous ammonia than the 2-N-isobutyrylguanine protecting group. 
Even more labile acyl protecting groups (Fig. 13) introduced by Teoule and coworkers can be 
removed without the need to heat in ammonia solution at all. It has been reported that 
phenoxyacetyl protection for guanosine and adenosine and isobutyryl protection for cytosine can 
be hydrolysed at room temperature in 29% ammonia solution in less than 4 hours47 
ooj*  H3C ° 	* 
Phenylacetyl Phenoxyacetyl Methoxyacetyl 
Figure 13. 
In the case of adenosine it has been shown that N(6) benzoyl protection promotes depurination 
during acid treatment48'49. Cyclic diacyl groups have been shown to slow this side reaction 
considerably-',O. Succinyl and phthaloyl groups (Fig. 14) are the most successful, N(6) succinyl 
protection increasing the half life of adenosine in 80% acetic acid at 700C  by 7-fold in comparison 
to benzoyl protection. In addition, where depurination is at its worst, at the 3' end of the 
oligonucleotide, succinyl groups can be introduced to the 3-nucleoside at N(6) and 3'-OH in a one 
pot reaction. Cyclic diacyl groups are not stable in the presence of fluoride ions50. 
An alternative depurination-resistant protecting group has been suggested by Froehler and 
Matteuci51  (Fig.1 4). Dialkylformamidines have been shown to increase stability of 2'-deoxyad- 
22 
enosine to 80% acetic acid by up to 24 fold relative to benzoyl protection. The di-n-butyl 
formamidine group is removed under the "standard "basic hydrolytic conditions and introduced 
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Figure 14. 
The use of amine protecting groups which can be removed nonhydrolytically, by treatment with 
non -nucleophilic bases in a beta elimination mechanism have also been reported. Pfleiderer and 
coworkers employed the 4-nitrophenylethylcarbamate group (Fig. 15) to protect the exocyclic 
amine groups of the bases. The group was introduced by N-specific acylation of cytosine using 
1 -(4-nitrophenylethoxycarbonyl)-benzotriazole and with the chloroformate and transient protec-
tion methodology to the N(6) amino group of adenine"'. The use of the 9-fluorenylmethoxycar-
bonyl group has been reported 521.53  for the protection of the N(4) site of deoxycytidine in 








Hata and coworkers have suggested the use of the butylthiocarbonylTM group (Fig. 15) for the 
protection of the N(2) amino group of guanine and also the amido 0(6)-position, which can take 
part in phosphorylation reactions in synthesis but is not commonly protected. The group is 
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iii = 1 M pyridinium hydrofluoride in pyridine 
Scheme ii.) 
Other groups used to protect amido-functions within the heterocyclic rings of the bases include 
acyl functions (eg. methoxybenzoyl) and alkyl groups such as cyanoethyl and nitrophen-
y1sulphonylethy155 . The latter type of protection is introduced at nitrogen by a Michael addition 
(Scheme 11) or at the oxygen atom of the amido function by a Mitsonobu reaction (Scheme 12). 
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TBAOH = tetrabutylammonium hydroxide 
R = CN or 4-nitrophenylsuiphonyl 
Scheme 12. 
24 
The 4-nitrophenylethyl group has also been employed in this way18 and can be removed in a beta 
elimination mechanism with strong non-nucleophilic bases. 
The amide ring proton is normally only nucleophilic enough to cause significant side reactions 
in the case of uridine, and then only in phosphotriester synthesis. The N(3) atom of uridine maybe 
protected by a methoxybenzoyl group. 
1.4.2 Temporary 5'-Hydroxyl protection. 
The key requirements of temporary protecting groups are that they must be completely stable 
during the condensation step and then completely removable thereafter without any concommi-
tant cleavage of permanent protection at amino, hydroxyl, or phosphorus. Selective addition of 
the protecting group to the 5'-hydroxyl group during synthesis of the monomer is also important. 
The most successful and widely used groups for this purpose are triarylmethyl ethers57( Fig. 16). 






Pixyl (9-phenylxanthen-9-yI) 	Moxyl [9-(4-methoxyphenyl)xanthen-9-yl] 
Figure 16.) 
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These groups are introduced by reaction of triarylmethyl halides with the alcohol in the presence 
of base and are cleaved quickly by acidolysis (the 4,4'-dimethoxytrityl group is removed in less 
than 30 seconds by 30/otrichloroacetic acid in dichloromethane2). The strongly coloured cations 
released during acid cleavage allow the amount of oligonucleotide present to be measured 
spectrophotometrically at 495nm and therefore the stepwise efficiency of the coupling reaction 
can be monitored during the synthesis. 
The 9-phenylxanthen-9-yl (Pixyl) group (Fig. 16) has the advantage of giving crystalline 
nucleoside products2 but 4,4'-dimethoxytrityl protection is the most commonly employed, as 4,4'-
dimethoxytrityl chloride is readily available commercially, whereas the 9-phenylxanthen-9-yl 
chloride is not. 
Acid washes during oligonucleotide synthesis can lead to depurination side reactions49'51  and 
so removal of the 4,4'-dimethoxytrityl group with Lewis acids such as zinc bromide have been in-
vestigated 59'60. However the rate of the cleavage reaction then depends upon oligonucleotide 
chain length and insoluble complexes can be formed if traces of pyridine are present. Hence zinc 
bromide is unsuitable for solid phase synthesis. A protected triarylmethyl protecting group has 
been employed which does not require acid deprotection. The 4,4',4"-tris(4,5-dichlorophthalim-
ido)-trityl group61  (Fig 17) is removed by cleavage of the phthaloyl groups with hydrazine. Levulinyl 
protection 62(Fig. 17) is also removed by hydrazine but its introduction at the 5'-OH is insufficiently 
specific for everyday use. 
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Figure 17. 
The dibromomethylbenzoyl group (DBMB) has been employed as a 5-OH protecting group 
removable under completely neutral conditions. Oxidation first converts the dibromo-derivative 
KI 
to a formyl moiety and the altered group is then rapidly cleaved by addition of morpholine. 
5'-Hydroxyl protection removable by a beta-elimination mechanism in the presence of non-
nucleophilic bases has also been proposed. 2Phenylsulphonylethyl64(Fig. 18) and 2-(4-chloro-
phenyl)-sulphonylethyl groups(Fig. 18), introduced as carbonates by reaction of the 5'-hydroxyl 
group of the sugar, withthe appropriate chioroformates, are cleaved by treatment with triethylam-
me. The 9-fluorenylmethoxycarbonyl group has been used in both oligodeoxynucleotide synthe-
sis" and oligoribonucleotide synthesis to protect the 5'-hydroxyl group of the sugar moiety. 
Cl  jLf 	
0 * 
0 
2-Phenylsuphonylethoxycarbonyl 2-(4-ch Iorophenyl)-sulphony let hoxycarbonyl 
Figure 18. 
1.4.3 Protection of the 2'-Hydroxyl Group of Ribose in Oligoribonucleotide Synthesis. 
Protection of the 2'-hydroxyl function of ribonucleosides has been found to be essential in 
oligonucleotide synthesis. Ideally, the protocol should be such that all other protection can be 
removed before the 2' -group is cleaved. This will generally prevent any 3'-2' migration of the 
internucleotide phosphate link occurring and will also prevent any enzymic cleavage of the oligori-
bonucleotide on long term storage.The movement of the internucleotide link from 6-3' or 3'-2', 
leading to chain cleavage, has been observed in strongly acidic media and in all basic conditions 
for phosphotriester linkages11. Thus where acyl base protection is used, 2'-hydroxyl protecting 
groups must be stable to mild alkaline hydrolysis. In general acetals and ethers are found to be 
stable to such conditions. 
Introduction of any group specifically at the 2'-hydroxyl site is difficult because of the need to 
differentiate it from the other secondary hydroxyl at the 3' position. Many reactions are found to 
occur more readily at the 2'-hydroxyl site than the 3'-hydroxyl site if the 5-hydroxyl group is 
27 
blocked. Thus triisopropylsilyl groups can be introduced in 60% yield to 2'-hydroxyl of 5'-0-(4,4"-
dimethoxytrityl)-4-N-benzoylcytidine69. 
A group which selectively and simultaneously protects at both 5' and 3' sites has been 
introduced by Markiewicz70(Scheme 13). Preparation of the 3',5'-O-tetraisopropyldisiloxane-1 ,3-
diyl nucleoside derivative allows the 2'- hydroxyl to be reacted with excess protecting reagent in 
forcing conditions. This silyl group is stable except in strongly acidic or strongly basic media and 
is removed by the action of fluoride ions.Thus almost any group stable to fluoride ions can 
theoretically be attached selectively to the 2'-hydroxyl position. 
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The tetrahydropyranyl group (THP) (Fig. 19) for the protection of alcohols introduced by 
Parham and Anderson 71  was the first acetal link investigated for RNA synthesis7273'74. The group, 
put on with dihydropyran and acid catalysis and removed with dilute acid, has good stability but 
is chiral, leading to the formation of diastereomers when attached to optically active alcohols such 
as nucleosides75. A symmetrical acetal, 4-methoxytetrahydropyran-4-yl(MTHP) (Fig. 19), was 
therefore designed and synthesised by Reese and coworkers76. It is generally introduced to the 
tetraisopropyldisiloxyl nucleoside and is removed from the oligonucleotide with hydrochloric acid 
at pH 2 in 1 hour after all acyl protection has been removed. It has been employed by Gait and 
coworkers with 5'-9-fluorenylmethoxycarbonyl and by van Boom using 5'-levulinyl protection 62. 




* 	 * 
THP 	 MTHP 	 CTMP 
Figure 19. 
protecting groups at the 5'-hydroxyl position77 and so 1 -[-2-chloro-4-methylphenyl]-4-methoxy-
piperidin-4-yl(CTMP)78(Fig. 19) has been introduced, which becomes protonated and therefore 
more stable at the low pH of 5'-acidolysis, while being unprotonated and easily cleaved at slightly 
higher(2.5) pH. Addition of electron withdrawing groups stabilises acetals to acid hydrolysis79. 
An alternative approach to oligoribonucleotide synthesis introduced by Ogilvie and coworkers69 
maintains 5'-O-(4,4"-dimethoxytrityl) protection but uses a teitbutyldimethylsilyl ether(TBDMS) 
(Fig. 20) group for 2'-hydroxyl protection.This moiety is introduced by direct reaction of 5'-
protected nucleoside with TBDMS-chloride in the presence of imidazole. The mixture of 2' and 
3' isomers produced can be separated chromatographically. The TBDMS group is removed with 
fluoride ions after all other protection has been cleaved80. This strategy for oligoribonucleotide 
synthesis has now been widely adopted and is standard on some commercial oligonucleotide 
synthesisers. A 70mer has been made 69  in addition to very large amounts of several dodecamers 
for NMR work"'. 
Tert-butyldimethylsilyl (TBDMS) 	Triisopropylsilyl 
(Figure 20. 
Other ether 2'-hydroxyl protecting groups used include methoxybenzyl (Fig. 21), o-nitrobenzyI83  
(Fig. 21), and methoxyethoxymethylM (Fig. 21). The first is removed oxidatively, while 0-
nitrobenzyl is cleaved by uv photolysis and treatment with zinc bromide catalyses the cleavage 
of the methoxyethoxymethyl group. 
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1.5 Fluorescent Labelling of Oligonucleotides 
Synthetic oligonucleotides are of vital importance in biological applications as sequence 
specific probes and as primers for DNA sequencing. For both applications the oligonucleotides 
must be labelled for identification. Commonly labelling is by enzymatic addition of a radioactive 
P phosphate group using the enzyme T4 polynucleotide kinase and gamma ATP, but more 
recently much interest has been shown in methods of incorporating non-radioactive labels and 
therefore avioding the problems of working with radioactivity, which can be hazardous to health 
and expensive. A further problem with radioactive labelling is that the lifetime of the label is short 
because of 32P decay. 
The labelling of oligonucleotides with biotin 85 (Fig. 22), an immunogenic tag which binds to 
eggwhite avidin and bacterially derived streptavidin, and with other groups such as dinitrophenyl 
(Fig. 22), also detected immunogenically, or fluorophores (Fig. 22) detected by laser induced 
fluorescence86 have been investigated. Enzymes such as horseradish peroxidase and alkaline 
phosphatase have also been used to label oligonucleotides. In these cases detection is by 
colorimetry or fluorescence 87,88 
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With the exception of the BM PM89 group (Fig. 22) which is a 5-hydroxyl group similarto the 4,4'-
dimethoxytrityl group, these chemical labels are introduced by reaction of their electrophilic 
derivatives with nucleophilic primary aliphatic amines.Thus the oligonucleotide must be modified 
to carry a primary aliphatic amine function.This is usually done so that the amine is added during 
routine oligonucleotide synthesis. Two general methods of achieving this are either to modify a 
nucleotide to carry a protected amine or to produce a simple nucleotide analogue with a protected 
amine function. Once synthesis is complete all protection can be removed and the oligonucleotide 
can be reacted with the activated label. 
Modification of the 4-amino group of cytosine to eventually produce a 4-N-[-N-(6-trifluoroace-
tylamidocaproyl)-2-aminoethyl]-5-methyl-2'-deoxycytidine88 can be achieved by production of a 
4-triazolocytosine9° derivative followed by displacement with ethylenediamine91'92 and reaction 
of this compound with N-hydroxysuccinimidyl N-trifluoroacetyl-6-aminocaproate. After conver-
sion to a N,N-diisopropylmethoxyphosphoramidite, this monomer (Fig. 23) can be used in 
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A similar displacement approach has also been adopted by Sproat and coworkers 93  to put an 
aminopentyl linker at the same position. The 5',3'-0- silylated nucleoside is reacted first with 
mesitylene sulphonyl chloride which is successively displaced by o-nitrophenol and diaminopen- 
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tane. The free amine is then protected with a trifluoroacetyl group and the silyl groups are 
removed. 
Amine groups have also been introduced by C(5) modification of deoxyuridines 94  (Fig. 24). In 
addition, 8-aminohexyladenosinetriphosphate (available tom Sigma) has been added enzymati-
cally to oligonucleotides which can then be reacted with dinitrofluorobenzene95. Primary aliphatic 
amines have also been attached to the N(4) amino groups of cytosine bases in polynucleotides 








Substitution of an amine function forthe 5'-primary sugar hydroxyl has been employed86. When 
protected at the amine site by trifluoroacetyl group, the resulting 5'-amino-2',5'-dideoxynucleo-
side can be phosphitylated and used as the final 5'-end base in an oligonucleotide synthesis. After 
deprotection, the amino-group is reacted with fluorescent dyes. These oligonucleotides form the 
basis of an automated sequencing scheme 97. 
The nucleotide analogue technique, where a simple aliphatic amino-alcohol is converted to a 
monomer suitable for oligonucleotide synthesis (Fig. 25), has been employed in a number of 
ways. 
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In general an aminoalcohol is protected at the amine site and then converted to the phospho-
ramidite, phosphodiester or phosphonate. Amino alcohols used range in carbon chain length from 
2 to 10 ( ie aminoethanoP8 through aminopropanoI99 to aminodecanol100). The following groups 
have been employed to protect the primary amine: phthaloyP°°. trifluoroacetyP, (removed by 
alkaline hydrolysis), 9-fluorenylmethoxycarbonyl'100 (hydrolysis or beta elimination) and 
monomethoxytrityl' (removed by acidolysis). Oligonucleotide synthesis has been by 
phosphotriester, phosphoramidite 99 and alkylphosphonate100 methodology. All these meth-
ods are limited to single label addition. However a commercially available, protected aminodiol 
monomer (Fig. 26) now allows multiple label addition101 The equivalent 0-succinate can be 
prepared and thence be used to label at the 3'-end of the oligonucleotide102 (Fig. 27). 
All the above routes require post deprotection solution phase reactions between the amino 
oligonucleotide and the label. While allowing a wide variety of labels to be used, this is a time 
consuming and sometimes low yielding process. Recently a method whereby a biotinylated 
monomer is added to the 5' end of the oligonucleotide has been reported103. 
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(Figure 26. 
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Results and Discussion 
2.1 5'-O-(9-Fluorenylmethoxycarbonyl) Ribose Protection in Phosphotriester synthe-
sis. 
Solid phase synthesis has been dominated by the use of acid labile 5'-hydroxyl protecting 
groups, popular because they are removed in acid conditions with no risk of breaking the 3'-
succinyl ester link to the support or of removing acyl exocyclic amine protection. The aim of this 
project was to apply beta-eliminating groups especially 9-fluorenylmethoxycarbonyl as temporary 
5'-hydroxyl protection removable with non-nucleophilic bases. This might allow use of acid 
sensitive bases in synthesis or of permanent acid labile protection elsewhere in,.,oligomer, eg 
acetal protection at the 2'-hydroxyl in the oligoribonucleotide series. 
The 9-fluorenylmethoxycarbonyl (FMOC) group introduced by Carpino104 and developed as a 
group for the temporary protection of alpha amino groups during peptide synthesis by Shep-
pard105, was first introduced into oligonucleotide synthesis for 5'-hydroxyl protection by Chatto-
padhyaya and coworkers106. 5'-O-(9-Fluorenylmethoxycarbonyl)-thymidine compound (2) was 
prepared by reaction of thymidine with 9-fluorenylmethyl chloroformate in dry pyridine (Scheme 
pyridine 
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(2) 
(Scheme 14.) 
The crystalline product of this reaction was tested for stability to common solvents and non-
nucleophilic bases. The compound was found to be stable for several hours at ambient 
temperature to ethanol, methanol, acetonitrile, chloroform, pyridine, dichioromethane and 1,2-
dichloroethane. 5'-(9-Fluorenyl methoxycarbonyl)-thymidine was also stable in freshly distilled 
DMF but decomposed when dissolved in SLR grade DMF, presumably due to the presence of 
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primary amine contaminants. Hence solvents of this type should be avoided when using the 9-
fluorenylmethoxycarbonyl protecting group. The FMOC group was cleaved from the 5'-0-(9-
fluorenylmethoxycarbonyl)-thymidine nucleoside by 10% DBU in acetontrile instantaneously and 
by triethylamine (10% in acetonitrile v/v) in 15 minutes (monitoring by t.l.c). 
5'-O-(9-Fluorenylmethoxycarbonyl)-thymidine-3'-O-(2-chlorophenylphosphate) compound(3) 
was prepared (Scheme 15) and used in a phosphotriester DNA synthesis of the deoxytetramer 
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Procedure Reagent Time/s 
Wash Pyridine 120 
Wash 1 ,2-dichloroethane 120 
Deblock 5'-hydroxyl 10% DBN in pyridine 180 
Wash 1 ,2-dichloroethane 120 
Wash pyridine 120 
Coupling reaction 20mg monomer, 15mg MSNT, 





Procedure Reagent Time/s 
Wash Pyridine 120 
Wash 1 ,2-dichloroethane 120 
Deblock 5'-hydroxyl Trichloroacetic acid in pyridine 
(3g/1 OOml) 
120 
Wash 1 ,2-dich loroethane 120 
Wash Pyridine 120 
Coupling reaction 120mg monomer, 15mg MSNT, 0.2m1 
10% N-methylimidazole in pyridine 
900 
(Table 5.) 
Long chain alkylamine controlled pore glass, functionalised with 5'-O-(4,4'-dimethoxytrityl)thymidine, 
was used as a support and the 5'-dimethoxytrityl group was cleaved off with trichioroacetic acid 
before synthesis began. Two thymidine residues were then added, using the 94luorenylmethoxycar-
bonyl monomer(3) and a synthesis cycle in which the 5'-protection was removed with 10% DBN 
solution in dichloromethane (Table 4). The fourth residue was added by means of a conventional 
5'-(4,4"-dimethoxytrityl)thymidine-3'-phosphate monomer, thus allowing the resin loading to be 
easily assayed colourimetrically. A control synthesis (b) of (T)4 using 4,4'-dimethoxytrityl 
monomers throughout was also performed (Table 5). The purity of the two products was 
compared by HPLC (Fig. 28 and 29 ) and found to be similar but the yield of the 9-
fluoreny1methoxycarbonyl synthesis was obviously poorer. 
Before cleavage and deprotection, samples of resin from each preparation were assayed for 
dimethoxytrityl content by treatment with 60% hydrochloric acid in ethanol and measuring the 
dimethoxytrityl cation absorbance spectrophotometrically at 498 nm. The amount of dimethoxytri- 
tyl protected oligonucleotide product was thus measured. For the standard synthesis this 
Oligonudeotide (a) T4 
(Figure 28.) 
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Oligonucleotide (b) T4 standard synthesis 
(Figure 29. 
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amounted to 37 micromoles oligonucleotide/g resin while for the FMOC prepared sample the 
resin loading was only 25 micromol/g. 
Loss of the oligonucleotide from the resin as a result of succinyl ester linker cleavage was 
suspected to be the cause of the reduced yield and by soaking the resin in DBN solution it was 
confirmed that the linker was not stable to strong non-nucleophilic bases (Table 6). 
Resin Conditions/Treatment Half life/minutes 
LCAA cpg 10% DBU/dichloromethane 20 
(Beckman) 
Sarcosyl (14) 10% DBU/dichloromethane >120 hours 
Phthaloyl (16) 10% DBU/dichloromethane 3.5 
(Table 6. Resin Stability) 
Chattopadhyaya and coworkers had also noticed significant instability of the linkage between the 
oligonucleotide and the support under similar conditions. They reported approximately 1% 
cleavage every 18 seconds upon treatment with 30 equivalents DBU in dry acetonitrile. This 
cleavage is thought to occur by a deprotonation mediated elimination mechanism.The strong 
base (DBU or DBN) removes the proton from the nitrogen of the amide bond joining the alkylamine 
spacer arm to the succinyl nucleoside and this is followed by a ring closure reaction to give the 
stable succinimide and the free nucleoside. Thus if the anion at nitrogen was prevented from 
forming, this reaction could be prevented. In order totest this theory a series of model compounds 
were prepared (Fig. 30). 
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Analogues of the linkage to the resin were prepared by reaction of 5'-O-(4,4"-dimethoxytrityl)-
thymidine-3'-O-succinate (4) with glycine and sarcosine ethyl esters(Scheme 16). As predicted 
the glycine model compound(6) was completely destroyed by non-nucleophilic bases in under 5 
minutes (monitoring by t.l.c.) whereas the sarcosyl model (7), incapable of forming an anion, was 
stable to the same conditions for more than 48 hours. 
0 
0 











OMe 	 0 
- 
H 
R = H = (6) 






The succinyl glycine ester compound may be of use as a protecting group in its own right. A 
5'-O-(glycylsuccinyl)-3'-O-benzoylthymidine(10) was prepared as a crystalline compound (Scheme 
17) and deprotected with DBU to give the free 5'-hydroxyl compound in tic monitored tests.The 
linkage appears to be slightly more stable than 9-fluorenylmethoxycarbonyl, being intact after 
treatment with triethylamine for 1 hour. Attempts to introduce the succinylglycyl moiety specifi-
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(Scheme 17. 5-0-succinyl glycine model compound) 
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Compound Treatment Half life 
5'-DMTr-3'-succinyl- 10% DBU in acetonitrile instant 
glycine ethylester (6) cleavage 
5'-DMTr-3'-succinyl- 10% DBU in acetonitrile >72 hour 
sarcosylethylester (7) 
5'-DMTr-3'-glutaryl 10% DBU in chloroform 2 hours 
glycine ethylester (12) 
(12). 5% piperidine in 48 hours 
acetonitrile 
(Table 7. Model compound stability) 
group would have the advantage of being produced from readily available starting materials. 
However it has no uv activity or colour by which to monitor its deprotection. Groups with similar 
cleavage mechanisms that dQ contain reporter groups could in principle be designed. 
A resin was prepared with a sarcosyl spacer between the alkylamino chain and the 3'-succinate 
of the first nucleoside(compound (14), Scheme 18). This was found to be stable to DBU in 
acetonitrile or dichioromethane, being cleaved by 10% DBU in acetonitrile at a rate of 0.4% per 
hour (Table 6). This small amount of cleavage may be due to moisture. 
If the proposed mechanism of non-nucleophilic base cleavage of the model compounds and 
resin is correct, then increasing the size of the product ring from 5-membered to 6-membered 
would be expected to slow down the rate of cleavage, supposing this ring closing step to be rate 
limiting' 07. A further model compound was therefore synthesised by condensing a thymidine 3'-
0-glutarate (11) with glycine ethyl ester (Scheme 19). This compound (12) proved to be more 
stable to DBU solutions than the succinyl glycyl model, having half life of approximately 1 hour 
(Table 7). 
Conversely when a 3'-O-phthaloyl resin (16) without sarcosyl spacer group was prepared it was 
found to be extremely labile (t112 < 5minutes) as opposed to the succinyl resin t112 of 30 minutes 
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2.2 Applications of Sarcosyl Resin 
The sarcosyl resin was initially tested with a routine 5'-O-(4,4"-dimethoxytrityl)-3'-O-(2-
cyanoethoxy)-N,N-diisopropylphosphoramidite synthesis of d(GAA GAA CTG GTA GAG TCG 
GT) (C) using synthesis cycle SSC El 03A (Appendix A), (Table 8). Coupling efficiency, monitored 
by dimethoxytrityl analysis, averaged at 98% and the overall yield was calculated to be 65%. The 
product was found to have equal purity by HPLC ( Fig. 31) to a product of the same sequence 
synthesis (d) prepared on commercial succinyl controlled pore glass. 
A 5'-O-(9-fluorenylmethoxycarbonyl)-6-N-benzoyl-2'deoxyadenosine-3'-O-methoxy-N ,N-diiso-
propylphosphoramidite(20) was prepared (scheme 20) and the deoxyoligonucleotide d(A)8 
synthesis(f) was synthesised .The resin was initially deblocked with 3%trichloroacetic acid in di-
chloromethane and then cycle SSME1 03A(Appendix A) (Table 9 ) was used with 10% DBU in 
acetonitrile for 5-deprotection of the 9-fluorenylmethoxycarbonyl group and capping with 10% 
trimethylsilyl chloride in pyridine. Methyl protection of the phosphotriester was removed by 
Operation Reagent/solvent Time/s 
1. Wash dichloromethane 30 
2.deblock 5' 3% trichloroacetic acid in dichloromethane 50 
3. wash dichloromethane 30 
4.wash anhydrous acetonitrile 60 
5.coupling step 0.1 M phosphoramidite in acetonitrile 
0.5M tetrazole in acetonitrile 
30 
6.capping step acetic anhydride/lutidine/THF 1/1/8 
17.6% N-methylimidazole in THF 
40 
7.oxidation 0.1m lwater/pyridine/THF 
2/20/80 
50 
(Table 8. SSCE1O3A) 
)peration Reagent/solvent Time/s 
Wash dichloromethane 30 
deblock 5' 10% DBU in acetonitrile 50 
wash dichloromethane 30 
wash anhydrous acetonitrile 60 
coupling step 0.1M phosphoramidite in acetonitrile 
0.5M tetrazole in acetonitrile 
30 
capping step 10% trimethylsilyl chloride in 
pyridine 
40 





Test 1(c), 0.03m1/lml at 2.56AUFS, 	489A (d), 0.03m1/lmI at 2.56AUFS 












treatment with thiophenol and tnethylamine and the oligonucleotide cleaved from the support with 
concentrated ammonia solution (Appendix A, end procedure depr ) (Table 12 ). Acyl base 
protection was removed by treatment with concentrated ammonia solution at 55°C for 6 hours and 
the product analysed by HPLC ( Fig. 32 ) comparison with a standard d(A)8 product from a 
synthesis (e) using 4,4'-dimethoxytrityl,cyanoethylphosphoramidite monomers (Fig. 33). The test 
product showed reasonable purity but was obtained in lower yield than the standard. This is found 
to be the case for all 9-fluorenylmethoxycarbonyl prepared oligonucleotides. 
The trimethylsilyl chloride capping reagent was abandoned in later syntheses because of the 
risk of creating insoluble salts and damaging the synthesiser. Capping in subsequent syntheses 
was performed with acetic anhydride and lutidine in THF, with N-methylimidazole catalysis 
synthesis (g) (Fig. 35). 
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d (A)8 (f), 0.05m1/lmI at 0.64AUFS 
Monitored at 254nm 
Ion Exchange HPLC 
d (A)8 (e), 0.01 5mV1 ml at 0.64AUFS 
Monitored at 254rim 
Ion Exchange HPLC 
( Figure 32. ) 
50 
d (A)8 (t), 0.05m1/1  ml at 1 .28AUFS 	d (A)8 (e), 0.05m1/1  ml at 1 .28AUFS 
Monitored at 254nm 	 Monitored at 254nm 
Reversed Phase HPLC 	 Reversed Phase HPLC(75% actual size) 
(Figure 33. ) 
d (A)8 (e), 0.025m1/lmI + d (A)8 (f), 0.005m1/lmI at 0.64AUFS 
Monitored at 254nm 
Reversed phase HPLC 
( Figure 34. 
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d (A)8 (g), 0.05mVlmI at 1.28AUFS 
	
d (A)8 (I), 0.025m1/lmI at 2.56AUFS 
Monitored at 254nm 
	
Monitored at 254nm 
Ion Exchange HPLC 
	
Ion Exchange HPLC 
Figure 35.) 
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A 9-fluorenylmethoxycarbonyl protected resin was not produced because of the difficulty of 
synthesising a 5-0-(9-fluorenylmethoxycarbonyl)-thymidine-3-succinate and of assessing the 
loading of the resulting resin. 
2.3 The Synthesis of Hexathymidjlic acid: A Comparison of Five Synthetic Strategies. 
5'-O-(9-Fluorenylmethoxycarbonyl)-thymidine-3-O-N,N-diisopropylmethoxyphosphoramidite (23) 
and 5-O-(9-fluorenylmethoxycarbonyl)-thymidine-3-O-N,N-diisopropylcyanoethylphoSphOramidite 
(24) were synthesised (Scheme 21) and the deoxyoligonucleotide d (T)6 was selected as a test 















° cy er 0 N°  
R=Me 
/ 	




T, 5'-protection 5'-cleavage N.N-diisopropyl 
phosphoramidite 
resin type 
h FMOC piperidine meth u,ls sarcosyl 




k FMOC piperidine cyanoethyl Beckman 
(succinyl) 
I FMOC DBU cyanoethyl sarcosyl 
(Table 10.) 
Short oligonucleotide sequences have the advantage that base modifications are clearly seen 
in their reversed phase HPLC . The use of strong non-nucleophilic bases with thymidine and 
trimethylphosphate in a model study has been found to cause base methylation108.The thymine 
base has pKa of 9.94 (25°C) and can therefore be deprotonated by bases such as triethylamine 
(pKa 10.75) and piperidine (pKa 11.23), leaving an active anion to accept a methyl group from 
a phosphotriester. Triethylamine has been shown to cause base methylation at a very slow 
rate(1 3% in 2 days) but DBU, with a significantly higher pKa, causes methylation at a much faster 
rate(95% in 3 hours). This result was confirmed in work done in this laboratory109 showing that 
thymidine would need to be protected in order to be used with DBU or DBN solutions. Previous 
workers 66,67  on FMOC deoxyoligonucleotide synthesis had not reported any base modification 
side reactions and so syntheses of T6 using 5% piperidine in acetonitrile as a 5'-hydroxyl 
deblocking agent were performed (syntheses h,i, and k). A longer deprotection time was 
necessary with the piperidine solution and therefore a longer cycle time (Table 11). However, it 
was discovered that the commercial long chain alkyl-amine succinyl resin was stable to this 
solution so subsequent deoxyoligonucleotide syntheses using piperidine solutions were carried 
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Operation Reagent/solvent Time/s 
wash acetonitrile 30 
deblock 5' 5% piperidine in acetonitrle 180 
wash acetonitrile 30 
wash anhydrous acetonitrile 60 
coupling step 0.1M phosphoramidite in acetonitrile 
0.5M tetrazole in acetonitrile 
30 
capping step acetic anhydride/lutidine/THF 1/1/8 
17.6% N-methylimidazole in THF 
40 










wash methanol 4 
cleave succinyl 
linker 
concentrated ammonia solution 60 
(Table 12. 
out with commercial resin (Beckman or ABI.). The 5%piperidine solution in acetonitrile was found 
not to cause significant base modification( reversed phase HPLC of syntheses ( h). and (I). as 
compared with synthesis (j). Fig. 36, 37 and 38). Yields from commercial (succinyl ) resin and 
sarcosyl resin for FMOC syntheses were found to be similar (estimated from HPLC peak 
integration). Piperidine can thus be used with succinyl linkage, it does not cause base modification 
side reactions and it is easily dried and purified. It therefore appears to be a useful deblocking 
reagent in 9-fluorenylmethoxycarbonyl mediated synthesis despite the fact that its use increases 
the synthesis cycle time. 
Of all the syntheses of d (T)6 using 5'-(9-fluorenylmethoxycarbonyl)-protected monomers 
synthesis (I), using sarcosyl resin with 10% DBU solutions and a cyanoethyl phosphoramidite, 
was the purest by HPLC (Fig. 42) and this scheme would have to be considered if long sequences 
were attempted. The use of cyanoethyl-phosphoramidites does not lead to alkylation of the 
thymine base as it is presumed that the cyanoethyl group is removed at every DBU treatment with 
the beta elimination product of this reaction being acrylonitrile. The growing oligonucleotide in 
such a synthesis would have a phosphodiester backbone with potential for side reactions. In 
phosphoramidite synthesis these side reactions are liable to be minimal as, unlike phosphot-
nester oligonucleotide synthesis, no strongly electrophilic activating agents such as triisopro-
pylbenzenesulphonyl chloride are used. In later work it was decided to employ the milder 
deprotection conditions and preserve the phosphotriester backbone. 
All the syntheses show, in ion exchange HPLC, a small peak which may correspond to a mixture 
of oligonucleotides of chain length 1 unit longer than the target and it was noted that the monomers 
had a lifetime of only about 48 hours in acetonitrile (t.l.c. showed lower running spot due to loss 
of FMOC from the nucleoside and higher running fluorescent spot due to dibenzofulvene). Some 
of the monomer may thus become 5'-deprotected in acetonitrile solution. Ten equivalents of 
monomer are added per coupling step and where a free 5'-hydroxyl monomer adds to a growing 
oligonucleotide it is likely that it will react with a further monomer to give a double addition. The 
solid 9-fluorenylmethoxycarbonyl monomers do not appear to deteriorate if stored at 4°C. 
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T6 (h), 0.05m1/lmI at 1.OAUFS 	 T6 (h), 0.05mVlmI at 0.64AUFS 
Monitored at 264nm 	 Monitored at 264nm 
Reversed Phase HPLC 	 Ion Exchange HPLC 
Figure 36.) 
T6 (I), 0.05m1/lmI at 0.64 AUFS 
	
T6 (I), 0.05mt/1 ml at 1.0 AUFS 
Monitored at 264nm 
	
Monitored at 264nm 
Ion Exchange HPLC 
	
Reversed Phase HPLC 
(Figure 37. 
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To (I), 0.04m1/1ml + T6 (j),  0.01 5m1/1  ml mixed sample at 0.5 AUFS 
Monitored at 264nm 
Reversed Phase HPLC 
(Figure 38. 
(I), 0.04m1/lmI at 1.0 A 
	
(I), 0.03m1/lmI at 0.64 AUFS 
Monitored at 264nm 
	
Monitored at 264nm 
Reversed Phase HPLC 
	
Ion Exchange HPLC 
( Figure 39. 
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r6 (k), 0.05m1/lmI at 0.64 AUFS 
Monitored at 264nm 
Ion Exchange HPLC 
Figure 40.) 
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T6 (k), 0.08m1/lmI at 1.0 AUFS 
Monitored at 264nm 
Reversed Phase HPLC 
(Figure 41.) 
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T (I), 0.07mVl ml at 0.64 AUFS 	 T (I), 0.08m1/1 ml at 1.0 AUFS 
Monitored at 264nm 	 Monitored at 264nm 
Ion Exchange HPLC 	 Reversed Phase HPLC 
Figure 42. 
2.4 Orthogonal Protection in Oligonucleotide Synthesis 
As 9-fluorenylmethoxycarbonyl proved to be effective as a base labile 5-0-protecting group, 
acid labile protection could now be applied to the exocyclic amine functions of the bases. This 
scheme would allow the complete deprotection of an oligonucleotide still bound to the solid 
support as the linker is stable both to the bases used to remove 9-flu&enylmethoxycarbonyl 
groups and to acid treatment. The use of such resin bound oligonucleotides for sequence specific 
hybridisation might then be a possibility. It should be possible to assess the purity of the bound 
oligonucleotide by cleavage of a sample of the resin, with concentrated ammonia solution, and 
by subsequent HPLC analysis of the product oligonucleotide. 
Initially, adamantyloxycarbonyl protection (25) was applied to N(4) of cytidine by transient 
protection followed by the addition of adamantoylfluoroformate(Scheme 22). However the 
adamantoyl protection was found to be too stable towards acidolysis for use in oligonucleotide 
synthesis, where there is the omnipresent risk of depurination.The adamantoyl carbamate was 
stable to 80% acetic acid but was cleaved quickly by treatment with 60% hydrochloric acid in 
ethanol. 






.70 (25) HO 
(Scheme 22.) 
4.4'-Dimethoxytrityl groups have been reported for amine protection in oligonucleotide synthe-
sis114 and so the amino-groups of dC, dG and dA were protected by 4,4'-dimethoxytritylation of 
trimethylsilyl protected nucleosides(Scheme 23) (26, 27, 28) . These compounds could be 
deprotected instantly by a solution of 3% trichloroacetic acid in dichloromethane. A standard 
synthesis of d(A)20  synthesis(n) was carried out to demonstrate that depurination of deoxyad-
enosine did not seem to occur to a significant extent even after the equivalent of 10 minutes 
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Me 	 OMe 
	
NH2 	 NH 
N: tjN 	 N 
:] 
HO 	 (i)pyridine/TMS-CI HO 	
N 
(ii)DMTr-Cl 
O 	 (iii)NH4OH 	HO 	 (28) 
(Scheme 23.) 
treatment with trichloroacetic acid (3% solution in dichloromethane)(Fig. 43). The ribose 5'-
hydroxyls were protected with 9-fluorenylmethoxycarbonyl groups(29, 30 and 31) by reaction 
with 9-fluorenylmethoxycarbonyl chloride in dry pyridine and the 3'-hydroxyl sites reacted with 
N, N-diisopropylmethoxyphosphonamidic chloride to produce the phosphoramidites (32, 33 and 
34) which were characterised by phosphorus NMR against a phosphate standard. 
Synthesis of oligonucleotides was then carried out using the P1 PM El synthesis cycle (Append. 
A., PIPME1), (Table 11) and 5%piperidine in acetonitrile asdeblocking reagent. With the final 
9-fluorenylmethoxycarbonyl group in place, all amine protection was removed by treatment with 
a solution of 3% trichloroacetic acid in dichloromethane (10 minutes). The final 5'-protecting 
group was removed and the oligonucleotide deprotected at the phosphorus and cleaved from the 
resin using the normal met hoxyphosphoramidite ending procedure. (Append. A., depr). All 
products were analysed by reversed phase and ion exchange HPLC and compared with 
oligonucleotide standards of the same sequence prepared by routine methods. 
In this way d(A)8 synthesis (m), d(GA)3 synthesis(q), and d(GT)3 synthesis(o) were successs-
fully prepared in similar yield and purity to the 5'-O-(9-fluorenylmethoxycarbonyl)- N-acyl product 
obtained previously(Fig. 44 - 52). The synthesis d(C)6 was unsuccessful showing only a tiny 
amount of product. 
Removal of all protecting groups before cleavage of the oligonucleotide from the support 
simplifies the post synthetic treatment of the oligonucleotide product, as heating in concentrated 
I LL. 
d (A) (n), 0.03mV1mI at 0.64 AUFS 
	
Monitored at 264nm 
Ion Exchange HPLC (75% of actual size) 
Figure 43. 
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d (GA)3 (q), 0.1 mI/l ml at 0.64 AUFS 
Monitored at 264nm 
Ion Exchange HPLC 
d (GA)3 (r), 0.03m1/1 ml at 0.64 AU FS 
Monitored at 264nm 
Ion Exchange HPLC 
Figure 44. 
d (GA)3 (q), 0.08mVlmI at 0.5 AUFS 
Monitored at 264nm 
Reversed Phase HPLC 
d (GA)3 (r), 0.03m1/lmI at 0.5 AUFS 
Monitored at 264nm 
Reversed Phase HPLC 
Figure 45.) 
d (GA)3: (q) 0.05m1/1 ml + (r), 0.03m1/1 ml mixed sample at 0.64 AUFS 
Monitored at 264nm 
Ion Exchange HPLC 
(Figure 46.) 
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d (A)8 (m), 0.05m1/1mI at 0.64 AUFS 
Monitored at 264nm 
Ion Exchange HPLC 
d (A)8 (e), 0.05m1/1  ml at 0.64 AUFS 
Monitored at 264nm 
Ion Exchange HPLC 
(50% of actual size) 
Figure 47.) 
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Cl (A)8 (m), 0.075m1/1 ml at 1.0 AUFS 
Monitored at 264nm 
Reversed Phase HPLC 
d (A)8 (e), 0.02m1/1 ml at 1.0 AUFS 
Monitored at 264nm 
Reversed Phase HPLC 
Figure 48.) 
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d (A)8: (m), 0.03m1/1 ml + (e), 0.01 mIll ml mixed sample at 0.64 AUFS 
Monitored at 264nm 
Ion Exchange HPLC 
( Figure 49.) 
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0.03m1/lmI at 0.64 AUFS 	d (GT)(q), 0.06m1/lmI at 0.64 AUFS 
Monitored at 264nm 
	
Monitored at 264nm 
Ion Exchange HPLC 
	
Ion Exchange HPLC 
(Figure 50.) 
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d (GT)3 (p), 0.05m1/lmI at 1.0 AUFS 
Monitored at 264nm 
Reversed Phase HPLC 
d (GT) (q), 0.07mI/lmI at 1.0 AUFS 
Monitored at 264nm 
Reversed Phase HPLC 
(Figure 51.) 
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d (GT)3 (p), 0.015m1/lmI + 
(q), 0.040m1/lmI at 0.64 AUFS 
Monitored at 264nm 
Ion Exchange HPLC 
d (GT)3 (q), 0.060m1/1  ml at 1.0 AUFS 
(p), 0.05m1/lmI at 1.0 AUFS 
Monitored at 264nm 
Reversed Phase HPLC 
Figure 52.) 
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ammonia solution is no longer required. Complete deprotection of resin-bound oligonucleot ides 
may also allow the simple preparation of materials for hybridisation experiments. 
The decamer d( GATGTAGTAT) synthesis(t) was synthesised by the above strategy and allowed 
to remain attached to the controlled pore glass resin. After annealing to d(ACTACATCATACTACATC) 
synthesis(u) at 700C  for 15 minutes, a drop in uv absorbance of the free oligonucleotide of 15% 
was observed indicating that some hybridisation had taken place. Further samples (in gram 
quantities) of the T, dG, and dA monomers were prepared for investigation at Pharmacia LKB. 
2.4 The 5'-O-(9-tluorenylmethoxycarbonyl) Group in Oligoribonucleotide Synthesis 
A strategy for oligoribonucleotide synthesis was designed, making use of 5'-hydroxyl 9-
fluorenylmethoxycarbonyl protection, acyl base protection and 4-methoxytetrahydrpyran-4-yl 2'-
protection.The 2'-group is acid labile but stable to bases and therefore should remain intact during 
both 5'-deblocking steps and acyl group cleavage. 
Benzoylcytidine (35) was prepared by a transient protection methodology (Scheme 24) and was 
3',5'-0- protected with the tetraisopropyldisiloxane group. This silylated derivative (36) was then 
converted to the 2'-acetal (37) and, after removal of the tetraisopropyldisiloxyl group with 
tetrabutylammoniumfluoride in THF, the 5'-hydroxyl position was protected with a 9-fluoren-
ylmethoxycarbonyl group (Scheme 24) (39). This nucleoside was then converted into a 3'-O-N,N-
dilsopropylmethoxyphosphoramidite (40) by reaction with N ,N-diisopropylmethoxyphospho-
namidic chloride in the presence of diisopropylethylamine (Scheme 24). 
A short oligonucleotide r(C)6 (v) was synthesised using synthesis cycle (RNA2P)(Table 13). 
Deblocking of the 5'-hydroxyl was exactly as with other 9-fluorenylmethoxycarbonyl syntheses 
but a longer coupling time is required in oligoribonucleotide synthesis. Phosphate methyl groups 
were removed by treatment with thiophenol and triethylamine in dioxane and the oligonucleotide 
cleaved from the resin using standard methodology (end procedure "depr" Appendix A.). The 
benzoyl protecting groups were cleaved by treatment with concentrated aqueous ammonia 
solution at 55°C for 5.5 hours and the methoxytetrahydropyranyl groups were cleaved with 0.01 M 
hydrochloric acid at pH 2 for 1 hour. 
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(Scheme 24.) 
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Operation Reagent/solvent Time/s 
wash acetonitrile 30 
deblock 5' 5% piperidine in acetonitrle 180 
wash acetonitrile 30 
wash anhydrous acetonitrile 60 
coupling step 0.1 M phosphoramidite in acetonitrile 
0.5M tetrazole in acetonitrile 
300 
capping step acetic anhydride/lutidine/THF 1/1/8 
17.6% N-methylimidazole in THF 
40 




The product was analysed by ion exchange and reversed phase HPLC both before and after 
removal of the methoxytetrahydropyranyl group (Fig. 53, 54). 
The HPLC chromatograms indicated that the product was of similar purity to the deoxyoligonu-
cleotides synthesised using 9-fluorenylmethoxycarbonyl protection. This would therefore seem 
to be a viable method of oligoribonucleotide synthesis (as later shown by Gait and coworkers) 
However our product still showed a significant peak after the product peak in the ion exchange 
HPLC trace and it was feared that in longer syntheses this might be difficult to separate from the 
product. 
In addition to this the 5,6-dihydro-4-methoxy-2H-pyran starting material for 2'-0-protection 
must be used in large excess for a successful reaction to take place. It can be synthesised in a 
3 step process from 1 ,5-dichloropentan-3-one110111  (Scheme 25) but the yields are relatively low 
and synthesis is time consuming. The compound is available commercially but the price reflects 
r (C)6 (v), before removal of MTHP 
	
r (C)6 (v), after removal of MTHP 
Monitores at 280nm 
	
Monitored at 280 nm 
Reversed Phase HPLC 
	
Reversed Phase HPLC 
(Figure 53 
We 
after removal of MTHP 
	
r (C)R (v), after purification 
Monitored at 280nm 
	
Monitored at 280nm 
Ion Exchange HPLC 	 Reversed Phase HPLC 
(Figure 54.) 
[1] 
the difficult synthetic route. Ina single protection reaction this cost/time factor would not be crucial, 
but in nucleotide preparation a further  reactions follow in the general synthetic scheme( scheme 
24) and the yield of the second of these, the 9-fluorenylmethoxycarbonyl addition is only of the 
order of 50%. Hence this route leads to 50% destruction of expensive protecting groups and is 
therefore unlikely to be viable for commercial or large scale oligoribonucleotide synthesis. As this 
strategy was then published by Gait and coworkersr,8 it was decided to investigate other 2'-
protecting groups. 
0 
C1 A H20/W ci 	-an— HC(0CH/W/CH30H 0) 	---------- NO— 
CH30..00H3 	 OCH3 
(0) 
(Scheme 25.) 
Reaction of methoxyethoxymethyl triethylammonium chloride(MEM NEt3CI) with uridine had 
previously been reported.TM The MEM group had previously been used to protect both 2'-ribose 
hydroxyl and N(3) of the base in the preparation of polyU but had not been applied to other 
nucleosides. The methoxyethoxymethyl ether originally designed by Corey and coworkers' 12  is 
stable to basic hydrolysis and is cleaved by the action of Lewis acid catalysts like ZnBr2 . Two 
mechanisms of cleavage were proposed' 12  (Fig. 55). The stability of this protecting group may 
also allow the use of a wide range of acid or base labile 5'-hydroxyl protecting groups. 
Reaction of 4-N-benzoyl-3',5'-O-(tetraisopropyldisiloxanedi-3-yl)cytidine with M EM N Et3Cl 
(41) in refluxing ether gave a crystalline product (42) with a single M EM group attached at the N(4) 
amide position (Fig. 56). This was confirmed by a combination of proton NM R and mass spectrum 
data. Upon treatment with ammonia solution at 60°C overnight the uv activity of this nucleoside 
was lost indicating degradation of the heterocyclic base had occurred. 
CH3 









ROH + CH2(OH)2 + CH3OCH2CH2OH (I) 
F_\ 





CH3-0 0 	 H20 
CH 2 	 ROH + CH2(OH)2 + CH3OCH2CH2OH (1) 
Br2ZnOR 
(Figure 55. Proposed mechanism of MEM cleavage) 
Figure 56.) 
A method of completely preventing the addition of a MEM group to the base was needed.The 
possibility of using cyclic diacyl groups to protect both reactive sites on the N(6) amino group of 
adenine was investigated; 6-N-phthaloyladenosine (44) (Scheme 26) and 6-N-phthaloyl-3',5'-O-
tetraisopropyldisiloxanedi-3y1-adenosine (45) were synthesised. Synthesis of 4-N-phthaloylcytid-
me (43) was also attempted but led to only a 10% yield. The diacyl groups were found to be 


















Alternative "double protection" at the amino-group of adenosine can be achieved with the use 
of dialkylforamidine groups51. 6-N-di-n-butylformamidine-3',5'-O-tetraisopropyldisiloxanedi-3- 
yladenosine (49) was easily prepared by reaction of 3',5'-tetraisopropyldisiloxanedi-3-yl-adeno- 
kn 
go 
sine (48) with di-n-butyldimethylacetal (47) in dichioromethane at room temperature and this 
compound was found to be stable to fluoride ions.The protected product was a mixture of 2 
geometric isomers at the formamidine N-C double bond. It was possible to crystallise the major 
isomer of the product of this reaction from hexane, the X-ray structure of which was determined 
by Dr G.A.Leonard. This clearly showed the trans geometric isomer of the formamidine group as 
well as the position of the 2'-hydroxyl function which appears to be unhindered by the 
tetraisopropyldisiloxyl group (Fig. 57).No successful addition of MEM to this compound was 
achieved, under a variety of conditions and it may be concluded that activated MEM derivatives 
are a little too unreactive to react with the 2'-secondary hydroxyl group in silylated nucleosides. 
2.5 Fluorescent Labelling of Oligonucleotides with the 2,4-Dinitrophenyl Group 
Antibodies specific for the dinitrophenyl moiety are well known and have been used to study 
proteins and peptides. Sanger reagent, 2,4-ainitrofluorobenzene reacts with primary amines of 
side chains and alpha-amino groups within the peptide. Din itrophe nyl labelling of oligonucleotides 
has also been reported but only in solution phase reactions. No direct solid phase labelling 
strategy has yet been reported. Solution phase labelling involves the reaction of 2,4-dini-
trofluorobenzene with an oligonucleotide carrying a primary aliphatic amine group. The amine 
group may be introduced by modification of a nucleoside base. A modified nucleotide monomer 
for oligonucleotide synthesis has the advantage of allowing multiple label addition within the 
oligonucleotide structure but may involve a lengthy synthetic preparation making it unsuitable for 
routine use. In a second approach to amino group introduction, a simple aliphatic amino alcohol 
is functionalised to produce a monomer suitable for oligonucleotide synthesis, carrying a 
protected primary amine site. These nucleotide analogue monomers have the advantage of 
being simple to prepare from inexpensive starting materials. 
z- 4- Dintrof luorobenzene does not react with the N(4) amino group of 5'-O-(4,4"-dimethoxytrityl)-2'-
deoxycytidine (50) and so the initial strategy investigated was to modify this N(4)-site to carry a 
short alkyl linker ending with a primary amino-group. 2'-Deoxycytidine was refluxed with 












was difficult to purify and was therefore only partially characterised. The product (54) of the 
reaction of this N(4) modified nucleoside with 9-fluorenylmethoxycarbonyl succinimide (Fig. 59) 
had the desired peak in the FAB mass spectrum. The oil (52) also reacted vigorously with 2,4-
dinitrofluorobenzene(53) (Fig. 58). Both the FMOC and the 2.4-dinitrophenyl derivatives were 
equally insoluble. 
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In an attempt to produce a labelled amine, for use in base modification reactions, ethylenedi-
amine was treated with 1 equivalent of dinitrofluorobenzene in ether and an insoluble yellow solid 
(51) was produced, thought to be a hydrofluoride salt. Attempts to solublise this salt in organic 
solvents by washing with 2M sodium hydroxide solution failed. The mass spectrum of this 
compound showed a signal at m/z = 227 corresponding to the expected molecular ion. 
A reagent with only one primary amine group was therefore selected, 6-aminohexan-1 -ol, and 
0 °  
H2N— (CH2)6  —OH 
pyridine 














a nucleotide analogue approach was now attempted. This methodology has the advantage of 
simplicity over the base modification approach. Readily available amino-alcohols can be N-
protected easily and converted by conventional chemistry to monomers suitable for oligonucleo-
tide synthesis. A monomer (56) was prepared with the amine protected with the 9-fluoren-
ylmethoxycarbonyl group (Scheme 28). This cyanoethylphosphoramidite was coupled to free 
hydroxyl of thymidine long chain alkyl-amine controlled pore glass resin and after oxidation of the 
phosphoramidite the FMOC group was removed with piperidine solution to give a resin with a 
primary amine group attached .This was shown by a positive ninhyd rin test' 13.2  for amines and by 
the fact that the resin turned bright yellow on treatment with dinitrofluorobenzene. 
The FMOC-amino-hexyl monomer was therefore used in oligonucleotide synthesis, coupled at 
the 5'-end in the sequence d(FMOC-aminohexanol-CGCGAATTCGCG) synthesis(w) .The 
FMOC group was removed with 5% piperidine in acetonitrile (5 minutes) and the resin soaked in 
10% dinitrofluorobenzene solution (v/v) in dichioromethane for 1 hour. The oligonucleotide was 
then cleaved from the resin, deprotected as normal and the product analysed by HPLC. No 
oligonucleotide was visible by HPLC at all, even when reversed phase analysis was carried out 
with 40% acetonitrile solution. The reason for this failure was not clear and so it was considered 
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Amino-hexanol was reacted directly with dinitrofluorobenzene to give compound (57) (Scheme 
29). It was found thatthe secondary amine produced in this reaction could not be further protected 
by benzoylation with benzoyl chloride in pyridine and it was therefore concluded that the 
secondary amine would probably be inert during oligonucleotide synthesis. The alcoholic function 
99 
was converted to the N, N-diisopropylcyanoethoxyphophoramidite (59) with cyanoethoxy-N ,N-
dilsopropylchiorophosphine in the presence of diisopropylethylamine (Scheme 29) and the phos-
phorus purity of this monomer was confirmed by 31 P NM R. After flash silica gel chromatography 
the product was isolated as an oil, soluble in acetonitrile and stable at 200C  for at least 1 month. 
This monomer (59) was then used directly in oligonucleotide synthesis (cycle sscel 03a, Table 
8). The 13mer d(DNP-CGC GAA TIC GCG) synthesis(x) was synthesised and deprotected 
using standard reagents and cycles to give a pure labelled oligonucleotide in good yield. The label 
was found to be stable to treatment with concentrated ammonia solution at 600C  for at least 48 
hours when monitored by HPLC (Fig. 60,61). Digestion of the oligonucleotide with snake-venom 
phosphodiesterase and alkaline phosphatase, at 37°C at pH 8,8 in tris buffer, revealed the 
expected four nucleosides and 6-N-(2,4-dinitrophenyl)-aminohexan-1-ol when analysed by 
reversed phase H PLC. The effect of the label on hybridisation was investigated by means of DNA 
melting study by Dr. T.Brown. The labelled oligonucleotide was found to have a melting tempera-
ture (70°C) identical to the native 1 2mer(70°C) indicating that the label neither prevents 
hybridisation (melting temperature would drop) or intercalates (which might be expected to raise 
the melting temperature). 
A number of labelled oligonucleotides were prepared by the same methodology d(DNP-CCT 
TTA TAG AAG CGT TCT CGC CCA GCC GCT GCC) synthesis(y) was used in a radioimmune 
competitive binding assay and in a hybridisation test, again showing that the label did not prevent 
hybridisation. 
The sequences d(DNP-CCT CAC AGA GCA AGA TAA GGA), d(DNP-AAG CTT GCA CAA 
TGC CAA AAA ACA G), and d(DNP-CTC GAG TAT GCC GAG ACC CCI AAT C) syntheses(z) 
were successfully used as primers for polymerase chain reaction by R.W.Honess at the National 
Institute for Medical Research, Mill Hill, London, and the PC R products were identified by antibody 
binding which was extremely efficient (preliminary results). 
This synthetic methodology provides a simple, inexpensive, reliable route to chemically labelled 
oligonucleotides which are especially easy to purify by HPLC. Reversed phase HPLC gives 
excellent separation between non-labelled failure squences and the more lipophilic labelled 
ME 
Oligonucleotide (y), at 0.125 AUFS 	Otigonucteotide (y) at 0.125 AUFS 
0.1 ml (after 22 hours in ammonia at 600C) 	0.1ml (after 22 hours in ammonia at 600C)  and 
0.1mI untreated 
Monitored at 290nm 
	
Monitored at 290nm 
Reversed Phase HPLC 	 Reversed Phase HPLC 
Figure 60. 
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Oligonucleotide (y), 0.1mI at 0.125 AU FS 
(After 40 hours in ammonia at 60°C) 
Monitored at 290nm 
Reversed Phase HPLC 
Oligonucleotide (y), 0.1 ml at 0.125 AUFS 
(After 1 week in ammonia at 60°C) 
Monitored at 290nm 
Reversed Phase HPLC 
( Figure 6l.) 
product which is eluted at higher acetonitrile concentration. The DNP-labelled oligonucleotide 
requires no special handling relative to a non-labelled oligonucleotide and the labelled phospho-
ramidite monomer can be treated exactly the same as a nucleoside phosphoramidite. In addition 
no post solid-phase synthetic procedures are required. 
The above method is limited to the addition of a single label which effectively blocks the 5'-end 
of the oligonucleotide chain. An amino-diol, however, could be used to produce an analogue 
capable of multiple additions at any point in oligonucleotide (Fig. 62). Aminopropan-2,3-diol was 
selected as a readily available starting material and reacted with dinitrofluorobenzene in 
methanol. The yellow crystalline product was then protected at the primary hydroxyl site by 
reaction with 1 equivalent of 4,4-dimethoxytrityl chloride in anhydrous pyridine. 
In the future this compound will be converted to the phosphoramidite at the secondary hydroxyl 
site and then used in oligonucleotide synthesis to produce multiply labelled products. Although 
the spacer between the 2,4-dinitrophenyl group and the oligonucleotide is short, if required other 
compounds could be produced with longer chains to facilitate antibody binding. However there 
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Materials and Methods 
3.1 Purification of Solvents 
Commercially available solvents were used without further purification, unless otherwise 
stated. Anhydrous pyridine, diisopropylethylamine and triethylamine were obtained by heating 
under ref lux with potassium hydroxide pellets, followed by distillation. Pyridine was stored 
under nitrogen in sealed bottles. Dichloromethane was dried by refluxing with calcium hydride 
followed by distillation and was stored over pre-dried molecular sieves. Tetrahydrofu ran 
(THF) was purified by heating at refiux with sodium and benzophenone, under nitrogen, 
followed by distillation. 
Diethyl ether and toluene were dried by addition of sodium wire. 
3.2 Chromatographic Separation 
Thin Layer Chromatography (tic) 
Analytical tic was performed using aluminium backed silica tic plates (Merck 5554) devel- 
oped in one of four solvent systems (unless otherwise stated). 
Solvent Systems; 
10% methanol in dichloromethane 
20% methanol in dichloromethane 
50% ethylacetate in dichloromethane 
5% methanol in dichloromethane 
After developing, the results were viewed under uv light (254nm or 280nm) and were visual-
ised with either iodine or anisaldehyde staining. 
Anisaidehyde Staining 
A solution containg 2% anisaldehyde, 20/o acetic acid and 5% sulphuric acid in ethanol was 
sprayed onto developed plates which were then heated on a hot plate for 5 minutes. All 
ribose containing spots are turned either dark blue or dark green while areas without ribose 
remain pale. (This operation must be carried out in a fume cupboard as the anisaldehyde 
reagent is extremely toxic). 
Chromatographic separation was carried out using silica gel (Fluka silica 60 mesh 230 - 400) 
and slight positive pressure (3psi) of nitrogen. 
High Performance Liquid Chromatography ( HPLC) 
Oligonucleotides were analysed by HPLC using either a Gilson or Perkin- Elmer system and 
detected by uv absorbance at 264nm. Strong Anion Exchange and Reversed Phase separa-
tion techniques were employed. 
Strong Anion Exchange HPLC was carried out with hypersyl and partisil columns using a two 
solvent system and an elution gradient of 0 - 70 % solvent B. 
Solvent A. 4g KH2PO4 in H20/acetonitrile 600/400m1 adjusted to pH 6.4 with KOH aqueous 
solution. 
Solvent B. 78g KH2PO4 in H20/acetonitrile 600/400ml adjusted to pH 6.4 with KOH aque-
ous solution. 
Reversed Phase HPLC was carried out using C. reversed phase columns (Brownlee Aq-
uapore, reference number RP200 ) with one of three elution systems. 
For all non-labelled oligonucleotides. 
Solvent A. 0.1M NH4OAc in H 2  0 
Solvent B. 0.1 M NH4OAc in H20/acetonitrile 8/2 v/v 
Elution was by means of a gradient from 0 - 70% solvent B over a period of 20 minutes. 
For Din itrophenyl labelled oligonucleotides. 
Solvent A. 0.1 M NH4OAc in H20. 
Solvent B. 0.1 M NH4OAc in H20/acetonitrile 6/4 v/v. 
Elution was with a solvent gradient from 0 - 70 % solvent B over a period of 20 minutes. 
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3.3 Analytical Techniques 
Melting points were obtained using a Kopfler Hot Stage apparatus. 
Elemental Analysis 
Microanalysis was carried out by Mrs E.McDougall  using a Perkin-Elmer 240 Elemental 
Analyser. 
X-Ray Crystallography 
X-Ray data was collected, solved and refined by Dr G.A.Leonard using a Stoe- Siemens 
AED-4 diffractometer. 
3.4 Spectroscopic Techniques 
Nuclear Magnetic Resonance Spectroscopy 
1H NMR spectra were carried out using a Brucker WP 200 SY spectrometer by Mr 
J.R.A.Millar and Miss H.Grant. Chemical shifts are quoted in parts per million against a 
tetramethylsilane standard. 
31  P NMR were obtained using a Jeol JMN FX900 spectrometer by Mr P Tan. The chemical 
shifts are quoted with reference to a phosphate standard. 
Infra-Red Spectroscopy 
Spectra were taken using a Perkin Elmer 781 spectrometer, with samples as nujol mulls 
between sodium chloride plates and were calibrated against a polystyrene standard 
(1603 cm'). 
Mass Spectroscopy 
All mass spectra were obtained using positive or negative Fast Atom Bombardment (FAB) 
ionisation techniques and were carried out on a Kratos MS 50 spectrometer by Mr A.Taylor. 
Spectroscopy was carried out on a Perkin-Elmer Lamda 15 double beamed spectrometer. 
Oligonucleotide Synthesis 
Oligonucleotide synthesis was carried out on an Applied Biosystems (ABI) 380B oligonu-
cleotide synthesiser using standard reagents and cycles unless otherwise stated. Cycles are 
included in Appendix A. All syntheses were of 0.2micromole scale 
Snake Venom Digest 
A sample of oligonucleotide( approximately 2 OD units) was dissolved in tris buffer pH 8.8 and 
to this was added 0.2mg of snake venom phosphodiesterase (Sigma) and 5 microlitres alkaline 
phosphatase solution ( Sigma). This mixture was then incubated overnight at 37°C. Analysis was 
by reversed phase HPLC (elution system the same as for normal oligonucleotides). 
4.4'-Dimethox4rityl Analysis 
The sample for analysis was dissolved in 60% hydrochloric acid in ethanol solution (25ml 
for the deprotection samples from a 0.2 micromole synthesis) and the absorbance at 495nm 
measured spectrophotmetrically. At 495 nm 1 micromole of 4,4-dimethoxytrityl cation gives a 















3-O-Benzoylthymidine-5-O-succinyl-glycine ethyl ester 
5'-O-(4,4'-Dimethoxytrityl)thymidine-3'-O-g lutarate 
5'-O-(4,4"-Dimethoxytritylthymidine-3'-O-glutaryl-g lycine ethyl 
ester 
 N-(9-Fluorenylmethoxycarbonyl)sarcosine 
 Sarcosylthymidine resin 
 Sarcosyl adenosine resin 






deoxyadenosine-3'-O-N , N-diisopropylmeth 
phosphoramidite 
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(22) 	 5'-O-(9-Fluorenylmethoxycarbonyl)-2-N-isobutyryl-2- 
deoxyguanosine 
(23) 	 5'-O-(9-Fluorenylmethoxycarbonyl)thymidine-3'-O-N , N- 
dilsopropylcyanoethyiphosphoramidite 
 5'-O-(9-Fluorenylmethoxycarbonyl)thymidine-3'-O-N , N- 












dimethoxytrityl)-2'-deoxyadenosine-3'-O-N , N- 
diisopropylmeth j L phosphoramidite 
 5'-O-(9-Fluorenylmethoxycarbonyl)-2-N-(4,4'- 
dimethoxytrityl)-2'-deoxygu nosine-3'-O-N N- 
dilsopropylmeth jL phosphoramidite 
 5-O-(9-Fluorenylmethoxycarbonyl)-4-N-(4,4"- 
dimethoxytrityl)-2-deoxycytidine-3'-O-N , N- 











methoxytetrahydropyran-4-yl)-4-N-benzoylcytidine-3-N , N- 
diisopropylphosphoramidite 
Methoxyethoxymethyl triethylammoniu m chloride 








 Di-n - Butylformamide dimethyl acetal 
 3,5-(Tetraisopropyldisiloxane-1 ,3-diyl)adenosine 
 6-N-Di-n-Butylformamidine-3,5-(tetraisopropyIdisiloxane-1 ,3- 
diyl)adenosine 
5'-O-(4,4'-Dimethoxytrityl)-2'-deoxycytidine 
Product from the reaction of ethylenediamine with 2,4-
dinitrofluorobenzene 
2'-Deoxycytidine ref luxed with ethylenediamine 
Reaction of (52) with dinitrofluorobenzene 
Reaction of (52) with FMOC-succinimide 
N-(9-Fluorenylmethoxycarbonyl)-6-aminohexan-1 -ol 
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(56) 	 N-(9- Flu orenylmethoxycarbo nyl)-6-aminohexan- 1 -01-1 -N, N- 
diisopropylcyanoethylphosphoramidite 
N-(2,4- Din itrophenyl)-6-aminohexan-1 -01 








5-O-(4,4 '-DimethoxytrityI)-thymidine (1) .-Thymidine(4.84g,2Ommol), dried by coevaporation 
from dry pyridine, was dissolved in dry pyridine(150m1) and dimethylaminopyridine (DMAP) 
(122mg,0.05 equivalents) , triethylamine(3.8ml,1 .4 equivalents) and dimethoxytrityl chloride 
(8.1249,1.2 equivalents ) were added. The solution was stirred for 2 hours and the reaction 
followed by tic (10% MeOH , 2% TEA, in dichloromethane). 4,4'-Dimethoxyjrityl chloride (2.2g,0.2 
eq) and triethylamine( 1 .4m1,0.5eq) were then added and after a further hour the reaction mix was 
poured into an equal volume of water. The product was extracted with ether (2x500m1) and the 
organic phase evaporated to dryness. Purification by flash chromatography (2% MeOH, 2% 
tnethylamine in dichloromethane) gave 5'-O-( 4,4"-dimethoxyfrityl)-thymidine (1) (1 0.89g, 99%), 
m.p. 118-120°C (lit, value (Aldrich) 117-121°C). 
50-(9-FIuorenyImethoxycatbony/)-thymidine (2).-To dry thymidine(lg,) in anhydrous pyridine(1 5m1) 
was added 9-fluorenylmethoxycarbonyl chloride (1 .2 eqs) .The reaction was protected from 
moisture with a silica gel drying tube and stirred for 2 hours at room temperature. When tic (5:1 
EtOAc:MeOH) indicated that the reaction was complete the solution was poured into water(200ml) 
and extracted into chloroform(5x3Oml ).The organic phase was dried over sodium sulphate and 
evaporated to dryness. Crystallisation from dichloromethane gave 5'-0-(9-fluoreny1methoxycar-
bonyl)-thymidine (2) (0.96g, 50%), m.p. 188-9°C (lit., 1900C); ?(MeOH) 265nm (810,000 
dm3mol1cm 1); m/z 487 (30%), 465( M+H, 100%). 
5'-(9-Fluorenylmethoxycarbonyl)-thymidine (2) stability in organic solvents (t.l.c. system A). 
10% DBU in acetonitrile ---- complete deprotection in 4 mins 
10% DBU in acetonitrile + 1 eq acetic acid-- complete deprotection in under 40 mins. 
10% DBU in acetonitrile +2equivalents acetic acid ---- incomplete deprotection. 
3'-O-Benzoylthymidine was not affected by 10%DBU in acetonitrile. 
5'-( 9-Fluorenylmethoxycarbonyl)-thymidine was stable in ; ethanol, methanol, acetonitrile, 
chloroform, pyridine, dichloromethane, 1 .2-dichloroethane (t.I.c. system A). 
5'-(9-Fluorenylmethoxycarbonyl)-thymidine (2) was stable in freshly distilled DMF, but 
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decomposed when dissolved in SLR grade DMF (t.l.c. system A). 
Triethylammonium[- 5'-0-( 9-fluorenylmethoxycarbonyl)-thymidine-- 3'-O-( 2-chiorophenyl 
phosphate)]. (3).- Chlorophenyiphosphorodichloridate (0.2m1) was added to a solution of 
1 ,2,4-triazole (0.23g,3.29mmol) in dry triethylamine (0,4 ml, 2.39mmol).After 30 minutes the 
white solid triethylamine hydrochloride was filtered off and the clear solution added to dry 5'-
(9-fluorenylmethoxycarbonyl)thymidine(0.4g,0 .B6mmol) and left for 5 minutes. The product 
was extracted with dichloromethane(3x3ml), dried over sodium sulphate, and evaporated to 
dryness. 
The product was precipitated from dichloromethane into dry n-pentane (with vigorous 
stirring), to give Triethylammonium[5'-O-( 9-fluorenylmethoxycarbonyl)-thymidine- 3'-0-( 2-
chlorophenyiphosphate)] (3) (0.357g, 64%); m/z 735 [M-(H+), 80%]. 
Stability of succinyl linkage to resin to 10% DBU solution on pyridine.- High loading resin 
1 50x10 (-6)  mol/g was tested. 
Two samples(each 10mg) were prepared; to the first was added 10% DBU in dry dichlorom-
ethane (v/v,1 ml)and the second was soaked in dry dichloromethane(1 ml) as a control. After 
40 minutes the resin was removed by filtration and the filtrates made up to 25ml with 60% 
hydrochloric acid! ethanol.The DBU solution gave a deep orange colouration characteristic of 
trityl cation. Cleavage of the first nucleotide from the resin had occurred. The solution from 
the control remained clear. 
III 
5'-O-(4,4'DimethoxytrityI)thymidine -3-0- succinate (4).- To dry 5'-O-(4,4"-dimethoxytrityl)thymidine 
(O.17g,O.3mmol ), dissolved in anhydrous pyridine, was added succinic-anhydride ( 0.03g,0.28mmol) 
and DMAP ( 0.02g,0.2mmol).The mixture was stirred at room temperature for 24 hours and the 
reaction was monitored by tic (system A) against a standard sample of the succinate. When the 
reaction was complete by tic(system A), dichloromethane(20m1) was added and the mixture 
washed with water (2x5m1).The organic portion was dried over sodium sulphate, evaporated to 
a small volume and precipitated into dry n-hexane to give 5'-0-( 4,4"-dimethoxytrityl)thymidine-
3'-O-succinate (4).(0.09g, 48%), [Found: C, 67.2; H, 5.5; N, 4.35; 0,24.9%; M(mass spectrum), 
643.22918. C 36  H 35 N2010 calc. C, 67.2; H, 5.5; N, 4.35; 0, 24.9%; M, 643.22915]; m/z 643 [M-
(H+), 80%], 543 (DMTrT, 100), 199, 99. 
Reaction of 5'-O-( 4,4" -Dimethoxytrityl)thymidine -3-O- succinate (4), with glycine ethyl 
ester.- 5'-0-(4,4"Dimethoxytrityl)thymidine-3'-O-succinate (0.2g,0.3mmol) was dissolved in a 
minimum volume of dichloromethane and DCCI (0.04g,0.1 5mmol) was added. This mixture 
was filtered into neutralised glycine methyl ester(0.04g/0.04m1 triethylamine) 
The reaction was followed by t.l.c(system A), Rf starting material = 0.2, Rf product = 0.45, 
but did not go to completion,some starting material remained.The organic phase was washed 
with citric acid solution(l5ml of 5%) and water (lOmI) and dried over sodium sulphate and 
evaporated to dryness to give only product (5) (66mg, 30%); m/z 543 ( DMTr T, 100%). 
5'-0-( 4,4"-dimethoxytrityl)thymidine- 3'- 0-succinyl-glycine ethyl ester (6).--5"-0-(4 ,4"-
dimethoxytrityl)thymidine-3'-O-succinate (0.1 266g,0 .20mmol) and hydroxybenzotriazole 
(0.02g,0. 1 5mmol) were dissolved in dioxan/pyridine (0.5/0.3 ml) and DCC (0.07g,0.34mmol) was 
added. The mixture was stirred at room temperature for 2.5 hrs until all the starting material had 
been consumed.The white precipitate of N,N dicyclohexylurea (DCU)) was removed by filtration 
and the filtrate was added to the glycine ethyl ester (0.030g,0.26mmol), previously liberated from 
its hydrochloride with diisopropylamine. This mixture was stirred at room temperature overnight. 
After addition of dichloromethane(2ml) the organic phase was washed with citric acid (5%,1 OmI), 
107 
water (lOmI) , sodium bicarbonate solution (50%,10ml) and water (lOml),dried over sodium 
sulphate,evaporated to a small volume and precipitated into hexane to give solid 5'-O-( 4,4"-
dimethoxytrityl)thymidine- 3'-0-succinyl-giycine -ethylester (6).(60mg, 40%) (Found C, 64.9; H, 
6.8; N, 6.02. C 39  H 43 N3Oil requires C, 64.9; H, 6.8; N, 6.0%); ?. 	(MeOH) 207nm (C 41,044 
dm3molcm), 223nm (1 4,640),266nm (6,303); ö (200MHz; CDCI3) 1.7 (31-1, s, methyl of T) 2.4-
2.75 (71-1, m, C2'+succinyl Hs), 2.9(2H, d, CH2 ), 3.5 (21-1, s, C5,  H), 3.8 (61-1, s, methoxy of DMTr), 
4.0 (2H, d, C4'), 4.2 (21-1, q, CH  ester), 5.5 (1 H, d, C3'), 6.1 (1 H, t, C1'), 6.4 (1 H, t, NH), 6.8 (4H, 
d, DMTr), 7.1-7.4 (91-1, m, DMTr), 7.6 (1H, s, T 6H), 8.2 (1H, s, N(3)H of T). 
5'-0-(4, 4"dimethoxytrityl)thymidine-3'-O-succiny! sarcosine ethyl ester. (7).-- 5"-0-
(4,4"dimethoxytrityl)thymidine-3'-O-succinate (0.1 266g, 0. 2Ommol) and hydroxybenzotriazole 
(0.02g,0.15mmol) were dissolved in dioxan/pyridine (0.5/0.3 ml) and DCC (0.07g,0.34mmol) 
was added. The mixture was stirred at room temperature for 2.5 hrs until all the starting 
material had been consumed.The white precipitate of N,N dicyclohexylurea (DC U)) was 
removed by filtration and the filtrate was added to sarcosyl ethyl ester (0.0373g,0.26mmol), 
previously liberated from its hydrochloride with diisopropylamine. This mixture was stirred at 
room temperature overnight. After addition of dichloromethane(2ml) the organic phase was 
washed with citric acid (5%,1Oml), water (lOml) ,sodium bicarbonate solution (50%,1Omt) 
and water (1 Oml),dried over sodium sulphate, evaporated to a small volume and precipitated 
into hexane to give solid 5'-0-(4.4"dimethoxvtritvl)thvmidine-3'-0-succinvlsarcosine ethyl 
ester. (7) (62mg, 40%) [ Found: C, 64.7; H,6.0; N, 5.7; 0, 24.2%; M (mass spectrum), 
742.29759. C4OHMN3O11  requires: C, 64.7; H, 6.0; N, 5.7; 0, 24.2%; M, 742.29755.]; Xm. 
(MeOH) 207nm ( C 49,954 dm3 mol1  cm-1), 233 (20,817), 266 (9,842); 
H (200MHZ, CDCI3) 1.3 (61-1, m, Me/T+ester), 1.7 (31-1, s, Me/sarcosine), 2.7 (2H, s, CH) 
sarcosine), 3.0 (1H, d, C3'), 3.1 (1H, s, C4'), 3.4 (21-1, d, C5'), 3.75 (31-1, s, methoxy), 4.0-4.25 
(4H, m, succinyl CH 2)'  5.5 (1H, s, water), 6.4 (1H, t, Cl'), 6.8 (41-1, m, DMTr), 7.2-7.5 (9H, m, 
DMTr), 7.6 (1H, s, 61-1/T), 8.1 (1H, s, N-H of T). 
Stability of glycine and sarcosine model compounds to 10% DBU solution in..dichloromethane. - 
Model compound(lOmg) was dissolved in dichloromethane(lmi) and 10% DBU in 
dichioromethane(1 ml) was added. The stability of the sample was monitored by tic (system D). 
The glycine compound (6) was immediately decomposed to give a product with the same Rf value 
as 5'-O-(4,4"dimethoxytrityl)thymidine. 
The sarcosine compound (7) compound was stable to 10% DBU solution for at least 24 hours. 
10% OBU solution in methanoL- Both compounds (6) and (7) were broken down within 30 minutes 
when dissolved in this solution. 
Triethylamine. - Both compounds (6) and (7) showed no change ( by tic) when treated with 
excess triethylamine for 1 hour. 
3-0-Benzoylthymkiine (8).-To a stirred solution of dry 5'DMTrT(0.436g,0.8mmol) and DMAP(0.02g) 
in dry pyridine(1 .2ml) was added benzoic anhydride(0.27g,1 .5equivalents).After 4 hours the 
mixture was poured into water(40ml), extracted into dichloromethane(3x1 OmI) and evaporated 
to dryness.The residue was then dissolved in 80% acetic acid(20ml), stirred and warmed 
(350C),until detritylation was complete (monitored by system A). Acetic acid was removed by 
evaporation under reduced pressure and azeotroping with toluene to give solid 3'-O-Benzoylthy-
midine (8) (1 00mg, 50%); ?. m= 201 n ( E 15,556 dm3 mol1  cm1), 228 (13,049), 265 (8,874). 
5'-O-succinyl- 3'-O-benzoylthymidine (9).-_3'-O-Benzoylthymidine( 68mg ) was dissolved in 
anhydrous pyridine(lml)in the presence of DMAP(catalytic amount).To this solution succinic 
anhydride (2equivalents) was added in portions over 20 minutes.The solution was stirred followed 
by stirring at room temperature overnight, diluted with dichloromethane(1 5ml) and washed with 
1 0%citric acid(2ml) and ice cold water (5ml).The organic phase was dried over sodium sulphate 
and evaporated to dryness. Crystal lisation from diethylether gave 5'- O-succinvl- 3'- O-benzovlthv-
midine (9) (95mg, 74%) (Found C, 56.8; H, 5.0; N, 6.3%. C21H22N209 requires C, 56.5; H, 5.0; 
N, 6.3%). 
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3'- O-Benzoylthymidine- 5'- 0-succinylglycine ethyl ester (10) .-Hyd roxybenzotriazole 
(0.02g,0.14mmol)and the 5'-O-succinate (100mg, 0.14mmol) were dissolved in dioxan/pyridine 
(0.5m1/0.03m1)and DCC (0.07g,0.34mmol) was added. This mixture was stirred at room tempera-
ture 2.5 hours until all the starting material had been consumed (monitored by system A).The 
mixture was then filtered into a solution of glycine ethyl ester (previously liberated from its 
hydrochloride with triethylamine) and stirred at room temperature overnight, after which it was 
diluted with dichloromethane (lOmi) and washed with 5% citric acid solution (2m1),water (2m1), 
1 0%sodium bicarbonate solution (2m1) and water (2ml). The organic phase was dried over sodium 
sulphate and evaporated to dryness. Precipitation from dichloromethane by the addition of n-
hexane yielded solid 3'- O-Benzovlthvmidine- 6- O-succinvlçilvcine ethyl ester (10) (35mg, 48%)mp 
124-7°C (Found C, 55.6; H, 5.5; N, 8.2%. C25H29N3010 requires C, 55.4; H, 5.5; N, 7.9%). 
5'-O-( 4,4"-Dimethoxytrityl)-thymidine- 3'-0-glutarate (11).--Dry DMTrthymidine (0.1 72g) was 
dissolved in anhydrous pyridine and protected from moisture with a silica gel guard tube. Glutaric 
anhydride(2.5 equivalents) was added and the reaction mixture was stirred at room temperature 
overnight and monitored by tIc (system A) (product Rf =0.25). After removing pyridine at reduced 
pressure the white oil was redissolved in dichloromethane(20m1) and washed with water (3x5m1). 
The organic layer was then dried over sodium sulphate and the solvent removed on a rotary 
evaporator. The product was precipitated into dry hexane from a small volume dichloromethane 
to give solid 5'-O-(4.4"-Dimethoxvtritvl)-thvmidine-3'-O-Qlutarate (11) (0.1 02g, 50%) [Found: C, 
65.8; H, 5.7; N, 4,3; 0, 24.3%; M (mass spectrum), 657.24485. C 36 H37N2O10requires C, 65.8; H, 
5.7; N, 4.3; 0, 24.3%; M, 657.24480]; ? m,, 206nm (E 45,145 dm3 mo1 CM-1 ), 232 (17,772), 266 
(8,591); m/z 657 [ M-(H),  75%], 543 (DMTr), 125 (30%) 
5'-0-(4,4 "-Dimethoxytrityl)thymidine- -3'-O-glutarylglycine ethylester.(1 2) .--To the dry glutarate 
(11) (0.2mmol ) and hydroxybenzotriazole (0.03g,lequivalent) in dioxan/pyridine (0.5/0.3m1) 
DCC (2.5 equivalents,) was added and the mixture stirred for 2.5 hours .The DCU produced was 
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filtered off and the active ester added to glycine ethyl ester (liberated with diisopropylethylamine 
(1 equivalent) ). This solution was then stirred overnight after which time dichloromethane(1 OmI) 
was added and the solution washed with water(2m1), citric acid solution (1 0%,2ml), water(2m1) 
and sodium bicarbonate solution (50%, 2ml). The organic phase was dried over sodium sulphate, 
evaporated to dryness and the product precipitated from dichloromethane into n-hexane to give 
5'-0-( 4.4"-Dimethoxvtritvl)thvmidine- -3'-O-çlutarv1çj1vcine ethyl ester. (12) (49%) [Found: 
C,64.6; H, 6.1; N, 5.6; 0, 23.7%; M(mass spectrum), 742.29756. C 40  HN3011 requires C, 64.6; 
H, 6.1; N, 5.6; 0, 23.7%; M, 742.29756]; X m,, (MeOH), 204nm (C 67,147 dm3mol-1  cm-1), 233 
(21,166), 266 (9,598); m/z 778(30%), 742 [M+(H+), 70), 543. 
Stability.- Small samples of the model compound (12) were dissolved in the following solvents and 
their stability monitored by tic (system A). 
1/. 10% DBU in dichloromethane/chloroform led to 50% cleavage in 2hours 
21. 5% piperidine in acetonitrile led to 50% cleavage in approximately 48hours 
3/.morpholine:acetonitrile 30:70: compond (12) was stable for 48 hours 
4/.triethylamine:acetonitrile 30:70: compound (12) was stable for 48 hours 
N-( 9-fluoreny1methoxycarbony1)-- sarcosine (13). --To sarcosine (1 .9g , 21 mmol) dissolved in 
sodium carbonate (1 0%sol. 1 8ml) was added dimethylacetimide(DMA) (1 8ml). The solution was 
cooled to 0'C and a solution of 9-fluorenylmethoxycarbonyl chloride dissolved in DMA (4g in 1 2m1) 
was added. The reaction was stirred for 15 mins while it warmed to room temperature. Water 
(240m1 ) was then added to the mixture and the product was extracted with diethyl ether (40ml) 
followed by ethyl acetate (2x40m1). The aqueous phase was then acidified to pH 1.5 with 
concentrated hydrochloric acid and further product was extracted with diethyl ether ( 6x30m1  ) .The 
combined organic phase was dried and the solvent removed under reduced pressure. Crystal-
lisation from ether gave N-( 9-fluorenylmethoxycarbonyl)--sarcosine (13) (2.6g, 41%) mp 119-
120°C standard value (Cambridge Research Biochemicals 121-1230C. 
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Resin functionalisation.- ig of long chain alkylamine controlled pore glass resin with 20 
micromol/g loading was functionalised with a sarcosine spacer unit and a succinyl thymidine first 
nucleoside. 
The resin of 500 Angstrom pore size was first dried over phosphorus pentoxide. 
Stages in functionalisation; 
1. Wash with 10% w diisopropylamine in DMF(3x2Oml). 
2.Wash with DMF ( 3x2Oml) 
Activation of 9-fluorenylmethoxycarbonyl-sarcosine.- To 9-fluorenylmethoxycarbonyl-sarcosine 
(0.0622g, 10 equivalents relative to the resin loading) dissolved in the minimum volume of DMF 
add DCC (0.02069g , 5 equivalents) . Stir for 20 mins and then evaporate to dryness and 
redissolve in dichloromethane(15m1). Filter this mixture into the resin functionalisation vessel. 
Add activated 9-fluorenylmethoxycarbonyl-sarcosine and allow to react 90 mins. 
Wash with DMF (3x20m1). 
Add a second batch of activated 9-fluorenylmethoxycarbonyl -sarcosine and allow to react 
for 90 mins. 
Wash with DMF (3x20m1) 
Kaiser test2 for free amine to check that all available amine sites have in fact reacted with 
the protected sarcosine. 
Wash with piperidine/DMF (2/8 v/v, 20m1) lOminutes 
Wash with DMF (3x20m1) 
Wash with piperidine/DMF (2/8v/v,20m1) 10 minutes. 
Wash with DMF (3x20m1) 
Wash with dichloromethane(4x20m1) 
Kaiser test to check that amine sites are deprotected 
Add activated nucleoside succinate and allow to react for 5.5 hours. 
Wash with dichloromethane(5x20m1) 
Wash with diethyl ether (3x20m1) 
Couple nucleoside succinate to the resin 
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Symmetric anhydride of nucleoside succinate.- Dissolve the protected nucleoside succinate (10 
equivalents over resin loading) in dry dichioromethane and add DCC (5 equivalents over resin 
loading). After 20 minutes filter the mixture into the resin functionalisation vessel and the coupling 
reaction is then left for 5 hours under nitrogen at room temperature. 
After the nucleoside coupling reaction the loading of the resin is determined as follows: 
A known amount of resin is suspended in HCl/EtOH (60/40) (25ml) and, after allowing 5 mins 
for complete deprotection a visible spectrum can be taken at 498nm. From this it is possible to 
calculate the amount of protected nucleoside attached to the resin (1 micromol of dimethoxytrityl 
cation has an absorbance of 70 AU). 
Unreacted sites within the resin structure can then be 'capped off 'by acetylation to prevent 
formation of uncleavable phosphate linked nucleotides. 
Acylation. Set aside the resin in acetic-anhydride/pyridine (2/8v/v,20m1) solution for 2.5 
hours. 
Wash with dichloromethane(4x2Oml) 
repeat '17'. 
repeat '18' 
wash with diethyl ether (3x2Oml) 
Sarcosvl thvmidine resin. (14).- Prepared by general method above gave support of loading 
18.828 micromol/g. 
Sarcosvl deoxvadenosine Resin (15).-same method after 2 couplings of nucleoside succinate 
gave 25micromol/g loading. 
Stability of sarcosyl resin to non-nucleophilic bases.- A sample of sarcosyl thymidine resin was 
soaked in 10% DBU/ pyridine solution for 18 hours and the resin was removed byfiltration,the 
solution assayed by spectrophotmetry at 495nm. 
To 25m1 HCVEtOH 60/40 was added the solution of DBU which had been used to treat 11.6mg 
of resin. 
Reading for 1 ml path volume =.002 A.U. 
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Total absorbance of sample =.002 x 25 =.050 A. U. 
Amount of dimethoxytrityl cation in sample = 0.05/71.7 = 0.0007micromol 
Resin loading = (0.0007/11.6) x 1000 = 0.06micromol/g 
Loss rate of 0.02% per hour 
Stability of sarcosyl resin to DBU in acetonitrile. -Sarcosyl thymidine resin (7.2mg ) was 
soaked in 10% DBU in acetonitrile overnight.The resin was removed by filtration and the 
DBU/acetonitrile solution was assayed for DMTr to see if any of the first base had been 
cleaved from the resin. 
Dilution to 1 OmI with 60% concentrated hydrochloric acid in ethanol 
1 c path length 
absorbance at 495nm = 0.075A.U. 
= 0.075x 10 / 71.7 micro mol 
= 0.4% per hour cleaved 
Phthal 'vlthvmidine resin. (16).-Prepared as follows: 
1/. Resin(0.5g) soaked in 10% diisopropylethylamine in dichloromethane(1 OmI) for 20 
minutes. 
2/. Wash with DMF(2xlOml) 
3/. Add 10 equivalents of activated DMTr I phthallate 
(activation by 5 equivalents of DCC in dichioromethane) 
4/. Allow to stand overnight ( under nitrogen) 
The resulting resin had loading of 11.02 micromol 1g. 
Stability to DBU.- A sample of resin(20.5mg) was treated with 10% DBU in dichloromethane 
for 10 minutes and then both the resin and the washings were assayed for dimethoxytrityl 
content by treatment with acid and spectrophotometric measurement. 
20.5mg (11.06 micromol/g) 
1 0.6micromol/g cleaved 
0.99micromol/g remaining 
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= 91% cleaved in 10 minutes 
t112 <5minutes 
Stability to aqueous ammonia.- Samples of resin were treated with concentrated ammonia and 
then after washing assayed for loading by the acid/spectrophotometric method. 
Phthaloyl resin was 85% cleaved in 23 minutes 
CPG dC commercial resin 42% cleaved in 23 minutes 
Fluorenyl-9-yI methanol (17).- Sodium-hydride (80% dispersion in mineral oil) (2.1638g ) was 
suspended in sodium dried diethyl-ether (35ml) and fluorene ( 2.7002g ) and ethylformate (3m1) 
were added. The mixture was refluxed for 10 hours and then cooled on ice. Ice chips were added 
to the mixture until gas evolution ceased. Water(150m1) was then added, the ether layer was 
discarded and the aqueous layer was washed with light petrol (b.p.40-600C) (40ml) and filtered. 
The aqueous phase was cooled on ice,acidified with acetic acid (15ml) and the resulting oil 
extracted with dichloromethane,dried over sodium sulphate, and evaporated to dryness under 
reduced pressure. The oil was dissolved in methanol (30m1) and sodium borohydride (0.99g) was 
added. This mixture was stirred at room temperature for 2 hours , after which time water(70ml) 
and acetic acid (5m1) were added. After stirring for a further 1.5 hours the white solid was filtered 
off and recrystallised from light petrol (b.p. 80-100°C ) to give fluorenyl-9-yl methanol (17) (60%), 
m.p. 98-100°C (lit. value' 14  100°C). 
Fluorenyl-9-ylmethylene chloroformate (18). 114 Phosgene in toluene (12%) (1 2.5m1) was cooled 
to 0°C and fluorenyl-9-yl methanol (2.4g) was added gradually. After addition of dichloromethane 
(1 4ml) the mixture was stirred for 5 hours at ice bath temperature. Solvent and excess phosgene 
were then evaporated off and the product recrystallised from diethyl ether/petroleum ether 40-60 
to give fluorenyl-9-ylmethylenechloroformate (18) (15%), m.p. 62-64°C (lit, value' 14  61.5-630C); 
v3200cm, 1790, 1150. 
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5-0-(9-fluorenylmethoxycarbonyl)-6-N-benzoyl-2'-deoxyadenosine (19).- 6-N-Benzoyi-2'-de-
oxyadenosine (1 .2g,3.4mmol), coevaporated from pyridine, was dissolved in anhydrous 
pyridine(30m1) and to this solution FMOC-Cl (1.0g J.2 equivalents) was added. The reaction 
mixture was protected from moisture with a calcium chloride guard tube and light by aluminium 
foil and stirred at room temperature for 3 hours. 
The reaction was followed by tic(system B) and when complete the reaction mixture was poured 
into water (1 20m1) and extracted with dichloromethane(3x35m1).This organic phase was then 
dried over sodium sulphate and evaporated to dryness.The product was solidified by trituration 
with diethyl ether. 
Flash column chromatography(30ml methanol in 250ml dichioromethane) and evaporation to 
dryness yielded the stable foam 5'-0-(9-fluorenyImethoxycarbonyI)-6-N-benzoyI-2deoxyadenosine 
(19) (0.5g, 25%); [Found: C, 66.5; H, 4.9; N, 12.1; 0,16.6%; M (mass spectrum), 578.20394. 
C32H28N506 CaIc. C, 66.5; H, 4.9; N, 12.1; 0, 16.6%; M, 578.20395]; X m,, 209nm (E 47,109dm3 
mol1cm1  ), 265(24,470); 	 CDCI3 ), 2.1 (1H, broad, -OH), 2.5-2.8 (21-1, d of m, C21, 
3.45(l H, s,), 4.2-4.5(7H, m, C5',C4',CH2Fmoc,CHFmoc), 3.9( 1H, h, water), 4.7( 1H, m, C3'), 
5.25 ( 1H, s, water), 6.5 ( 1H, t, Cl'), 7.2-7.8 ( 15H, m, Ar/Fmoc,Bz,CHCI3,NH), 7.9- 
8.0( 2H, m, Bz), 8.25 (1 H, s, Adenosine C8), 8.75 (1 H, s, Adenosine); m/z 686 (M+thioglycerol, 
70%), 600 (40), 578 [ M+(H), 60). 
5'- 0—(9-F!uorenylmethoxycarbony/)-6-N-benzoyl-2'-deoxyadenosine-3 '-0-N, N-
diisopropylmethytphosphoramidite (20).- 5'-O-(9-Fluorenylmethoxycarbonyl)-6-N-benzoyl-2'-
deoxyadenosine ( 0.5g,0.9mmol), dried in vacuo for3 days, was dissolved in drydichioromethane 
(12ml) and the reaction vessel flushed with nitrogen. N,N-Diisopropyl-ethylamine (0.9m1,2 
equivalents) and methoxy-N,N-diisopropylchloro-phosphoramidite (0.2m1,1 .2equivalents) were 
added. The reaction was then stirred under nitrogen for 15 mins, monitored by tic(system C) Rf 
product = 0.55, Rf SM = 0. When the reaction was complete by tic, anhydrous methanol (0.01 ml) 
and ethyl acetate (21 .4ml) were added and this solution washed with 10% sodium carbonate 
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solution(2x15m1) and brine (2x15m1). The organic phase was dried over sodium sulphate, 
evaporated to dryness and precipitated from ethyl acetate ( 35% w/v solution of product in ethyl 
acetate) into dry hexane to give solid 5'-0—(9-Fluorenylmethoxycarbonyl)-6-N-benzoyl-2'-deox-
yadenosine-3'-O-N,N-diisopropylmethjtphosphoramidite (20) (479mg, 72%); 31 149.9(d); mz 
793, 771, 739 [M+(H), 60%). 
5'- 0-(9- Flu orenylmethoxycarbonyl)-2-N-isobutyryl-2'-deoxyguanosine-3 '- 0-N, N-
dllsopropyImeth (.' phosphoramidite (22).- 5'-O-(9-Fluorenyimethoxycarbonyl)-2-N-isobutyryl-
2'-deoxyguanosine (0.5g,0.9mmol) dried in vacuo ( oil pump) for 3 days was dissolved in dry 
dichloromethane(lOml) and the reaction vessel flushed with oxygen free nitrogen. N,N-
Diisopropylethylamine(0.9ml, 2 equivalents ) was added and methoxy-N , N-diisopropylchioro-
phosphoramidite (0.2m1,1 .2equivalents) was added.The reaction was stirred under nitrogen for 
15 minutes, monitored bytic(system C) .Rf product = 0.3-0.4 ,Rf SM = 0 
When the reaction was complete by tic (system C), anhydrous methanoi(0.Olml) and ethyl 
acetate (21 .4ml) were added This solution was washed with 10% sodium carbonate solution(2x1 5m1) 
and brine (2x1 5mi). The organic phase was dried over sodium sulphate, evaporated to dryness 
and precipitated from ethylacetate into dry hexane gave solid 5'-0-(9-Fluorenylmethoxycar-
bonyl)-2-N-isobutyryl-2'-deoxyguanosine-3'-0-N, N-diisopropyImethj phosphoramidite (22) 
(487mg, 75%); 31P 149.6 (d). 
50-(9-FIuorenyImethoxycarbony/)thymidine-3 '-O-N,N-diisopropylcyanoethylphosphoramidite 
(23).- 5'-O-(9-Fluorenylmethoxycarbonyl)thymid me (0.767g, 1 .7mmoi) was dissolved in dry TH F 
(4ml) and to this diisopropylethylamine (1 equivalent) and N,N-diisopropyicyanoethyl-chioro-
phosphoramidite( 2equivalents ) were added . This mixture was stirred under nitrogen for 60 
minutes and monitored by tic (system C,Rf product = 0.45 and 0.55 two isomers separate). When 
the reaction was complete, ethyl acetate presaturated with nitrogen, (40m1) was added. The 
organic phase was then washed with sodium carbonate solution (10 % 2x1 2mi) and brine 
(20 2mi), dried oversodium sulphate and evaporated to a dry foam. The product was precipitated 
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by addition of a dry toluene solution to a large volume of n-hexane giving 5O-(9-
Fiuorenylmethoxycarbonyl)thymidine-3'-O-N,N-diisopropylcyanoethyl-phosphoramidite (23) 
(0.6713g, 60%); 31PMR 149.9, 149.4. 
5.O-(9-FIuorenyImethoxycarbonyI)thymidine-3O-N,N-diisopropyImeth Lphosphoramidite (24).-
5'-O-(9-Fiuorenylmethoxycarbonyl)thymidine (0.8g), dried by coevaporation from dry pyridine, 
was dissolved in dry dichloromethane (1 2m1) and the reaction vessel flushed with nitrogen. N,N-
Diisopropyl-ethylamine (0.95m1,2 equivalents ) and methoxy-N ,N-diisopropylchloro-phospho-
ramidite (0.35m1,1 .2equivalents) were added. The reaction was then stirred under nitrogen for 15 
mins, monitored by tic (system C) Rf product = 0.47, Rf SM = 0. When the reaction was complete 
by tIc anhydrous methanol (0.01 ml) and ethyl acetate (21 .4ml) were added and this solution 
washed with 10% sodium carbonate solution(2x15m1) and brine (2xl5mi). The organic phase 
was dried over sodium sulphate and evaporated to dryness and precipitated from ethyl acetate 
into dry hexane to give solid 5'-O-(9-Fluorenylmethoxycarbonyl)thymidine-3'-O-N, N-
diisopropyImethjtphosphoramidite (24) (563mg, 60%); 31P 149.8, 150.2 (d); m/z 793, 771, 
739 [M+(H), 60%). 
4-N-Adamantyloxycarbonyl-2'-deoxycytidine (25) .-2'-Deoxycytidine ( 132mg,0.6mmol) was 
suspended in dry pyridine(3m1) and chiorotrimethylsilane (10 equivalents ) was added. After 40 
minutes adamantyl fluoroformate ( 200mg, 2equivaients) was added and the reaction mixture, 
protected from moisture with a silica gel drying tube, was stirred overnight.The product, 
(tic(system A) Rf product = 0.2), was isolated by adding water/pyridine(1/1 ,2ml) to the mixture, 
followed, after 30 minutes by more water(20ml). The aqueous phase was extracted with 
chloroform (5x4m1), dried over sodium sulphate and evaporated to dryness.The product was 
recovered by addition of a dichloromethane solution to a large volume of n-hexane to give solid 
4-N-Adamantvloxvcarbonvl-2'-deoxvcvtidine (25) (90.7mg, 45%); ? 	211 nm ( 6 15,507 dm3 
mol1  cm-1 ), 242 (12,513), 292(6,309); 8 H  (200 MHz, CDCI3 ), 1.6 (6H, s, Adoc), 1.9-2.3 (11 H, 
m, Adoc+C2'), 3.6 (2H, m, C5'), 3.8(1 H, m,8, C4'), 4.25 (1 H, m, C3'), 5.0-5.3 (broad, water/OH), 
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6.1 (1H, t, Cl'), 7.0 ( 1H, d, C), 8.25(l H, d,C6), 10.3 ( 1H, h, NH); m/z 476(40%), 4041 M-(W), 
100], 136 (100). 
Deprotection. - The group was stable to TCA (3% in dichloromethane) and acetic acid (80%) but 
was removed by 60% HCI in ethanol in under 10 minutes monitored by t.l.c. 
2-N-( 4,4 DimethoxytrityI)-2'-deoxyguanosine (26).- 2'-Deoxyguanosine( 0.57g,2.1 mmol) was 
suspended in dry pyridine (8ml) and trimethylsilyl chloride (2.7m1,5equivaients) was added. This 
mixture was stoppered and stirred for 30 minutes, after which time 4,4'-dimethoxytrityl chloride 
(0.8g,1.1 equivalents) was added.The mixture was again protected from moisture, with a silica 
gel drying tube and stirred at room temperature for 2.5 hours, monitored by tic (system B, Rf 
product 0.45). When the reaction had gone to completion a 1/1 mixture of pyridine/water (9mi) 
was added and stirring was continued for30 minutes. More waterwas then added and the mixture 
stirred for 2 hours during which time the product precipitated out. 
The aqueous phase was extracted with chioroform(5x3Oml) and the solution added to the crude 
product. The combined organic phase was then dried over sodium sulphate and evaporated to 
dryness. Crystallisation from benzene/pyridine gave 2-N-( 4,4'Dimethox)trity!)-2'-deoxyguanosine 
(26) (1.1g, 100%), m.p.180-182°C, [ Found: C, 65.5; H, 5.3; N, 12.3; 0, 16.9%; M (mass 
spectrum), 568.219591. C31H 30 N5O6 calc. C, 65.5; H, 5.3; N, 12.3; 0, 16.9%; M, 568.21959]; ?. 
rrm 209nm (8 24,381 dm3 mol 1 cm), 276 (13,706); 5 k(200MHz,  DMSO-D6 ) 1.7-2.0 (21-1, d/m, 
C2'), 3.3 (18H, broad, water+C5'), 3.75 (6H, s, OMe), 3.7 (1 H, m, C4'), 4.1 (1 H, m, 03'), 5.5(1 H, 
t, Cl'), 6.8(3H, m, DMTr), 7.1-7.35 (1 OH, m, DMTr), 7.6(1H, s, CH/G), 7.75 (1H, s, G-2-N), 10.6 
(1H, s, NH imide); m/z 1137 (polymer? 100%), 722, 639, 568 [M-(H), 70%) 
4-N-( 4,4"-Dimethoxytrityl)-2'-deoxycytidine (27).- 2'-Deoxycytidine (0 ,5g,2 .2mmol) was sus-
pended in dry pyridine (8ml) and trimethylsilyl chloride (2.7ml,5equivalents) was added. After 
stirring 30 minutes 4,4'dimethoxytrityl-chloride (1.1 equivalents, 0.71g) was added and the 
reaction mixture was stirred at room temperature overnight, monitored by tic(system B) Rf 
product 10/17. When the reaction was complete a 1/1 mixture of pyridine/water (gml) was added 
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and stirring continued for30 minutes. More water(1 50m1) was then added and the mixture stirred 
for 2 hours. The aqueous phase was extracted with chloroform(5x3Oml) and this solution was 
dried over sodium sulphate and evaporated to dryness. Crystallisation from benzene gave 4-N-
(4,4"-Dimethoxytrityl)-2-deoxycytidine (27) (0.35g, 30%), m.p.180-1840C, [Found: C, 68.2; H, 
5.7; N, 7.95; 0, 18.2%; M (mass spectrum), 528.21 343. C 30  H 30 N306 requires: C, 68.2; H, 5.7; N, 
7.95; 0, 18.2%; M, 528.213431; m/z 600(70%), 528 [M-(H), 100), 412,199,168,122,46,42 
6-N-(4,4"-Dimethoxytrityl)-2'-deoxyadenosine (28).- 2-'Deoxyadenosine( 0. 5g,2mmol ) was 
suspended in dry pyridine ( 8m1) and trimethylsilyl chloride (2.7ml, Sequivalents) was added. This 
mixture was stirred at room temperature for 30 minutes monitored by tIc (5% methanol in 
dichioromethane). When the reacion was complete 4,4'dimethoxytrityl-chloride (0.8g, 1.1 equiva-
lents) was added and the reaction mixture stirred overnight. Water/pyridine (1/1,1 Oml) was then 
added and the solution stirred 40 minutes, followed by addition of more water (1 20m1) and further 
stirring 2 hours.The product was extracted into chloroform (5x3Oml), dried over sodium sulphate 
and evaporated to dryness, yielding the solid foam 6-N-(4, 4"-Dimethoxytrityl)-2-deoxyadenosine 
(28) (0.8g,73%) [ Found: C, 67.4; H, 5.5; N, 12.7; 0, 14.5; M (mass spectrum), 552.22470. 
C31H31N505 requires: C, 67.4; H, 5.5; N, 12.7; 0, 14.5%; M, 552.22468]; ?206nm (E31,240dm3 
mo11  cm1), 278 (7,293); m/z 706, (silylated, 30%), 552[ M-(H), 100%); 
5-O-(9-Fluorenylmethoxycarbonyl)-6-N-(4,4 "-dimethoxytrity!)-2-deoxyadenosine (29).- 
To 6-N-(4,4"-Dimethoxytrityl)-2'-deoxyadenosine (0.602g,1 .1 mmol), dried by coevaporation 
from dry pyridine,and dissolved in dry pyridine( 8m1) was added FMOC-Cl (1.2 equivalents). The 
reaction mixture was stirred for 3 hours,monitored by tic(system A), and when no starting material 
remained the reaction was poured out into water (SOml) and the products extracted into 
chloroform(5x30m1). The organic phase was dried over sodium sulphate and evaporated to 
dryness. Flash chromatography(5% methanol in dichloromethane) yielded the solid foam 50 
(9-FIuorenvIrneThoxvcarbonvI)-6-N-L4.4"-dimethoxvtritvi)-2deoxvadenosine (29) (216mg, 25%); 
dH(200MHz, CDCI3 ), 2.5(1 H, m, C2'), 2.7-2.8 (2H, m, C2 +OH), 3.75 (6H, s, OMe), 4.25 (2H, m, 
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C5'), 4.4 (31-1, m, C4'+CH2), 4.7 (2H, m, C3' +9-f luor), 6.4 (1H, t, Cl'), 6.8 (41-1, m, DMTr), 7.2-7.5 
(14H, m, Fmoc+DMTr), 7.55-7.8 (81-1, m, Fmoc), 8.0 (21-1, d, adenosine 2 and 9); 8.6 (1 H, broad, 
NH); m/z 775 (mol ion, 80%) 
5'-O-(9-FIuorenyImethoxycathonyI)-2-N-(4,4'-dimethoxytrityI)-2'-deoxyguanosine (30).- 
Dry 2-N-(4,4"-dimethoxytrityl)-2'-deoxyguanosine (1 g, 1 .8mmol) was dissolved in anhydrous 
pyridine( 10 ml) and FMOC-Cl (1 .2equivalents) was added. The reaction mixture was protected 
from moisture with a silica gel drying tube and stirred at room temperature for 3 hours monitored 
by tic(system A) Rf product=0.65. When all starting material had been consumed the reaction was 
poured out into water and the solid precipitate collected by filtration. 
Purification was by flash chromatography ( 20m1 methanol in 230m1 dichioromethane ) to give the 
solid foam 5'-O-(9-FIuorenvImethoxvcarbonvi)-2-N-(4.4"-dimethoxvtrftvI)-2'-deoxvçuanosine (30) 
(0.7g, 50%) [Found: C, 69.7; H, 5.3; N, 88.35; 0, 16.15%; M (mass spectrum), 792.30331. 
CH42N508 Requires C, 69.7; H, 5.3; N, 88.35; 0, 16.5%.]; 5.(200MHz,  CDCI3 )1  1.05 (<1H, t, 
impurity), 1.8 (1 H, m, C2'), 2.1 (1 H, m, C2'), 2.6(1 H, broad singlet, 3'OH), 3.5 (61-1, s, methoxy 
of DMTr), 3.8(1 H, m C3'), 3.9-4.25 (51-1, m, C5', C4', CH2 ), 5.1 (1.21-1, s, H20), 5.6(1 H, t, C1'), 6.6 
(1H, d, C-H 9), 6.9-7.25 (41-1, m, aromatic), 7.3-7.9 (18H, m, aromatic FMOC+DMTr); m/z 792 
[M+(H), 90%). 
5'-O-(9-Fluorenylmethoxycarbonyl)-4-N-(4,4 "-dimethoxytrityl)-2'-deoxycytidine (31).- 
4-N-(4,4"-dimethoxytrityl)-2'-deoxycytidine ( 2.Og,3.8mmol) was dried by coevaporation from dry 
pyridine and dissolved in dry pyridine(16m1) . To this solution FMOC -Cl (1.0g, 1.1 equivalents) 
was added and the mixture was protected from moisture with a silica gel drying tube and stirred 
at room temperature for 3 hours, monitored by tic (system A, Rf product = 0.6,Rf starting material 
= 0.25). When the reaction was complete it was poured into water (200m1) and extracted with 
chIoroform(5x6Oml). Purification by flash chromatography (5%methanol in dichioromethane) 
gave the solid foam 5'-O-(9-FIuorenyImethoxycarbonyI)-4-N-(4,4"-dimethoxytrityI)-2deoxycytidine 
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(31) (0.847g, 30%) [Found: C, 71.8; H, 5.6; N, 5.6; 0, 17.0%; M (mass spectrum), 752.29716. 
C45H42N308 requires C, 71.8; H, 5.6; N, 5.6; 0, 17.0%; M, 752.29717]; m/z 774 [M+(H), 75%). 
5'-O-(9-Fluorenylmethoxycarbonyl)-6-N-(4,4 "-dimethoxytrityl)-2'-deoxyadenosine-3'-O-N,N-
diisopropyImethj L phosphoramidite (32).- 5'-O-(9-Fluorenylmethoxycarbonyl)-6-N-(4,4"-di-
methoxytrityl)-2'-deoxyadenosine (463mg, 0.6mmol) was dried by coevaporation from dry 
pyridine and dichioromethane and then dissolved in dry dichloromethane(1 2ml). To this solution 
diisopropylethylamine (0.7ml,2 equivalents) and N ,N-diisopropylmethoxyphosphonamidic chlo-
ride ( 0.23m1,1 .2equivalents) were added. This reaction mixture was stirred under nitrogen for 20 
minutes until all starting material had been consumed (tIc system C,Rfstarting material= 0, 
Rfproduct= 0.4) at which point dry methanol ( 0.01 ml) and ethyl acetate, presaturated with 
nitrogen, (20m1) were added. This solution was washed with sodium carbonate solution (10% 
2x1Oml ) and brine (2xlOml) and after drying over sodium sulphate was evaporated under 
reduced pressure and precipitated by the addition of a dry toluene solution to a large volume of 
n- hexane at -20°C. The resulting white solid was collected by filtration and stored under nitrogen 
at 4°C. 
5'-O-9-FIuorenvImethoxvcarbonv!)-6-N-4.4"-dimethoxvtritvI)-2'-deoxvadenosine-3'-O-N.N-
diisoProPImethyJ.Phoshoramidite (32).- (350mg, 64%); 31P NMR (90MHz, CDCI3), 149.693 
(d) 
5'-O-(9-Fluorenylmethoxycarbonyl)-2-N-(4,4"-dimethoxytrtyl)-2'-deoxygu anine-3'-O- 
N,N-diisopropyImeth 1L phosphoramidite (33).- 5'-0-(9-Fluorenylmethoxycarbonyl)-2-N-(4,4"-
dimethoxytrityl)-2'-deoxyguanosine (0.7g,0.9mmol) was dried by coevaporation from dichlorom-
ethane containing 10% pyridine and dissolved in dry dichloromethane(2m1). To this was added 
diisopropylethylamine(0.8m1,2equ ivalents) and N, N-diisopropylmethoxyphosphonamidic chlo-
ride (0.3m1,1 .2equuivalents) .This solution was stirred under nitrogen for 20 minutes and 
monitored by tic ( system C, product Rf = 0.2). When no starting material remained methanol 
(0.01 ml) and ethylacetate, presaturated with nitrogen, (20ml) were added. The resulting solution 
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was washed with sodium carbonate solution (10%, 2x1 OmI) and brine (2x1 OmI), dried oversodium 
sulphate and evaporated to dryness. The product was then precipitated by the addition of a di-
chioromethane solution to a large volume of n-hexane at -20°C to give 5'-0-(9-Fluoren-
ylmethoxvcarbonyl)-2-N-(4. 4' '-dimethoxvtrtvl)-2'-deoxvQuanine-3 '- 0-N. N-
diisoProPvImeth,j phosphoramidite (33) (0.578g, 66%); 31  P NM R 149.559 (d). 
5'-0-(9-Fluoreny/methoxycarbonyl)-4-N-(4, 4 "-dimethoxytrityl)-2'-deoxycytidine-3'-0-N, N-
diisopropyImethgL phosphoramidite (34).- 5'-O-(9-Fluorenylmethoxycarbonyl)-4-N-(4,4"-di-
methoxytrityl)-2'-deoxycytidine (0.8g,1.1 mmol) was dried by coevaporation from 10% pyridine in 
dichioromethane(x2) and dissolved in dry dichloromethane(3m1) with diisopropylethylamine( 
1 .3ml,2equivalents) and N,N-diisopropylmethoxyphosphonamidic chloride (0.4ml, 2 equiva-
lents). This mixture was stirred under dry nitrogen for 15 minutes until no starting material 
remained(tic system C, Rf product = 0.33) and dry methanol (0.025m1) and ethyl acetate (40m1), 
presaturated with dry nitrogen gas, were added. The organic phase was washed with sodium 
carbonate solution (1 0%,2x25m1), and brine (2x25ml), dried over sodium sulphate and evapo-
rated to dryness under reduced pressure. The product was precipitated by the addition of a 
toluene solution to a large volume of cold n-hexane (-70°C) yielding 5'-0-(9-Fluorenvlmethoxvcar-
bonv!)-4-N-(4.4"-dimethoxvtritv!)-2'-deoxvcvtidine-3'-0-N.N-diisopropvlmethjl phosphoramidite 
(34) (0.584g, 60%); 31  P NMR 149 (d) 
4-N-Benzoylcytidine (35).- Cytidine (4.2g,1 7.3mmol) was suspended in dry pyridine (50m1) and 
chlorotrimethylsilane(30ml,1 0 equivalents) was added.This mixture was protected from moisture 
with a silica gel drying tube and stirred at room temperature for 40 minutes, (monitored by tic 
system C). 
When the reaction was complete benzoyl chloride(1 2ml ) was added and the reaction was 
stirred overnight. Pyridine/water 1/1 (25m1) was added and stirring continued 40 minutes in an ice 
bath, monitored by tic (tIc system B, Rf product = 0.51). The mixture was then evaporated to 
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dryness under reduced pressure and the crystallisation from water gave 4-N-Benzoylcytidine 
(35) (3.5g, 60%)[ Found: C, 55.2; H, 5.2; N, 12.1; 0,27.6%; M (mass spectrum), 348.11956. 
C16H18N306calc. C, 55.2; H, 5.2; N, 12.1; 0,27.6% M, 348.11955]; 8 H(200MHz,  DMSO-D6), 3.5-
3.8 (2H, m, C2'+C4'), 3.8-4.1 (3H, m, C5'+C3'), 5.1-5.2 (3H, broad, 5'-i-3'-i-4'OHs), 5.8 (1H, d, Cl'), 
7.3 (1H, d, C/Ar), 7.4-7.7 (3H, m, Bz), 8.0 (21-1, m, Bz), 8.5(1 H, d, C/Ar), 9.8(1 H, broad, NH); m/ 
z 348 [M+(H), 100%), 216 (80). 
3c5'-0-(Tetraisopropyldisiioxane- 1,3-diyl)-4-N-benzoylcytidine (36).- 4-N-Benzoylcytidine 
(2.556g,7.3mmoi) was suspended in dry pyridine(25mi) with dry DMF(6mi) and to this was added 
1 ,3-dichloro-1 ,1,3 ,3-tetraisopropyldisi!oxane(2.7m1, 1 .2equ ivalents). The mixture was protected 
from moisture with a silica gel drying tube and stirred at room temperature for 1 hour.When no 
starting material remained( tic system A, Rf SM =0.2,Rf product = 0.7), triethyiammonium 
bicarbonate solution (2M,15ml) was added and the solution evaporated to dryness.The crude 
product was redissolved in dichloromethane(150m1) and this solution washed with sodium 
bicarbonate solution(lOml) and water (30mi),dried over sodium sulphate and evaporated to 
dryness.The product was coevaporated with dry toluene twice to give the stable stable foam 3',5'-
0-(Tetraisopropyldisiloxane- 1,3-diyl)-4-N-benzoylcytidine (36) (3.825g, 86%) 
Z-O-(4-methoxytetrahydropyran-4-yI)-3ç5'-O-(tetraisopropyldisioxane- 1,3-diy1)-4-N-benzoylcytid-
inc (37).- 4-N-Benzoyl-3',5'-0-(tetraisopropyldisiioxane-1 ,3-diyl)-cytidine (3.5g,6mmol) was dissolved 
in dry dioxane (30m1) and p--toluene suiphonic acid (1 g,1 equivalent) was added.This mixture was 
stirred at room temperature for 2 hours and 5,6-dihydro-4- methoxy-2H-pyran ( 2.6mi ,4 
equivalents) was then added. The reaction was stirred at room temperature a further hour and 
followed by tic.(system C, product gave intense purple colour on heating with anisaidehyde.) 
When the reaction was complete the mixture was neutralised by addition of pyridine (to pH 7) and 
dichloromethane(200ml) was added.This solution was washed with water(2x4Omi) ,dried over 
sodium -sulphate and evaporated to dryness to givethe oil 2'-0-(4-methoxytetrahydropyran-4-yI)- 
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3', 5'-O-(tetraisopropyldisiloxane- 1 ,3-diyl)-4-N-benzoylcytidine (37) (3.4682g, 85%) [Found: C, 
58.0; H, 7.7; N, 6.0; 0, 20.4; Si, 8.0%; M (mass spectrum), 704.33986. C 34 H54 N3O9Si2 requires 
C, 58.0; H, 7.7; N, 6.0; 0, 20.4; Si, 8.0%; M, 704.33983]; 8 H  (200MHz, ODd 3)1  0.9-1.3 ( 28H, 
m, TIPDS), 1.75-2.(4H, m, mthp), 3.3 (31-1, s, OCH3), 3.6-3.9 (41-1, m, mthp), 4.0 (1 H, d, 04'), 4.2-
4.5 (4H, m, C5'+C3'+C2'), 5.8 (1H, s, Cl'), 7.4-8.0 (6H, m, Bz+cytidinyl H), 8.5 (1H, d, cytidinyl 
H). 
Z-O-(4-methoxytetrahydropyran-4-yI)-4-N-benzoylcytidine (38).- 2'-O-(4-methoxytetrahydropyran-
4-yl)-3'5'-0-(tetraisopropyldisiloxane-1 ,3-diyl)-4-N-benzoylcytidine(3.Og,4.3mmol) was dissolved 
in dry TH F (30m1) and tetrabutylammoniumfluoride (3g in 1 OmI TH F) was added. The mixture was 
stirred for 10 minutes and the reaction monitored by tic (system A). When no starting material 
remained and predominantly a single low running product spot had appeared the solution was 
evaporated under reduced pressure to dryness, redissolved in dichloromethane(lSOml) and 
washed with water(2x25ml).The organic phase was then dried over sodium sulphate and 
evaporated to dryness again to give the oil 20-(4-methoxytetrahydropyran-4-yI)-4-N-benzoyIcytidine 
(38) (1.2g, 61%). 
5'-O-(9-Fluorenylmethoxycarbonyl)-2'-O-(4-methoxytetrahydropyran-4-yI)-4-N-benzoylcytidine 
(39).-2'-O-(4-methoxytetrahydropyran-4-yI)-4-N-benzoylcytidine (1.1 53g,2.5mmol), dried by coe-
vaporation with pyridine was dissolved in anhydrous pyridine (1 4m1) and stirred in ice. FMOC-CI 
(0.711g,1.1 equivalents) was added over a period of 20 minutes and the mixture was stirred, 
protected from moisture with a silica gel drying tube, overnight. Tlc(system A, Rf starting 
material=0.35,Rfproduct=0.7) revealed reaction had not gone to completion so more FMOC-Cl 
(0.2g) was added and reaction stirred until no starting material remained. 
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When the reaction was complete it was poured into water (1 50ml) and the products extracted 
with chloroform(5x4Oml). The organic phase was dried over sodium sulphate, evaporated to 
dryness and precipitated by addition of a dichloromethane solution to a large volume of n-hexane. 
The product was purified by flash chromatography(2-5% methanol in dichloromethane) to give 
the solid foam 5'-O-(9-Fluorenylmethoxycarbonyl)-2'-O-(4-methoxytetrahydropyran-4-yI)-4-N-
benzoyicytidine (39) (590mg, 36%) [Found: C, 64.95; H, 6.7; N, 5.3; 0, 17.55%; M (mass 
spectrum), 684.25568. C37H 38 N3O1Ø requires C, 64.95; H, 6.7; N, 5.3; 0, 17.55%; M, 684.25570]; 
rr=209nm ( 36,001 dm3 molcm 1), 264nm (24,225): 8 H  (200MHz, CDCI3) 1.7-1.9 (4H, m, mthp), 
3.2 (31-1, s, OMe), 3.5-3.8 (41-1, m, mthp), 4.15 (1H, m, C3'), 4.3 (21-1, m, C5'), 4.5 (51-1, m, 
FmocCH2+C4'+C2'+Fmoc 1-19), 6.2 (11-1, d, Cl'), 7.1-8.0 (15H, m, Bz+Fmoc+Ar/C), 8.75 (11-1, 
broad, NH/C). 
5'-O-(9-fluorenylmethoxycarbonyl)-2'-O-(4-methoxytetrahydropyran-4-yI)-4-N-benzoylcytidine-3'-
O-N,N-diisopropylmeth jL. phosphoramidite (40).- 5-O-(9-flou renylmethoxycarbonyl)-2'-0-(4-
methoxytetrahydropyran-4-yl)-4-N-benzoylcytidine(0. 5g, 0.7mmol) was dissolved in dry 
dichloromethane(2ml) with dry diisopropylethylamine(0.7m1, 2equivalents) and the reaction flask 
was then flushed with nitrogen (approximately 5 minutes). N,N-Diisopropylmethoxyphospho-
namidic chloride(0.3m1) was then added and the reaction was stirred for 1 hour, under nitrogen, 
at the end of which time tic showed that the reaction was complete (system C, Rf starting material 
= 0,Rf product = 0.33). Methanol (0.1 ml) and nitrogen saturated ethyl acetate (35ml) were then 
added and this solution was washed first with sodium carbonate solution (1 0%,2x1 OmI) and then 
with brine (2x1 OmI). The organic phase, dried over sodium sulphate, was evaporated to dryness, 
under reduced pressure at room temperature, and precipitated by addition of a toluene solution 
to a large volume of cold hexane(-700C). Product was purified by flash chromatography(system 
C) to yield the solid foam 5'-O-(9-fluorenylmethoxycarbonyl)-2'-O-(4-methoxytetrahydropyran-4-
yI)-4-N-benzoyIcytidine-3'-O-N,N-dllsopropyImeth C phosphoramidite (40) (200mg, 35%) 
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Methoxyethoxymethyl-triethylammonium chloride (41).- Methoxyethoxymethyl chloride (1 ml) 
was dissolved in dry diethylether(20ml) and dry triethylamine (1 .4ml) was added. The reaction 
was stirred for 16 hours at room temperature after which the product was collected by filtration 
and dried in vacuo to give Methoxyethoxymethyl-triethylammonium chloride (41). (1.81 g, 100%). 
The compound is unstable in air (moisture) so analysis was not attempted. 
Methoxyethoxymethyl-3ç5'-O-(tetraisopropyidisioxane- 1,3-diyl)-4-N-benzoylcytidine (42).-
3',5'-O-(Tetraisopropyldisiloxane-1 ,3-diyl)-4-N-benzoylcytidine (0.68g,1 .1 5mmol) was dissolved 
in dry acetonitrile,with the M EM salt(0.32g) and this mixture was heated at refiux for 16 hours.The 
reaction was monitored by tic (EtOAc/MeOH/NH3 5/1/1 ) Rf starting material = 0.58 product = 
0.76. When no more starting material remained the reaction was quenched in water(1 50ml) and 
the crude products extracted into chloroform (1 OOml).The organic phase was dried,over sodium 
sulphate and evaporated to dryness under reduced pressure. Crystallisation from hexane yielded 
4-N-(2-Methoxyethoxymethyl-3',5-O-(tetraisopropyldisioxane- 1,3-diyl)-4-N-benzoylcytidine (42) 
(0.65g, 20%), m.p. 133-5°C; Ar  203nm ( F, 21,809 dm3 moi cm), 243nm (10,753), 312nm 
(14,260); 8   1.0 (28H,m,120,(tipds), 3.25-3.4 (3H, d, O-CH3); 3.6-4.4 (11H, m, C2', C5', C4', C3', 
CH2-CH2, OH); 5.75 (2H, m, O-CH2-O); 6.3 (1H, d, C1'), 7.3-7.6(5H, m, Bz), 8.0-8.2 (21-1, d of d, 
cytidyl C-H); m/z 1052, 700,678 [M+(H), 85%), 304, 105 
Stability of methoxyethoxymethyl protected product 
1/. Addition of a solution of 3% trichloroacetic acid in dichioromethane to Methoxyethoxymethyl-
3'5'-(tetraisopropyldisiloxane-1 ,3-diyl)-4-benzoylcytidine gave no degradation overnight (detct-
able by tic,EtOAc/MeOH/NH3 5/1/1) 
2/.Concentrated ammonia gave a mixture of products many of them not uv positive but sugar 
positive 
4-N-Phthaloylcytidine (43) .-Cytidine (1 g, 4.1 mmol) was suspended in dry pyridine and protected 
from moisture with a silica gel drying tube and chlorotrimethylsilane(1 Oequivalents) was added 
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After stirring for 40 minutes phthaioyi chloride(2equivaients) was added and the reaction mixture 
was stirred at room temperature for 2 hours. The reaction was quenched in ice and extracted with 
ethyl acetate (60m1), product tic (system B, Rf product = 0.26). The organic phase was washed 
with brine (2x 30ml) and the brine was extracted with a further 2 portions of ethyl acetate (40m1). 
The organic phases were combined, dried over sodium sulphate, and evaporated to dryness 
under reduced pressure. Crude product was precipitated by addition of a dichloromethane 
solution to a large volume of n-hexane yielding 4-N-Phthaloylcytidine (43) (0.2g, 10%). 
m/z 590, 574, 518, 446, 356, 314, 259, 242, 103. 
The product was unstable to fluoride ions (tIc system B). 
6-N-Phthaloyladenosine (44).- Adenosine (1g,3.7mmol) was suspended in dry pyridine and 
chlorotrimethylsilane(10 equivalents) was added. After stirring for 40 minutes phthaloyi chloride 
(2 equivalents) was added and the reaction mixture, protected from moisture with a silica gel 
drying tube, was stirred at room temperature for 2 hours. The reaction was then quenched in ice 
and extracted with ethyl acetate (60m1) which was then washed with brine (2x 30ml). The brine 
was extracted with a further 2 portions of ethyl acetate (40ml) and the organic phases were 
combined, dried over sodium sulphate and evaporated to dryness. Crude product (tic Rf = 0.35 
system A) was precipitated by addition of a dichioromethane solution (8ml) to dry hexane(250ml). 
The precipitate was collected by filtration to give 6-N-Phthaloyladenosine (44) (1.4g, 98%) 
[Found: C, 54.3; H, 4.05; N, 17.6; 0,24.1%; M (mass spectrum) 398.11007. C181-116N506 requires 
C, 54.3; H, 4.05; N, 17.6; 0,24.1%; M 398.11005.]; m/z 470, 416, 398 [ M+(H),100%), 358, 
350,338,308,292,284; 
3c5'-O-(Tetraisopropyldisi/oxane- 1,3-diyl)-6-N-phthaloyladenosine (45).- 6-N-Phthaloyl adeno-
sine (0.5g,1 .2mmol) was dissolved in dry pyridine (1 5ml) and 1 ,3-dichloro-1 ,1 ,3,3-tetraisopro-
pyldisitoxane (0.5m1,1 .2equivalents) was added. This reaction was protected from moisture with 
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a silica gel drying tube and stirred for 2.5 hours at room temperature. (tic system A Rf product 
=0.83). When the reaction was complete, triethylammoniu m bicarbonate solution (2M, 5m1) was 
added and the mixture evaporated to dryness. The residue was redissolved in dichioromethane 
(lOOml) and this solution was washed with sodium bicarbonate solution (saturated 20m1) and 
water (20m1). After drying, over sodium sulphate, the organic phase was evaporated to dryness 
and coevaporated with toluene (x2) to obtain a foam of 3ç5O-(TetraisopropyIdisiIoxane-1,3-
diyl)-6-N-phtha!oyladenosine (45) (80%)[ Found: C, 56.2; H,6.55; N, 10.9; 0, 17.5; Si, 9.05%; 
M, (mass spectrum), 640.26226. C 30 H42N5O7Si2 Requires: C, 56.2; H, 6.55; N, 10.9; 0, 17.5; Si, 
9.05%. ]; m/z 731 (M+gIycerol, 30%), 639 [M-(H), 70%), 509, 460. 
2'-0-Methoxyethoxymethyl-6-N-phthaloyl-3', 5'-O-(t etraisopropyldisioxane- 1,3-diyl)-adenosine 
(46).-6-N-Phthaloyl-3',5'-O-(tetraisopropyldisiioxane-1 ,3-diyl)-adenosine (3g ,4.6mmol) was re-
fluxed in dry ether (75m1) for 20 hours with methoxyethoxymethyl-triethylammonium 
chloride(4equivalents ). The mixture was then evaporated to dryness and the residue redissolved 
in chloroform(1 50m1). This solution was washed with water(2x50m1),dried over sodium sulphate 
and evaporated to dryness under reduced pressure to give the oil 2'-O-Methoxvethoxymethv!-6-
N-phthaloyl-3'.5'-O-(tetraisopropvldisiloxane- 1.3-d1:v1)-adenosine (46) (2.96g, 87%); d H  (200MHz, 
CDCI3 ), 1.0 (28H, m, TIPDS), 3.0 (1H, broad, OH), 3.25-3.6 (1 H, m, C2'), 4.0-4.6 (41-1, m, C5', 
C41, Ci'), 5.2 (<1H, m, water), 6.1 (1H, d, Cl'), 7.75-8.1 (4H, dim, Phth), 8.3 (1H, s, Adenyl), 9.0 
(1H, s, Adenyl); m/z 761, 675 [M+(H), 68%), 657, 639, 527, 509, 266, 136. 
Deprotection of 2'-O-Methoxyethoxymethyl-6-N-phtha/oyl-3',5'-O-(tetraisopropyldisi/oxane- 1,3-
diyl)-adenosine with tetrabutylammonium fluoride . - 2'-O-M ethoxyethoxymethyl-6-N-phthaioyl-
3',5'-O-(tetraisopropyldisiloxane-1 ,3-diyl)-adenosine was not stable to tetrabutylammonium fluo-
ride in dichloromethane giving a baseline spot by tic (system A). 
6-N-Phthaloyladenosine was also found to be unstable to tetrabutylammonium fluoride treatment 
under similar conditions. The product from the reaction was adenosine by tic (methanol/ 
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ethylacetate/ammonia 5/1/1) Rf=0.22 for both adenosine and the product from treatment of 
phthaloyl adenosine with tetrabutylammonium fluoride in dry dichloromethane. 
Di-n-butyiformamide dimethylacetal (47).- Di-n-butylamine (21 ml) and N,N-dimethylformamide 
dimethyl acetal (1 8.2m1) were mixed and heated at 100°C for3 days ,with protection from moisture 
by a silica gel drying tube. Fractional distillation (bp 158°C at 20mmHg) gave the colourless oil 
Di-n-butylformamidedimethylacetai ( 47) (40%); 8H  (200MHz, CDCI3), 0.75-1.0 (6H, m, methyl), 
1.1-1.7 (8H, m, methylene), 2.4-2.75 (41-1, m, methylene), 3.25 (6H, s, methoxy), 3.4 (1H, s, 
methine). 
tic scale reaction of (47)with adenosine.- adenosine (50mg) was dissolved in dry dichlorom-
ethane (1 ml) and di-n-butylformamidedimethylacetal(2 equivalents) was added.The solution was 
stoppered and set aside for 20 minutes monitored by tic(system A, Rf starting material = 0.21  Rf 
product = 0.32). The reaction was complete after 20 minutes. The product was not isolated. 
This product seemed to be stable to tetrabutylammonium fluoride in dichloromethane for at least 
2 days by tic(system A). 
3ç5'-0-(tetraisopropyidisioxane- 1,3-diyi)adenosine (48) .-Dry adenosine (3g ,11 .2mmol) was 
suspended in DMF/pyridine and 1 ,3-dichloro-1 ,1 ,3,3-tetraisopropyldisiloxane (4m1) added dropwise. 
After stirring at room temperature 1 hour, monitored by tic(system A, Rf product = 0.44 Rf starting 
material=0.2, the mixture was neutralised with triethylammonium bicarbonate (2M,10ml) and 
evaporated to dryness. The residue was taken up in dry dichloromethane(200ml) and this solution 
washed with saturated sodium bicarbonate so!ution(40ml) and water (50m1). The organic phase 
was dried over sodium sulphate and concentrated to a colourless oil. Cystallisation from 
acetonitrile yielded 3, 5'-0-(tetraisopropy1disioxane- 1, 3-diyl)adenosine (48) (3.04g, 52%), 
mp 90°C, [Found: C, 51.8; H, 7.9; N, 13.7; 0, 15.7; Si, 11.0%; M (mass spectrum), 510.25677. 
C 22 H40N505Si2 calc. C, 51.8; H, 7.9; N, 13.7; 0,15.7; Si, 11.0%; M, 510.25678]; d   (200MHz, 
IKIeI 
CDCI01  1.1 (28H, m, tipds), 2.1 (1 H,s, OH), 2.9 (1 H, d, C2'), 3.5 (1 H, s, OH), 4.0-2 (21-1, m, CO' 
4.6(1 H, d, C3'), 5.1 (1 H, m, C4'), 5.8 (21-1, s, Adenyl amino), 6.0(1 H, d, Cl'), 7.25(1 H, s, CHCI3), 
8.0 (1 H, s, adenyl), 8.3 (1H, s, adenyl); m/z 510 [M+(H), 90%]. 
6-N-Di-n-butylformamidine-3ç 5'-O-(tetraisopropyldisiloxane- 1,3-diyl)adenosine (49). 
(Tetraisopropyldisiloxane-1 ,3-diyi)adenosine (1g, 2.Ommoi) was dissolved in dry dichiorom-
ethane (20m1) and di-n-butyiformamide dimethylacetal (4 equivalents) was added. The reaction 
was protected from light with aluminium foil and moisture by suba-seal and stirred at room 
temperature for 2 hours under nitrogen (tic system A, Rf SM=0.44 Rf product = 0.65 and 0.7). 
When no more starting material remained more dichioromethane(1 1 OmI) was added and the 
solution washed with saturated sodium bicarbonate (20ml x2) .The organic phase was dried over 
sodium sulphate and evaporated to dryness under reduced pressure. One isomer, the lower by 
tic, crystallised from hexane to give 6-N-Di-n-butylformamidine-3',5'-O-(tetraisopropyldisiloxane-
1,3-diyl)adenosine (49)(0.5g, 40%) (Found: C, 57.3; H, 8.8; N, 12.95%. C31H57N6O5S12 requires, 
C, 57.4; H, 8.7; N, 13.1%.); X max  (MeOH), 201 nm ( E 20,3478 dm3moi cm'), 231 nm (13,0637), 
314nm (37,5894); 6H(200MHz,  CDCI3), 0.9-1.8 (55H, 3m, TIPDS+DBF), 3.25(1 H, s,2' OH), 3.3-
3.4 (21-1, t, C5'), 3.7-3.8(2H, m, C3'+C4'), 4.0-4.2 (41-1, m, CH2 of DBF), 4.6(1H, d, C2'), 5.2(1H, 
t, water), 6.0 (1 H, d, Cl'), 7.25 (<1 H, s, CHCI3), 8.0 (1 H, s, CH of DBF), 8.5 (1 H, s, Adenyl), 9.0 
(1H, s, Adenyl); m/z 755, 663, 649 [M+(H), 50%), 275. 
This product can be deprotected by F- ions(tetrabutylammonium fluoride) in dichioromethane. tic 
result(system A), Rf 6-Dinbutylformamidine-3' ,5'-(tetraisopropyldisiloxane- 1 ,3-diyi)adenosine = 
0.65, Rf after fluoride treatment = 0.3, (adenosine = 0.2 same system). 
50-(4,4 "dimethoxytrityI)-2deoxycytidine (50) .-To a solution of dry 2'-deoxycytidine (0.887g) in 
anhydrous pyridine was added dimethoxytrityi chloride (1.72g) and the mixture was stirred at 
room temperature protected from moisture and light for 2 hours. The product mixture was poured 
into water and extracted into diethyl ether(500ml), and evaporated to dryness.The products were 
separated and purified by wet flash chromatography (5%MeOH in dichioromethane) to give 5 
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0-(4,4"dimethoxytrityl)-2'-deoxycytidine (50) (0.783g, 50%); m/z 636, 528 [M-(H), 60%), 110, 
107. 
5'-0-(4,4"-Dimethoxytrityl)-2'-deoxycytidine; Reaction with 2,4, -Ditrofluorobenzene( Sangers 
reagent) in_dichioromethane.- A sample of 5'-0-(4,4"-dimethoxytrityi)-2'-deoxycytidine was 
dissolved in dichioromethane and excess dinitrofluorobenzene added. The reaction was moni-
tored by tic (system A). 
A very faint product spot was observed Rf = 0.54, the starting material Rf = 0.15. 
Reaction time was 6 hours 
Reaction of Sangers. reagent with ethylenediamine.- Ethylenediamine (1 ml,1 7mmol) was 
dissolved in dry ether and Sangers reagent(3g,1 7mmol) was slowly added (10 minutes). A violent 
exothermic reaction took place, and a bright yellow powder was produced which was collected 
by filtration to give (51) (2g, 52%) [Found: C, 42.3; H, 4.8; N, 24.7; 0,28.2%; M, (mass spectrum), 
227.07802. C8H11N404 Requires: C, 42.3; H, 4.8; N, 24.7; 0,28.2%; 227.07802]; m/z 319(40%), 
227[M+(H), 70%]. 
This product was found to be very insoluble in; CHCI3, water, water / Na2CO3 1/1, MeOH very 
slightly soluble, MeCN, 2M NaOH 
tic (systemA) showed a single low running spot Rf = 0.07 
2'-Deoxycytidine refluxed with ethylenediamine (52).- 2'-Deoxycytidine (0.58g) was dissolved 
in ethylenediamine(lOml) and this solution was refluxed for4 hours with protection from moisture 
with a silica gel drying tube. Reaction monitored by tic (nBuOH:AcOH:H20 3:11), Rf SM = 0.44, 
Rf product = 0.25. The reaction mixture was poured into water (1 OOml) and washed with diethyl 
ether(2x2Oml).The aqueous phase was evaporated under reduced pressure to give a brown 
viscous oil (52) 
Reaction of (52) with dinitrofluorobenzene (53).-The oil (52) was dissolved in ethanol and to this 
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solution was added 2,4-dinitrobenzene; a bright yellow precipitate resulted. Attempted liberation 
of this salt by sodium hydroxide solution (2M) wash of a suspension of (53) in chloroform was 
unsuccessful, the insoluble precipitate remained. m/z 455, 433(100%), 321. 
Reaction of (52) with 9-fluorenylmethoxycarbonyl- succinimide (54).- (52) (0.5g) was dissolved 
in dry DMF anf FMOC-succinimide (0.6g) added. This mixture was stirred at room temperature 
overnight and the resulting solid collected by fitration giving (54) (0.427g); m/z 493 [M+(H+), 60%]. 
N-(9-fluorenylmethoxycarbonyl)-6-aminohexan- 1-0/ (55).- 6-Aminohexan-1 -ol (0.35g,2,96mmol) 
was dissolved in dry pyridine (lOmI) and 9-fluorenylmethoxycarbonyl-succinimide (1 g, 2.96mmol) 
was added. This mixture was stirred at room temperature overnight, protected from moisture with 
a silica gel drying tube (ticsystem A, Rf product = 0.55). The reaction was poured into water and 
extracted with chloroform (4x40m1),dried over sodium sulphate and evaporated to dryness to give 
solid N-(9-fluorenylmethoxycarbonyl) -6-aminohexan-1-o! (55) (0.588g, 58%) [Found: C, 74.1; H, 
7.7; N, 4.1; 0, 14.1%; M (mass spectrum), 340.19128. C21H2603N requires C, 74.1; H, 7.7; N, 
4.1;0,14.1%;M,340.19126]; 	209nm ( E35,466dm3mo11cm 1), 264nm (17,068); 8 
MHz, CDCI3), 1.1-1.5 (5H, m, methylene), 2.9 (2H, d, CH2-N), 3.4 (2H, t, CH2-O), 5.2 (2H, broad, 




1-01 (100mg,0.3mmol) was dissolved in dry dichloromethane and dry diisopropylamine 
(0.1 ml,2equivalents) was added. The reaction vessel was flushed with dry oxygen free nitrogen 
and chlorocyanoethyl-N,N-diisopropylphosphoramidite (0.08m1, 1 .2equivalents) was added. The 
reaction mixture was stirred under nitrogen for 1.5 hours until the reaction appeared to be 
complete by tic (system C, Rf product =0.78. One drop of dry methanol was added followed by 
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ethyl acetate (1 Oml). This solution was washed with sodium carbonate solution (10%, 2ml) and 
brine (2m1) ,dried over sodium sulphate and evaporaed to dryness to give the oil N-(9-
Fluorenylmethoxycarbony/)-6-aminohexan- 1-0/- l-O-N,N-diisopropy/cyanoethy/phosphoramidite 
(56) (1 30mg, 80%). 
The product from this rection was reacted with deblocked sarcosyl resin and then the resin 
was treated with 10% DBU in dry dichloromethane .The resulting resin was then found to give 
a positive result when tested for primary amines(Kaiser test). This resin turned bright yellow upon 
treatment with dinitrofluorobenzene. 
N-(2,4-dinitrophenyl)-6-aminohexan-1-oI (57).- 6- Aminohexan-1 -ol (0.8g,6.8mmol ) was dis-
solved in ether and 2,4-dinitrofluorobenzene(1 .3g,1 equivalent) was added. The resulting yellow 
solid, tic Rf product = 0.52 (tic system A) was collected by filtration giving N-(2,4-dinitropheny/)-
6-aminohexan-1-oI (57) (1.3g, 70%) [ Found: C, 50.7; H, 6.4; N, 14.8; 0, 28.15%; M (mass 
spectrum), 284.12462. C12H18N305 requires C, 50.7; H, 6.4; N, 14.8; 0, 28.15%; M, 284.12463]; 
H  (200MHz, CDCI3), 1.1-2.0 (9H, m, CH  +OH), 3.25-.75 (41-1, m, CH  each end), 6.9 (1H, d, 
sangers 6), 8.25(1 H, d of d, sangers 5), 8.5 (1 H, broads, N-H), 9.1 (1 H, d, sangers 3); m/z 284 
[M+(H), 80%), 217. 
1 -O-(4,4'-dimethoxytrity!)-6-N-(2,4-dinitropheny!)-6-aminohexan- 1-o/ (58).- N-(2,4-dinitrophenyl)-
6-aminohexan-1 -ol( ig) was dissolved in dry pyridine (15m1) and DMTr -Cl (1 equivalent) added. 
The reaction was protected from moisture with a silica gel drying tube and stirred at room tem-
perature for 1 hour and monitored bytic(system A, Rf starting material = 0.48, Rf product = 0.78). 
When the reaction was complete water (150m1) was added and the products extracted into 
chloroform(5x3Oml). The organic phase was dried over sodium sulphate and evaporated to 
dryness at reduced pressure. Purification was by flash chromatography(250m1 dichlorometharie 
/5m1 triethylamine) to give the oil 1-O-(4.4dimethoxvtritvI)-6-N-(2.4-dinitrophenv/)-6-aminohexan-
j.j (58) (60%) [Found: C, 67.7; H, 6.0; N, 7.2; 0, 19.1%; M (mass spectrum), 585.24744 
C 33 H55N3O7 requires C, 67.7;H, 6.0; N, 7.2; 0, 19.1%;M,585.24748]; 13400cm1, 1600,1400; 
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H (200MHz, CDCI0, 1-3.5 (12H, m, alkyl CH2), 3.75 (61-1, s, methoxy), 6.8 (51-1, m, DMTr), 7.2-
5 (9H, m, DMTr+Sangers 6), 8.25,(1 H, d, Sangers 5), 8.5(1 H, broad, N-H), 9.1 (1 H, d, Sangers 
3); m/z 585 [M-(H+), 100%]. 
Attempted N-benzoylation of (58).- (58) (0.6g ) dissolved in dry pyridine (1 5m1) and benzoyl 
chloride (2 equivalents, 0.25m1) was added dropwise. The reaction was protected from moisture 
with a silica gel drying tube and stirred at room temperature for 1 hour, monitored by tic 
(dichloromethane/triethylamine 5/1) 
No reaction was observed .Product was starting material (57); v 	3400cm-1  (OH). 
Also no reaction after addition of triethylamine. 
N-(2,4-dinitrophenyl)-6-aminohexan- 1-o/-i -O-N,N-diisopropylcyanoethylphosphoramidite (59).-
6-N-(2,4-dinitrophenyl)-6-aminohexan-i-ol (1 40mg ) was dissolved in dry THF(5m1) with dry 
diisopropylethylamine (0.1 ml) and 2-cyanoethyl-N,N- diisopropylchlorophosphoramidic chloride 
(0.132 ml 1.2 equivalents). When the reaction was complete by tic (system C, Rf product 0.8, Rf 
sm = 0.39) methanol (5 drops ) and ethyl acetate (20ml ,nitrogen saturated ) were added . The 
organic phase was washed with sodium carbonate (1 0%,5m1 x2) and brine(5m1 x 2), dried over 
sodium sulphate and evaporated to dryness under reduced pressure. The product was purified 
by flash column chromatography (EtOAc/dichloromethane,i/i) to give the oil N-(2,4-dinitro-
phenyl)-6-aminohexan- 1-0/- 1-0-N,N-diisopropylcyanoethylphosphoramidite (58) (100mg, 80%); 
31PNMR 147.21(s). 
3-N-Dinitrophenyl-3-amino- 1,2-propanedioL (60).- 3-Amino-1 ,2-propanediol (0.5g, 5.5mmol) 
was dissolved in methanol (50m1) and to this was added 2,4-dinitrofluorobenzene (1.0g, 
5.5mmol). This solution was set aside overnight. The solution was then evaporated under 
reduced pressure and triturated with diethyl ether (the insoluble orange oil being retained). 
Further evaporation evaporation yielded an orange oil 3-N-Dinitrophenyl-3-amino-1,2-propane-
dio/(59) (1 g, 78%); m/z 258[ M+(H), 80%). 
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1-O-(4,4'-Dimethoxytrityl)-3-(dinitrophenyl)-3-amino- 1,2-propanediol (60).- 3-N-Dinitrophenyl-
3-amino-1 ,2-propanediol (0.5g,1 .94mmol) was dissolved in anhydrous pyridine (1 2m1) and to this 
solution was added 4,4'-dimethoxytrityl chloride (0.722g, 2.1 mmol). The mixture was protected 
from moisture with a calcium chloride guard tube and stirred at room temperature for 2 hours. The 
mixture was then poured into water (1 OOml) and the product extracted with chloroform (4x 30m1). 
After drying over sodium sulphate, the solution was evaporated to dryness. Purification was by 
flash chromatography (3% methanol in dichloromethane ) to give the yellow oil 1-0-(4,4'-
Dimethoxvtritvi)-3-(di2itrophenvl)-3-amino- 1.2-propanediol (61) (0.7g, 64% ); SH  (200MHz, 
CDCI3) 2.4(1 H, s, OH), 3.25-3.6 (41-1, m, C11C), 3.75 (61-1, s, We), 4.1 (1 H, m, C2)1  5.3 (1 H, s, 
water), 6.8-7.5 (14H, m, trityl+DNP 5), 8.2 (1H, m, DNP 6), 8.75 (1H, m, NH), 9.1 (1H, m, D N P 
3); mlz 558 [M+(H), 100%]. 
136 
Oligonucleotide Synthesis cycle 5' Protection 5' Deblocking reagent End 
procedure 
T4 Phos 1 DMTr 3% TCA/ dep-phosl 
(Table 4) dichloromethane (Table 5a) 
T4 Phos 2 FMOC 10% DBN/ dep-phosi 
(Table 5) dichloromethane 
(C) test 1 sscel 03a DMTr 3% TCA/ deprce03 
dichloromethane 
489A ssce103a DMTr 3% TCA/ deprce03 
dichloromethane 
d (A)8 sscel03a DMTr 3% TCA/ deprce03 
dichloromethane 
d (A)8 ssmel03a FMOC 10% DBU/ depr03 
acetonitrile 
d (A)8 ssce103a FMOC 10% DBU/ depr03 
acetonitrile 
T6 PIPME1 FMOC 20% piperidine/ depr03 
acetonitrile 
T6 PIPME1 FMOC 20% piperidine/ depr03 
acetonitrile 
T6 ssce103a DMTr 3% TCA/ deprce03 
dichloromethane 
T6 PIPCE1 FMOC 20% piperidine/ deprce03 
acetonitrile 
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Oligonucleotide Synthesis cycle 5 Protection 5 Deblocking reagent End 
procedure 
(I) 	T6 ssce103a FMOC 10% DBU/ deprce03 
acetonitrile 
d (A)8 PIPME1 FMOC 20% piperidine/ depr03 
acetonitrile 
d (A) ssce103a DMTr 3% TCA deprce03 
dichioromethane 
(0) d (GT)3 PIPME1 FMOC 20% piperidine/ depr03 
acetonitrile 
d (GT)3 ssce103a DMTr 3% TCA/ deprce03 
dichloromethane 
d (GA)3 PIPME1 FMOC 20% piperidine/ depr03 
acetonitrile 
d (GA)3 sscel 03a DMTr 3% TCA/ deprce03 
dichloromethane 
d (C)6 PIPME1 FMOC 20% piperidine/ depr03 
acetonitrile 
 PIPME1 FMOC 20% piperidine/ depr03 
acetonitrile 
(U) ssce103a DMTr 2%TCA deprce03 
dichioromethane 
(v) r (C)6 RNA2P FMOC 20% piperidine/ depr03 
acetonitrile 
138 
Oligonucleotide Synthesis cycle 5' Protection 5' Deblocking reagent End 
procedure 
 ssce103a DMTr 3%TCA/ deprce03 
dichioromethane 
 sscel 03a DMTr 3% TON deprce03 
dichloromethane 
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CYCLE NAME: 	 i I 
NUMBER OF SIEPS: 0? 
DATE: 	 EE', ',:'l  1909 
TIME: I : 40 
S1EP FUNCTION STEP 
STEP ACTIVE FOR BASES SAFE 
NUMBER # NAME TIME A 6 C T 5 6 7 
STEP 
1 to #19 	To Wto 4 Yes Yes 
Yes Yr's  Yes Yen Yen 
2 9 #111 In 	Ce] 	imn /')) Yes 
Yen Yr's Yr" Yes Yen Yr'S Yen 
2 evers? Flush 2: yp Yes Yes 
Yen Yen 'lcss Yen Yr's 
4 1 FElock 	1'1001 4 Yes ''po 
Yr's Yen Yes Yes '(en Yes 
21) F'hos Prep ', Yr's yr's Yr's 
Ye' yr's Ye Yr's yr- 
o +45 Or oup 	1 On I Yen 
Yes Vs's Yes Y's Yes Yen Yes 
7 90 ILl to column 2 Yr's 
Yes Yes ''es Yes Yes Yr's Yes 
El 19 FE-riFT 	I Cc'] 	I Yes Yr's 
Yen '1 '(C" 	. Yr's 'Er's Yr" - 
'1 90 IF I to cnlumn 2 Yen 
Yen Ye s Yes Yr's Yes Ins Yr's 
10 19 Fri -lET 	To 	Cc,] 	1 2 
Y  s Yr's Yr's Yr's Yr's Y€•'s Ye. '(P5 
11 9 #10 Ia Cal urnn 2 Yen Yes 
YeS Yes Yes '(r"5 Yes Yes 
12 -46 I3rr'rp 	1 01+ 1 Yen 
yr,s Yen Yen Yr Yen Yes Yen 
3 +47 Liroup 2 On I Yen Yr's 
Yr's Yr's Yes '(cnn Yes Ye 
14 1( tIlt) 	IL' 	Waste 1 Yen '(en 
Yen Yen Y,' Yen Yen Yc'n 
15 1 FibrE Flush 4 
yes Ye s es Yes Yes Yes Yes Yen 
90 TEl 	to cnlrmn 2 Yr's Yr's Yes 
'(en Yen Yr's Yes Yes 
17 22 FeE [FT To 	Cob 	2 2 Yr's 
Yen Yr's Yr's Yes Yr's Yen Yen 
10 90 fF1 	In teEn 
'(rn Yr's Yr's Ye' . Yr ' s Yr's YeS Yes  
19 20 P+lEf Ic, 	D112 7 
Yr's yr's Yr's Ye yr's Yen Yen Yr's 
'1 410 	In I7n1 usa :- Yen Yen Yes 
Yr" Yen Ye' Yen Yen 
21 Ur uup 2 	IJI 1 1 --40 
 Yen yr'; Yes YPS 'Er'S yes V's Yr'S
+9 4 Ur 3 On  u Yr'r' Yr's Ye" 
Yen Yen Yes Ye Yrs  
23 10 1118 	Fe 	W'stc' 1 Yen 
Yes Yes Ye's 'Ens Yen Yes YE'S 
24 1 OlurE flush 4 Yen 
Yes Yen Yes, Yes Ye" Irs Ye" 
9c) 11--1 	Icy 	column ,' Ye's Yr's Yen Ye's 
ys Yen Ye's Ye" 
21 0+11'] to I"nl 	3 Yen- Yr's 
Yen Yr's Yen. Yr's Ye" Yen 
27 9') Fl 	to cnlunn 2 Yes 
Yr's Ye'; Yr's Yes Yes Yr's Yes 
211 .1 El-i-IF I In 	luI 	3 2 
yes Yr'S Yes Ye" Yr' Ye" Ye" Yen 
29 9 01 P 	In Lol rune 2 Yr-''s S 
es. Yen Vi's 'Ii's 0" 'r'' Y"'; 
Yen 
IJr'c'up 2 Of  sr's Yen Yen Yu' 
Yen Yr"' ii"' 
Yes 
21 4 Wnt i 
's) In"; Yen 5 '-"S y 	S Ye'-, Ye's V's's 
16 L-sp 	E'rep fI) Ye. '(c's 
Yc.'n Ye's '(c's Yes Vi's Ye" 
1118 1 	b.lsstr' S Ye;; Yen Yes 
Yr's Vi"; Ye's son Ye'; 
Ye" 
1-4 I(rverSP Flush Yen. 
Yen Yr--" Yry- Ys"'- Yen 'Er"'. 
Yen  
35 1 Block Flush 4 
Yen Yr's Yr's Ye's 5 's'; '("n Yc"S 
1-6 ±45 ('recut) 	1 till Yr"' 
Yes Yr's Yr's Yr's Yen V 
37 22 Lap Jo rc,b 	1 to Yr's 
Yr's yes Yes Yr's Yen Yr's Yr's 
19 -41, Orcucup 	1 1)1+ 1 
Yr's Yes Vi's Yr"r 1"s Ye"' Yc's Yr's 
±117 L,ruscup 2 In I yen Yr's Yes Yen 
lee Yes Yr'S Yr'S 
4':' 23 (-"AllTo 	Col 	2 8 Yen 
Yes Yr's Yen Vp's yr'r, Yr"' Yr's 
41 --40 llrnup 2 Off I 
Yr's Yen Yr's YE-s Yes Ycs Ye'; Yes 
Yr's 
42 +49 (1rcup 	3 (in 1 Yes 
Yr's Yen Yes Yen Yr's Yen 
42 24 Lap In Col 	3 (1 
Yr's 	Yr's Yr's Yes ye's Yen YE-s Yr's 
(Lontinued next paqe.) 
SYNTHESIS CYCLE 
VERSION 1.34 
CYCLE NAME: 	ShCE1034 
NUMBER OF STEPS: 89 
STEP FUNCTION STEP STEP ACTIVE FOR BASES SAFE 
NUMBER Is NAME TIME A_13, C,  1 5 6 7 STEP 
44 -50 Ih oup 3 Off 1 yen yen Yen yes Yen Yes Yen Yen 
45 4 Wait I Yen Yen Yen Yen Yes V Yen Yen 
46 10 4118 	to 	WrM5tF? 7 YES Yes YC Yt' 1  yEs Yen YCO 
Yen 
41 2 Reverse Flush 51 Yes Yen Yen Yen Yen 
$pr;  Yes Yen 
48 1 Block Flush 4 Yes Yen Yes yen Yen yes Yen Yen 
49 Iii IllS 	In 	nfr' / Yen, Yes Yen Yr-n Yen Yen Yr-n Yr- 
13 1415 to Column 19 Yen Yes Yen Yen Yen Yet Yen 
Yen 
51 1 Wait 30 Yen Yen Yr's Yvs Yen Yen Yes 
Yen 
52 10 #18 	in 10 Yes Yes Yr-s von Yen Yen Yen Yes 
51 2 Fevern 	I-lush .0 yen Yr-n Yr-c' YOS Yr's Ye Yr-n 
Yen 
54 1 Flock Flush 4 yen Yen Yr's Ye'; 'lc-?'5 Y Ye'; 
Yes 
55 9 0111 	in 	Coi i;mn 20 Yr's Yen Yes Yen yes Yc:.n 'ten Yen 
56 2 krvr'r';t' El u';h S Yen Yen Yen Y"; Yrt'; Yen Yr-n 
Yr's 
51 9 $4111 	In 	Loiiunri Hi Yr's Yen Yr-s Vi''-; Yr-S Ye Yr-n 
Yr-n 
513 2 Yr-verse Flush S Yec' Yr-n Yr's Yr-n Yen Yen Yc' Yr-n 
57 7 4418 	To 	Colt Into 1 	) Ye" Yes •• y'e Yen Yrcy ye' Vt'". Yen 
60 2 Reverse Flush S Yen Yes Yet; Yr-n Yen Yr-ct Yen 
Yen 
i-i 9 4418 	To 	Eni untti 19 vt-n yen Yen yr" Yr'; Yr'- Yr-n 
Yr" 
62 2 Er-er-cnn Flush S Yen Yen Ye'; Ye'; Yen Yen vi"; 
1 f-hoc1-: 	I -loch I '-'., Yen Vt"' 'yç";  Ye" 'yr's Vr"- Ye" 
64 33 Cycle Entry 1 Yes Yes Yes Yes Yes Yes Yes Yen 
65 10 4110 	In 	(')c'tr 3 Yen Yen Yr-tn 'y r-n 'ye;- Ye' Yin YI' 
66 9 #113 to Col rimn 20 'yen Yes Yes Yr-n Yen Yr-n Yen 
Yr-n 
67 2 Reverse Flush Yr's Yen Yen Vt';; Yr-n Yr-n Yr'S 
611 1 Flock Flush 6 yen Yen Yen Yen Yen Yr-s Yen 
Ye'; 
69 6 lJ,nnte-Pert I Yes Yes Yen 'Yr-c; Yen Ye;; Yen 
Yen 
7)) 5 ()dvence FE 1 Yes Yen Yen, Yen Yen Yr-n Yr-n 
71 112 #14 	In Waste S Yes Yen Yen Yr-c' 'ten Yr.';. Yen, 
Yr's 
72 14 #14 To 	Coli.imn to Yen Yr-n Yen Yen Yen Yen 
Yr's No 
73 2 h'vernr' Fitch 1 Yes Yen Yen Y;' Yr-n Yr-' Yr-n 
Yr's 
74 14 4114 	to Column 10 Yes Yen Yen Yen Yen yen ye'; 
Yen 
75 2 hoverer Fl itch 1 Yes Yr'n Yen Yen 'i'r'n Yen 
Yr'n Ye' 
76 14 4114 To Column it' Yen Yr's Yen Yen Yen Yr-n 
Yen Yen 
77 2 hr-verne F luh 1 'Yen Ys Yr-- Yi;: Yr-c', Yr-n \ rn 
Yr-n 
113 14 #14 To Column 10 Yes Yes Yr'S Yen Yes Yr-n Yen 
Yen 
79 2 r;rvernn Flush 1 Yen Yen Yr-" Yes Yen Yin- Yr's 
Ye'- 
8') 14 4114 	To Column 10 Yen Yen Yen Ye'; yr"' Yen Yen 
Yen 
131 1 fYI nrC Fl 	.t-'I, 4 Ye" Yen Yen Yr'S. Yen 
Y t"' Yes MCI 
82 10 1118 	To 1-JesFe S Yes yen Yen Yen Yen Yes Yr"; 
Nih 
113 9 4118 To 	Fol umri 30 Yen Yes Yr-n V re Yen yr's Ye;; 
No 
84 2 koverso FILI'Sh 5 Yen, Yr-s Yen Yen Yen 'tr-'nn 	Yen 
No 
145 10 018 	in 	t'jst,p 5 yen Yr-n 'ye" Yr-s Yr-n yr-. len 
Yr" 
136 9 1518 10 Column 30 'yen Yen Ye s ii-"; Yes Ye" Yen 
87 2 Fever no Flush 5 Yen Yes Yes Ye" Yr-n Yr-n yes 
Ye"- 
813 1 Flock Flush 4 Yen Yen Yen Yen Yen Yes Yen 
Yen 
89 7 Waste-Bottle 1 Yes Yen, Yen Yen Yen yes Yes 
Ye" 
SYNTHESIS CYCLE 
	 Page I 
VERSION 1.34 
CYCLE NAME: 
NUMBER OF STEPS: ElY, 
DATE: 	 8ep 21, 1909 
TIME: 
STEP FLJFJCTIDN STEP STEP ACTIVE FOR BASES SAFE 
NUMBER * NAME___ TIME A 13--C V-5 6 7 STEP 
Ici #113 	to Waste 4 'Yen Yes Yes Yes yen Yen Yes Yes 
2 9 44113 Ii' 	Column <Si. ) Yen Yen Yes Yen 'Yen Yen Yen Yen 
- 2 Rr'vernc,< Flush 20 Yes 'Yen Yes Yen Yes Yes Yes Yes 
4 1 131 	cI 	flush 4 Yes Yr', Yr's Yes Yes Yes Yes Ye- 
5 1:8 Hicis Prep .1 Yes Vi's Yes Yr's 'YciS Yes Yes V 
<S +45 hr oup 	I (in 1 Yr's Yes Yes Yen Yr's Yr's Yes Yr's 
/ <Si El In Waste 2 'yr's 'Yr's Yes Yes Yes Yen Yen Ye 
S 
U 19 13+IE1 	1 ci 	Ccl 	1 5 Yes Yes Vs's Yes Yes Yen YE'S Yr's 
9 9 #111 Ia Column 3 Yes yen 'Yr's Yr's Yen Yes Yes Yes 
10 -'46 Group 	1 Off 1 Yen Yen Yr's Yen Yen Yes Yen Yen 
ii +47 Group 2 On 1 Yes Yes Yr's Yes Yes Yen 'Yr's Yes 
12 li:i #18 	In Waste / Yen 'Yes Yen Yr's Yes Yen Yen Yen 
1.1 1 L(lark Flush 4 Yes Yen Yen Yr's Yen Yes Yes Yr's 
14 61 iLl 	ici 	l'Jsstc' 2 Vt's Yes Yr's 'Yr's Yes 'Yr's Yr's Yes 
lb 2(3 0+11:11 I Lr'l 	2 5 'Yes Yr's Yes Yes Yr's Yes Yes Yr's 
16 9 ff111 	In 	Column Yes Yr'n Yes Yes Yes Yen Yes Yen 
17 -'413 Group 2 Off 1 yes Yes Yes Yen 'Yr's Yes 'Yr's Yr's 
113 +119 Group 3 On 1 Yes Yen 'Yen 'Yen Yr's 'Yen Yes Yr's 
1/ In #10 	ri 	ff<,fr 7 Yr'S Yr's 'Yes Yes Yen Yen Yes ye- 
21) 1 Block F- lush 4 Yr's Yes Yr's Ycyr 'irs Yr's Vi's Yr's 
21 61 IF -I 	In 	Wstr' 2 Yr's Yes Yr's Yr's Yes Yr's Yes Yen 
22 21 R+ICT Io Cal 	3 5 Yes, Yes 'Yes Yr's Vt's Yen Yes Yen 
'3 '14114 	In 	I'niiunn ". Yr's Yr ,  "-.; Yen Yen Yes Vi's Vi's Yes 
24 --5i) ('Jr cup 3 (If + 1 Yr-s N i's 'Yes Yr's Yr's Yes 'Yr's Yen 
25 4 Wait 20 Yes Yes Yen Yes Yr's Yes Ye'; Yes 
26 16 Lap 	Fr r'p 10 Yes Yr's Yr's Yes Yes Yen Yes 'Yes 
2/ In $11 H In 	Waçtp S Yen Yes Yes Yr'S (05 Yr'S Yr'S Yr's 
211 2 I<'ir'r ne I - i ush S YE'S Vi's, Yr's Yr'S 'Yr's Yr's Yr's Ye's 
29 1 Oicinl:: 	Flush 'I Yes YE'S Yr's Yes Yen Yr's Yes Yr's 
3.: 445 Or OUP 1 Un I Yes Yen 'Yr's Yen Yr'n 'Yr's 'Yen Yr's 
1.1 22 Lap 	lo Col 	1 in Yes Vi's Yes Yes Yes Yr's Yes 'Yes 
32 --46 Group) 1 Of 1 Yen Yes Yes Yes Yr's Yes Yr's Yea, 
441 hrnup 	2 liii 1 Yes Yr's Yen Yr's Yes Yes Yen Yr's 
34 23 Cap 1 Ccii 	2 El Yes Yr's 'Yr's Yr's 'Yes Yr's Yes Yr' 
35 -413 Group 2 Off 1 Yen Yes Yes Ye;; Yes Yes Yes 'Yes 
36 +49 Group 3 LIn 1 Yen Yr's Yes Yin Yr's. Yes 'Yen Yen 
3/ 24 Lap 	Ic 	Lni 	.3 8 Yen Yes Yen Yes N en Yen Yes Yes 
113 -50 Urciup 3 Off 1 Yes Yr's Yen Vi's 'Yr's 'Yr's Yr's Yes 
.39 4 Wait .3,,.,  Yes Yr's Yr's 'Yes V's Yr's Yes Yes 
4',) 10 #111 	lo Waste '/ Yes Yes Yen Yes Yes Yr's Yes Yes 
41 2 Reverse Flush 5, Yes Yes Yes Yes Yes Yr's Yr's Yes 
42 1 Plod: 	Flush 4 'Yes Yes Yes Yes Yr's Yr's 'ic's Yr's 
41 131 11115 In Waste / Yes Yes Yen <'c's Yr's Ye's Yes Yr's 
(Continued next pear'. 
SYNTHESIS CYCLE 
VERSION 1.34 
CYCLE NAME: 	ssrne10.3 
NUMBER OF STEPS: 136 
STEP FUNCTION STEP STEP ACTIVE FOR BASES SAFE 
NUMBER $$ NAME TIME A 6 C T 567 7 STEP 
44 15 015 	To Column 15 Ys Ys Yes Yes 'Yes Yes Yes 
45 4 Wait .30 Yes Yes Yes Yes Yes Yes Yes Yes 
46 10 #18 	to waste in yes Yes Yen Yes Yes Yes Yes Yes 
4/ 2 Reverse Flush Yes Yen Yes Yes Yes Yes Yes Yen 
48 1 block Flush 4 Yes Yes Yes Yes 'Yes Yes Yes Yen 
49 15 013 	To Column 20 YSS Yem Yes Yes Yes Yes Yes Yes 
50 2 Reverse Flush 5 Yen Yes Yes Yes Ys Yes Yes 'ic's 
Si 15 #1 	ro Column 10 Yes Yes Yes Yes Yes, Yes Yes Yes 
52 2 Rc-?versr? Flush S Yes Yes Yes Yes Yes Yes Yes Yr's 
53. 15 #1.2. 	To 	Column 10 Yes Yes Yes Ys Yes Yen Yes Yr's 
54 2 ksverss Flush S Yes yes Yes Yes Yes Yes Yes Yr's 
05 15 #13 	Ic Column 10 Y Yes Yes Ys 'ic's Yes 'ic's, Yen 
58 2 kvers 	Flush 5 Yes Yes Yes Yen Yes Yes 'Yes Yr's 
51 1 Id 	oct. F lush /T Yes Yes Y  Ycn, Yes Yu Yes Yc''; 
58 33 Cycle Entry 1 Yes Yes Yes Yes Yes Yes Yes Yes 
59 113 TIlL 	In 	1'Jyyste .1. Yes Yes Yes Yes; Yr's Yes 'yes Yr's 
60 11 #14 i Ecl 050 10 Yes Yes Yes Yes '(cps Yes Yes Yes 
61 2 Fy'vrrep Flush 0 Yes, Yen Yes Yes Yr's Yes Yes 'iFS. 
62 1 hI oc:I 	I tush .5 Yes Yes Yes Yes Yes Yes Yes Yes 
6 ljnste-Pork; 1 Yes Yes Yes Yes Yes, Yps Yr's Yrs 
64 5 (11 vol r:e 	1-12 1 yes Yes Yes Ye Ye'; Yes Yc's Yes 
65 5 (yclv,yricr' I-F 1 Yes Yes Yes 'Yes Yes Yes Ye Yr's 
66 5 (lvnnco FL; 1 Yes yes Yes Yes Yes Yes Ys Yr's 
87 5 (-Sivmrce FL I Yr's Ye Yes Yr's Yes Yr's Yes Yr's 
68 82 #14 	lo Wsste J Yps Yr's Yes Yr's Yes Yes Yes Yr's 
69 14 414 In Col nmn 10 Yes Yes Yes Yes Yr's Yps YpEr, IF 
/0 2 kover's. 	I' lush I Ye'; Yes Yr's YeS Yes Yes Yes 
71 14 #1 1I 	To Culumn I U Yes, Yes Yps, Yes Yes Yes Yes Y..... 
/2 2 kevr'i'se Flush I Yes yes Yes Yes Yes Ye n 'yes y(- 
7 3- 14 014 	In 	12c"lumr; 
es
10 Yr's Yr's Yps Yr's Yr's Ye'; Yet; Yr's 
74 2 F,y'yersr' Flush 1 'rU's Yes Yes Yes Yes Ye;; Yes Yes 
75 14 #J4 	To 	Lot ;rmr 1c' Yes Yes Yr's, Yes Yes Yes Ys Ye 
76 2 I':evor- s'y F] ush I Yes Yes Ye;; Yen 'yes Yes Yr's Yes 
77 14 1-tl'I 	In 	Column 0 Yr's Yr's Y 's Yr's Yr's Yr's Yr's Yr' 
/8 1 FyIor:I. Flush 4 Yes Yes Yr's Ye'; Yes Yes 'Yes No 
79 18 Ole, 	lo 	Fissle 5 yes Yes Yes Yr's Yr's Yr's Yes Nn 
H(j 12 014 In Column o yr's Yes Yes Yes Yes Yes Yr's No 
81 2 Rvcr 'ye Flush Fi Yes Yes Yr's Yes 'Yr's Yes Yr'c No 
1,32,  111 hIs 	in 	tJ,ysl:c; S Yes Yes Yes Yes Yes Yes Yes Yr's 
11.1 12 016 In Column .20 ;r's yr's Yps Yes, Yc';, ye'-; yr's Yr's 
84 2 Fever- se Flush S Yes 'yes Yes Yes Yes Yes Yr's Very 
135 1 };lock 	Flush 'I Yes Yen Yr's Yes Ye;; Yes yr's Ye,; 
86 7 Flsntrr - hrottl,e t Yes Yen Yes Ys Yes Yen Ye;; Yes 
SYNIHESIS CYCLE 
VERSION 1.34 
CYCLE NAME: 	F1F1'IE1 
NUMBER OF STEPS: FI 
DATE: 	 Sep 21, 1989 
TIME: 16:45 
STEP FUNCTION STEP STEP ACTIVE FOR BASES SAFE 
NUMBER * NAME TIME A 0 C T 6_-.7,  STEP 
1 10 #13 in Waste 4 Yen Yen Yen Yen Yes Yen Yen Yen 
9 #18 	Ia Column 60 Yen Yen Ye s Yen Yes Yes Yes Ye 
3 2 Peverne Flush 20 Yen Yen Yen Yen Yen Yen Yen Yen 
4 1 btc,c:i' 	Flush 4 YPS Yes Yen Yr's Yen Yes Yes  
5 213 F'hon Prep 3 Yen Yen Yes Ye S Yen Yes Yen Yen 
6 +45 Uroup 	1 Un 1 Ypn Yen Yes Yen Yes Yes Yen Yes 
7 nI 1151 I 3onle 2 Yes Yes Yes Yen YCS Yen Yen Yen 
8 19 E+IEI 	In 	Cr1. 1 5 'Yes Yes Yen Yr's Yr's Yen Yes Yen 
'1 9 010 In Column s  Yes yen Yen Yen ye Yen Yes Yen 
10 -46 Group 	1 041 1 Yen Yes Yes Yes Yes Yes Yes Yen 
11 +47 Croup 1 (in 1 Yen Yen Yen Yen Yen Yes Yen Yen 
12 ii: 1118 	In 	L'J,+st:e / Yen Yen Yes Yen Yr's Yr's Yen Yen 
13 1 Block Flush 4 Yen Ys Yen Yes es Yes Yr's Yes 
14 81 1151 	ic 	Waste 1 Yes Yen Ye Yen Yes Yen Yr'c Yes 
15 IF' loin I In 	ISni 	2 Yr's Yes Yen Yen Yen Yen Yen Yen 
16 '3 #18 	In Column 5. Yes Yen Yrn Yes Yes Yr's Yr's Yen 
I/ -48 Lirciup 2 U++ I Yes Yes Yes Yen Yen Yen yes Yen 
18 +49 I-irc:n.ip 	.1 Un 1 Yen Yen Yes Yes 'yen Yes Yen Yen 
19 #18 in Waste / Yes Yen Yen Yes Yes Yr's Yr's Yen 
20 1 131 	cI 	Flush 4 Y's Yes Yes Yes Yes Yes-, Ype Yen 
21 61 tEl In Waste 2 Yes Yes Yen Ye'Y Yen Yen Yes Yen 
22 21 l31FI 	Icy 	Ccii 	3 5 'Yen Yen Yen Yen Yen Yen Yen Yen 
23 9 #19 In Column 3 Yen Yen Yr's Yen Yr's Ye's Ye's Yen 
24 -50 E(rciup3 U++ 1 Yes Yr's Yr's Yen Yr's Yen Yr's Yes 
25 4 W,Yit. Ii.) Yen Yen Yes Yen Yen Yen Yes Yen 
28 16 Cop Prep 1') YeS Yes Yen Yen Yen Yen Yr's Yr's 
2/ .10 #13 	In Waste S Yen YeS Yen Yes Ye's Yr's Ye'S YeS 
29 2 heverse Hush u S Yr's Yes Yr. Yr's Ye", Yes Yr" Yes 
29 1 Illor:I.. 	Flush 4 Yes Yes Yen Yen Yen Yen Yes Yen 
30 445 Group 1 Un 1 Yr's Yen Yen Yes Yen Yes Yr's Yen 
31 22 Cop 	In Cal 	1 10 yon Yen Yes Yen Yes Yr's Ys Yen 
32 -46 Group 1 	Off I Yr'n Yes Yen Yes Yen Yen Yr's Yen 
-.3:3 +47 Group 2 Un 1. Yen Yen Yes Yes Ye'; Yen Yen Yen 
34 23 Cop 	In 12o1 	2 3 Yr's Yr's Yen Yr"' Yes YPn Yr's Yen 
35 --48 Group 2 	(3-Cf I Yr'S Yes Yr's Yen Yr's Yr's Yr's Yen 
16 +49 (Yr ('up I in I Yen Yes Yen Yen 'Yr'n Yen Yr's Yen 
31 24 C,,p 	In 	Col. 	3 U Yin; Yen Yen Yen Yr's Yen y 	's Yen 
TO -50 Group l 11ff 1 Yr's Yes Yen Yr's Yen Yen Yes Yes 
.39 4 Wait .0 yen Ye's Ye Yen Sri;; Yen Ye,; Yen 
40 10 #19 	In 	('isIe 7 Ye' Yr's YO 7, Yr's Ye's Yr's Yen Yes 
41 2 Reverse Flush 5 Yr'S Yes Yes Yes Yes Yes Yen Yen 
42 1 Illoc:Is 	Flush 4 Yes Yr's Yr's Yes Yen Yes Yen Yes 
43 81 015 1 I'Jo'ste 7 Yes Yen Yr's Yen Yes Yen Yr"s Yr's 




CYCLE NAME: 	1ilME1 
NUMBER OF STEPS: 115 
STEP FUNCTION STEP STEP ACTIVE FOR BASES 
SAFE 
NUMBER it NAME TIME A 13 C T 5 6 7 
STEP 
44 1:. it  S 	I o Lo 1 umn I S 1 n 
yes y -?r; Y no Y no 
'IS 4 Fini F Yn Yns Yrs Yno 'uc Yc'c 
Yr's YE's 
46 10 4F13 	to 	rJt' li.' Yr Vt's tr's Yr'S Vt's 
Yr's Yes 
4/ 2 Fnvnr op F- inch u Yr't' Vt's ',r' yr-cs 
Yr's 'no Yr's 
48 1 BIc'cic 	F lush 'I 'r'cs Yns Yes 'ic's 
Yr's Vr'5 Yr-to Yes 
49 '-/ #18 Ic' C;c31 ,,rnr, 20 Yr's Vt's Yr-co V Yes 
'it's Yet' 
1 F-n'vnrocc 	Flush S Yes yos YeS .S Y•' yes Yes Yes 
Yes 
9 #113 	in Folio, F ,) Yr-co Yro Yr Yr's Y Yr'S Yr" 
Yr's 
1J2 2 F:rcv' oe 	F - lu -cl, 5, Yes Yr's Yes Yr-cs Yr'S 
'Er-St Yt'S Vt's 
Y #1P 	in I7r.,Iu,nn 10 Vr-' Yr's Yr's Vt's 'yet, Yes Yr's Yr's 
54 2 11c'versn El ush S Yes Yr's Yes yes Yes Yes 
Yr's V 
9 #113 	Ic, 	Fol,,n,rc II) 'u's yr's Yes Yr's Yet; Yr-s 'u's 
Yes 
56 2 Fever or-' El ,,,cch 3 'rcc'c, Yes Yes 'yr's VerY Yes 
Yes Yes 
3/ 1 F'lrcE 	Fluch  Yes Yr's Yet' Yes Yr's Yr' 
Yr's 
58 33 Cycle Entry 1 Yes Yes Yes Yes Yes Yes Yes 
Yes 
59 10 ii 10 	In 	Flscc,F p 5 cc's, Vt"; Yr-ct' 
'y C". Yrcs 'yet. 'il's 
9 011-I In Column .-:u 'ic-"-c Yr's Yes Yr-c'; Yr's Yes Yr-nY 
Yr's 
61 2 verse Flush IT, 'ire Yes Yet' 'it's 
Vt's Yes 'Yr's Yr' 
62 1 Plock 	F Irish 6 Yes Yes 'u's Yr-cs yin; Ye'; 
'YE'S 
ic Wact p--Fort 1 Yr--s Yr's Yr-s Yr's 'Er-r Yr'S Yrs 
'Yes 
64 3 (lv;cncr-? 	Fl; 1, cs Yes Yr's Y etc Ic-cs Yr-cIF, Yr-cs 
'Yr-cs 
65 112 414 	in Waste 'iris Yr-sc Yes Vt's' 
yr's Yr's 'its. Yr-, 
66 14 1114 Icc 	C1nn,n :0 'Er's yes Yes cc's Yes ns 
Yr-c'; No 
6/ 1' Fir'vrrse Flush 1 'u's Yc.cr; Yr's Yr'S Yr's Yr". 
Yc''' YES 
613 14 01/4 	In 	LToI usri Ti' yes Yr's Ye'; ic's Yr's Yr-cs 
VinY 'Y (to 
69 2 Fic-'vr-'ror I- iunh 1 Yes 'yr's 'yr's Yr's 'ir'c, Ye'' 
Yr's yr's 
/0 14 #14 	In 	LoIU,nfl cl' Yi-ccc'E'° Yr'S Yr'S 'Y'tc" Y( 
Y"S Yt 
Yr's YE'S 'inc 'yrs ins 'jc'cc Yr's  
/1 14 II 14 	In 	Fol ,,n,r, 5., cc's. o Yes Yes Yr's Er's 
Yi)S Yr-cs 
i. I R't'VF'rOt' I1t'li .1 Vt'S' 'Er'S 'it's crc ri - s 
cr'' 'E'' Yr's 
/4 14 #14 	I i-c 	(TnI if (fill ri) 'c Yr- cc Yr-n', cc'; ,,c'c 
Yr's  
hi I F-<nvrr';r' F-lush 5 'i's Yr's 'yr'c.; Ye',  cr' Yr's 'tn' 
Yr-s 
/6 14 4113 	In 	Loins,, -.3 cr-cr 'ins, Yr's Yr's Yr's 
Ycco coY Yet, 
1:3 (IC 	F I-Iu-  I, 1 Y r-'s yes yes Yes f f.,  -1 'Yr's 'Yr 
No 
Ye,; 'ins yr's Y 	w, ;,'s Yr-cs 'i"•; Nn 
7'? 9 1110 	In 	Fc'Iumn 'u yr.':. yes 'us. 'yrt. 'u" ,  Yet 'uS No 
Wi) I Fr'versc' 81 ush S Yr''ieS Yr's 'ir-YS YE'S VEtS 
Ic-cs No 
FF1 14) 018 	In 	I'Js.i p 5 'Yr's 'it'S Yes 'icc's Vi"' Vt's Yr" 
Yr" 
82 9 0111 in tTol 	en ' TO Yes 
y   y,?-,Yr-cs Yns Yes Yr's Yr's 
151 2 Firv€'r or' 	F-i not, IT, 'ic's 'yc•'o Yr's Yr's Yr'c; Yr-'t. 
Yr's Yet' 
84 1 [cluck 	Flush 4 Y fl. eyr's Yes Yes Yr's 
'yr's Yr's Yr-c" 






NUMBER OF STEPS: 
DATE:  
TIME: 	 I 
STEP FUNCTION STEP 51 EP ACTIVE FORBASES 
SAFE 
NUMBER £ NAME TIME A 
Iii 
 S 	C 	T56,,.7.. STEP
1 ['111 	1') 	L'J,-i' 	I p '1 "- 'p 	Vr'U 	'S" i 	I' 	'(flP 
 
I? I I 1 I UI ( '( 	•' 	- ', 'i 
' Vi Vi'.- 	'(i -' 	y 	.,-  V 
- '.' I'i-vc'r'ie 	F1uIi 75) '6•'' 'ifl" 	'ic' 	'c i':,. 	'; Vu'; 
'r'r,  
4 III n( 	I-' I -mi-i 1 . 
UU1,, 5U',. 1 p 	'pn Yr"- 	Vi" 
I LU 	p p r r' P V p 	Vi-'- 'U' I P 	'iF' 	
"U 	 U 
Vc' 'vi '' '(cu 
unii.i IT) r' - (n 	Vu'; 	'(P 	Y'' 	Yr''; 	Vr;u 
1'? flI't[ ' F 	in 	11 	1 V 
yp Yi' 
ti; ciii nun; " (p 'v'p; 	'(rU'. 	')'iUU; 	')''' 	'vji. 	'(PP 
in '  D 	It 	I Ii U 	I CO 	1 7. yr- . ','i ,' 
y 	.'- yç.' Vt-c 'ir"' 
1n 	Pi'vI)IIUUiU' ::. 'i'c.-'i'. 'y'pr; 	'(pu 	
')'nU. 	'jr.; 	'(pU, 	''•, yr- 
i? U'......-1' 'in 	1'(il 	1 'v'i' 'Ut-,''.- 	'iU: 	
U• Vip.- 	5jp (n, 
P TEL 	to 	rulc.unn .', '(r'' Yr'p 'ip': 1 
Yl- Yr"; 	U1'1,, 
4 -16 Pr I If I (II 4 1 
U(-  Vr"; 	j(  
4 Lv 	Ir, 	On I '(p '.; 
'(p p v ic; 	V 	u 	V 	i r' 	'(I V ri 
16 10 - I'll Ii" 'i.UP 1 	r' / 
Vr'. Yr-c. 	Vt';: '(ru '(i- -p 	'I 
17 1 II 	us) E'Iii'ii 
 '(PU: 	'i''; 'i'''. 	'ii''; Vi-'; 
3 'Jii I I I U 	U U U '• '' 	
(5V, Vi''  
IV UUi III 	I Ii' 	f't,I'," 
U' 'v' icP 'i'icp 	'fin;  
'v  r , . (n-. '()'U 	',i ,' 	Yi, 	 ','iU '(r' 
P 	1Yl','S'' 'I'. 	'Si', 'ii''. 




'' '(U 	U. 'i'i. V( 	Y('! ylil'l'  (i 
U, 
711 l?i111 Isp ('()I  'v'r'v 'cr'' 	'vi'; 	'('I'' 	
'(iSU '1 	Y(" Yr'' 
'P I I 	I I 	F 	US 'Ui I 	liii; . _. '(p.'. 'fr-' "'t 	
U ( 	p 
131' imp 	2 	flU - 
 
I -'III 
 U(P_U iU'3' 	'''P 	'U 	Ujr. 'v''.' 
4'? (ii 	("Ip Iii 
'vi 	''-  
i 	oh 	uric i i 'fr', 'v' ic'v 	'ft-'Ii'' 	
' 	ii'' 	' 75 
1 'lv I ri: 	F 	i' 	sI 	liii) 7 Vi ' 
 ""—w')'p ". 	'(S 	'- 'p'P 	'(p'; 	'ii 
71) II 	lu 	ploys, , 
Up 5(ç' 	)U', 	('5''" 	"U'' 	'(S,"ti'l ,  
Sf ,.,.  
7, '7n p., 	to 	r'r'l'iivi,
'it''' 'ii"; 	Yf 
1.1fF 1 'vP'- Yn 	
' 'U-, 	)'U, 	'(r' 	'(,' Yl 
'vt'''  
Ii- 'I 	l'InIi 
I',i ,'i'. ',ip 	'ti:  
'ci;'; '(in'; 	Vi-' 	',  
', 	''v 	't u., 'ii " ,'s'i 	'ii f  Vi 'p 
Il I 'Port' 	rio';), '1 'is", ',•n , 'y', :'P 	
'i' 	"i 	- 'c' 'ci'' 'ii"', 
Yt'r','s "s 






NUMBER OF STEPS: 
S-31 EP FuNCTI[IN S1 EP STEP ACTIVE FOR OASES 
NUMBER £ NAME TIME ASC 1' 5 	67 STEP 
I 	OFF Y,•"r;': if'', 	'r 'if 	 Yr'.; 	'ri'',  
'14' 11r'rfI:.f " I 'vi, 'r'r'', 	',r': 'I c:" 1...... 	'Y'I', 	'y'r'  
"yr's 7 Cii' 	1 rs 	17s 	I '' P. 'yr"; YI-1; 'f''; 	'r , 'f '"'" 'y',- , . 'y', 	,''; 
"IH (;I [,III, I 1111 I Yr'r 'is':' 	''c..... 'it'' 'if'': 	'i'(; Vt'', 
411 I 	"11 I'r'urip 	. Ocr I Yr.""; 'f  Fl. '; Y R 7, 	'iil':-, 'fp", Yp": 	'fp'; 
Iris lo (7rsi 	, i' Yr-n Yt:'r 	Yr":"' V.......Yr:'.' 'fr' 
1 1 'ri''', 'ri':; 'ii:": 	Yy ''; 'cr 	Y"'; 	Yr 
4 11:11 1, Yr'" Vt"'' 	Yr'': Yr''' 'ri'': 'yi:'.. yo'- - 
I_' 1 fl hr. 	W,,  '% I 	p 7 V " 
ro'
L1 1 'r'  i-'" 'r' '7 	.' Yr p 
r1rr"c . Yr."; "i":: 	'fri' i" 'frrn 	'fr",.: 	Vi".: Vi'' 
'cl 1. i,rlr',r:I: 	I I 	'';l', 'I '"i"'', fr"'; Y , " 	','r''" 5''"  
F-li I 	I'' In W;,r'tc' ",r'", 'fr'" 	Yr.'r. Yr:':. fr'.............. Sfç,,  
IC' 	Ir.'r 	Lrrlr_rry',i'r .' 'r' c  '((,,7 	'r''.:n 	Vt''"', 'yr.""' 	'r'r''' 'r 
I_fl 4 W;ai t 'lI_s Yr. , '' 'in" 'fpc, 'fr''  'f 	...., sj , Yr"', 
I_rI_i In Cli' 	ic', 	'yj,'-r",ir" I'' 'if"',' 'fr''' 	Vi'', 	'(pp 'cr'',', 'r'"n: 	'f':"; 
'7' 'ivy rrr:: I 	lyric 'fr 'cr': Yin' ','p' 'y'  I. ", 'in": 	'ri'. 'in:. 
Vp"; 	Yr'', 'fr'- 'r' r: 	Yr'", 'ri'', 
('1 Q ('111 	IC, 	I7n1urrsrr '. 's. '(ç'' 'rr',; 	'it''', Vt'". 'f ,..... V ,r', Yr'' 'fr'' 
2 :' , ;'py' ;"c" 1 	1 r.! 'yr' 	, ',', •'', 'yr' 	, 'ii''' 'yr.:": 	Sr I, 	'fr'"; 'y'y 
'7 lIlt 	in(r'1,'r;r, Try ', .... r 	'''': 	Yr''' ''c'' 'yr." Yr' '.''' Yr'' 
I"lr,r';i'r 4 ""n', ''1"" 'i,: 	'yr'.: 'yr: 	',';'n 	'rn", 
1 i': 	1'hlr:Is " yr., ' ',', 	'': ''p 'cr'':: 'sf '"' 'ri"' 
66 33 Cycle Entry I Yes Yes Yes Yes Yes Yes Yes Yes 
in (.11' 	Is' 	I',r,,'Ir. ', 'f  c 	" I-- 	Y4 Yr'',' 	';,' 	'yy' VI': 
'in'; 4' r'''', ',.'s, fr'; 'cr'. ' 
k( 	I, 	I iris ", c  v - 	f I "I 	, 	ii'', 'ic'' 
7, 1 I 11 1'isr',Ii ,, ',,'.'' 'rn'-, 's's .'. 'fr'', 'i's'' '"n' 
71 c'  W. 	I i-Fr, 	1 i 'i"' 'yr'': 	'yr',. 	'fr''':: 'ri,';:. 	'n 	'sc'' 'cc'' 
r',,Iv,',r',n I'1. I '7':'; 'sn;: 'rn'; 'ii:". 'i'r , 4, 5 ,,.. 'yrs', YI 
IC' LI 	'I I 	's I',cn;'.l 	5'' 'sr' Yr' 
I 	'1 I' I 'I I r" I'rnl rrrrrrc r 4' , 	., 	's r 	''', ',r ', 	: .'. 	'," s'' 	. 'fr 	' Firs 
rr':t, 1 ''i 	''..,r''',r' ','r''''s''.: (F- 
71' ,  11 1 	1 In 	I'r"Irrrr'rrr 'f 's':''' '7'; 	'i's:",  
r-. Ilrr'"Ir  
Is, 	;s , Irr'riir ', Y' _ ' 	f I  
yr ii 1.1.1 	l'ys 	I2'',Irr;rrrr ''r 'yr''.'' 'y's'' 	'r"''"; 	'ri": 'r' r''' 	y',,:; 	'y l"':  
1.11 I"I h 4' 
 
I 'is'''  
141 II'! 	Ii" 	ilsrlccrnrs '' 'cr"'' ''n'', 	Yr.; 	Y, o ',"r'''; 	'r' r"'' 	Y_.: 'cc'': 
'7"'''  
I"Irr,'' 	lIrr''Ir 'I :':''. 'rn" 	'rn"; 	'sr'  
77 lr'r 11.4: ic' I,;',"s' 'ii' I'' ri''' ','' 'y' I'''',  
Is'' '7' fIT 	Is's 	C.:nlu IT, r, '1ff r 	'''"s. s 	'"r'''. 'r' ''''5,'',  




NUIIPER OF STEPS: 
51 LP FUNCTION 51FF 	 STEP ACTIVE FOR POSES 
NIJNOER £ 	NAME TIME A 	G 	C 	T 5 6 	7 STEP 
i:l '' ',r• 
• n 	1 1 . '1' 	• Y 
9 I 	 I 1 c• 
END PROCEDURE 
VERSION 1.34 
PROCEDURE NAME: 	cIc2pr c.nCLI 
NUMBER OF STEPS: 2/ 
DATE: 	 24, 191-1 
TIME: 1).): If,  
S1EP FUNCTION STEP STEP ACTIVE FOR BASES SAFE 
NUMBER # NAME TIME A OCT_-5 6-  7 STEP 
F lush .5.) Sun YPS VP5 Yr's yr'5 Ycss 
2/ $410 	I si 	1,rilir'r.t. IFS Yus, Yr YFn:; Y 	u Yrç 'run Yr's 
is) 11153 Is.) FJ,ssf.p S YHS 555; Yes 555 YP) Yes Yr'S 55'; 
4 1 [sincl 	Flush '5 'run 'run 55's Yc)5' y5C. yr 55's VP", 
Wo j F. 5)5.) 'I 
 
'rr'r Yr's Yc'n Yr; 5r?', 55Sr y-5 
/ 441 	I 	n1 I sc - F I 'r yr's Yr ri. Yr's Sr's yr 
/ 1)) 44115 1 Was tp 5 yr"s yr's yr's Yr's Yp's YU5 5')''; '555 
IrS 1 hJrirl 	F- isIs S 's'r y.'-r Yr's 'sr's yes 'Sr's yr's VP" 
9 4 1'Is', t 9ss Yr's S r'5  y55 'rr'5 5)'s 'sr's Yps Yes 
:7 flis' 	Irs 	1.51 	lcr- t 18 ss' sr. S 5' 5)5 5')) y Y,• 
11 11) 14113 I tIscstc? 2' 'ru; 'ru', Ys'; 'Y v? is''; Yr's Yr's Yr's 
12 111 Of. 	Flush 1 'yr's Yr's Yr's Y f sr's 'Sr- Vs's 
4 Ms ',F: 9s 	's 'r r" 5 yr's '(PS VP" 5r'5 7r 5)59 
11 2 1II) 	In 	tuli c-'rt IS) '5ns'r'', 'yr's ly f s  yp Vu'; 
15 Is) Ff11.3 In WIrr' ' ''r''; yy''; Ye',; S Y.s's Yr'" Sr's V 
15' 1 FsiccI; 	Flsssh '' Yr's Yr" S Vs's Yr's Yr's Yr's Yr'" 
1 / 4 M's t F; 7,.) "- Yr.,  Yr's S 5''V ''3 Vt's S s's V P'S 
III .3 FJu'.is 	in 	11 .5,1 V....... Sr'' Sr Yr's Yr''5 Yr's Yr's Yr 
19 /7 05)) Irs l2nliuc:t is_i, sc's cr"'- Yr''- Yr" yr'', Yr's 'ru-s Yr's 
H F lush 	I 	L'[.IT 9 Yr'' yr's Sc"" Yr's 'H's Yr' Yr's  
2 iYr'',,sr's," F'ls,ssIi f, -.i Yr'" rt'' Y . Vs's 'H''; 
I IrlisrI. 	I lii'sl, 4 Yr  Y Y Y f " (fl'. yr '';,s.'- Yr'S 
lu 4118 In 1"2r) 1 Sr.... ir'' Yr's. 'rr'5 Sr"" 'H''s H'" yr's 
24 2 1418 	I 	12,H,rmn , sr's yr's Yr's Vt"; 'yr's yr's. Sc''; '55.55 
f -lush .,') sc's', yr's 'is'" Ye's Y""c Yr's Sc"'; (P'S 
1 [sIns - i 	Flush I 'H'-- Yr -   5';. 'y-  y ,. yç', y 




PROCEDURE NAME: 	rIeprO3, 
NUMBER OF STEPS: '(4 
BATE: 	 np 24 • 1 'VP'? 
TIME:  
STEP FUNCTION STEP STEP ACTIVE FOR BASES 
SAFE 
NUMBER * NAME TIME A SCTS...6.7 
STEP 
2 Ivr?r';e 	F-ln';h -'t' Vt''; yn'; Vt"; Y"; Ye; Ye'; 
Ye'; Vt' -; 
Onliinin 'in '1€"; 'it;' i';'; y 	'; Vt"; VP'; Vt';' Vt''; 
2)) #1? 	In 	Wi';te 7 Vt"; Vt"; 'it"; 'i';'; Vt"; 
Vt"; Vt"; Ye'; 
4 F PitiCk F lii"h 'n";' iC" Vi"; Vit': 
Yt'! Vt"; Vi';' 
5 'F I'i,ij F 5'n'i 'n's 'tr";yec3'i"z 
yr"; '7p'; Vi VP'; 
6 1 IJitirk 	Fln';h 2- Vt"; '7;"; Vt"; 
Vt)! VP'! 'it"; Yr's Vt's 
VP';'ii j'; ys Ye'; Ye'; Vt's VP'; Vi)'; 
14 2 18'vrr 	1 1 iii,h 'ii"; ' t';' Vt"; 
Vt-;;' irs ye's 'it's Vi"; 
'7 V III  Vt''; i"i Vt"; 
y'; V."; 7;"; Yr's Vt"; 
ii 411 	/ It' 	i.:tiiiinn 7')) Vp'; yps '7;"; Vt"- 'n"; Vt"- Vt's 
Vr' 
14t'','r'rsi'; (1 U-11 S Yes 'in'; V P's Vt''? Yr''; Ye'; ii''; Yes 
12 11 #17 	In [nInen Vt"; Vi"; ye'' 
Vt;' '7;"; Ye'; Vt';' Yr; 
13 '2 F7i"vr'r ';n 	F lush 5 Vt"; Vii'; 
'5 'It"; Vt's 'Ii"; Y"s Vt"; 
14 11 #1/ 	It' Pcjlnnui it) Vt's '7"; Vu"' Vt". 
Yr's Vt" Vt"- Vt"; 
1'S 1' h''ver';p 	Ii n';h / Vt''; 
Y—Yt''; Vi''; Vt"; Vu'" I;s Yr'; 
16 1 F4irurk Flush 5 'fr"; '7;"; /r'; Yr' 
Ye'; 'ic" Vt"- 
17 27 #10 	In 	('si Ir'c;t  Vu"; Vt"; Vt"; 
'it'' ; 'iii'; 'y'uy'; 'H"; Vi"; 
10 Flu'sh 1 'ic';' Vt"! 'it-"; Vt"; Vt"; 
'It"- V et'; V u". 
19 1/ 4th) 	ici 	(:rjhin;'t III Ye'; Ye';'Ye'; 'iuy;; 
VP'; 
20 1: #10 Iti lJt'stt' 5; Vu";' Vu'-"; '7;" 
'7;"- Vp's Vp'; it';' Vet'; 
21 1 titcinI- 	(lush S Yr's 'Ic''; Vi'!! V's 
itt"; 'it';' 'i',' Vi";, 
:2 4 Onit 9)))) Vp;' it;' 'i'c"s Vu";- Ye;'- Vt';' 
V;"; Yr', 
23 27 #10 	In 	I;nllnc. F 113 y s 'in'; Vt"; 
Ye'; 'ye' Vu"'; Vi'? yf,-, 
24 3( #10 iti huJt";tt' VP VU"; Vt"; VP'! 
Yf-" Vt';' Ye;' Vu"; 
25 1 hInd' 	Flush S '7; 
 'Y yes V u"'; Vt''; vu"! 'in'; 
21, 4 Oci F  Vt"; '7'."; Vt"; 
Vt-;'; Vu"'; Vt :'; Vt''; Vt';' 
27 27 410 	In 	(1ohiet-1 11$ Vt)'; 'tt't4 Vt'!; 
Vt-"; 'ii;'! Yuy'; n"! Vu?'; 





4 1,1,-Of 8 .., 'ir;' yc"; 'ii"; Sc-';' 
it''; Vt"; 'ii';'; Vt';- 
21 Lolle:t 18 Vt"; Vt"; 
Vt's ;t;'; it's Yr's Vt's Vt"; 
Vt's '7r;; '7' 'ii' 'ii'; Yu" - Vt's 
31 1 libel 	Flu';h Y-4 Vt"; V'S 
Vt": Yr"; Vt!"! Vt"; 
34 4 Urn t '7'S' Vi';' 'n,.',  it"; Vu"'; 
'it's Vt''  
'513 13 F- 
 
lush 	In 	L:ICI '? y,- 	, 'it"; Vii'; 'it"; ,p'; 
yp'; ye'; Ye'! 
:7/ #in IiJ ::n.tlr;'t. 15 Vt"; Vi"; y F—1 
Yr'S V;" Vt"; 
17 Ii I- 1 ush 	it' 	L;I. 51 ' Vt';' yr's Vt"; 
Vu"'; vt';' 'it"; 'e e';  
1-El 2 F-8,".-er sp F 1n';h 7)) Vi";' Vt';' Vu;' 
Vt,"! V"'V, V;'!. 'Ye'; Vt"; 
,,,4)  4 Vt's Vu";; ii''; 'it';-; Yns it';; Vt' -,; Vt''; 
40 10 It I R 	In 	I'J,i';-t:n 5 , Yi' Vt:'; V'"; 
it's 7 ,-'- Vi'!, It" 
41 9 1418 (a Polu,iin 1'.' Ye;' Vt?'! Vii'; y 
fi"; Vi"; 'ii"? 'VP'; 
42 2 l-1r'vt'rt- e 	1- lush 1') ut's Yr's i'-''; 
'7';-;: ;'r's Vu'-', Vt"- 'Y t"; 
11- 1 FiInt'I 	Flush 1;) 'it';' u'-; yr'"' 
'ii''; ,r';' 'i,' -; ii'" 
44 42 #l() Vent 5 Yrs 'ic'; yp;' 
it'' 'es Vi - "; n''; 
